{"meta":{"query_hash":"32e024ca60d7","filters":{"venue":"Pharmacogenetics and Genomics"},"cohort_total":133,"direct_labels_cover":0,"predictions_cover":133,"exported":133,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/32e024ca60d7","api":"https://metacan.xera.ac/api/v1/cohort?venue=Pharmacogenetics+and+Genomics"},"results":[{"id":"W1267412639","doi":"10.1097/01.fpc.0000189798.11468.6a","title":"P2Y2 receptor polymorphisms and haplotypes in cystic fibrosis and their impact on Ca2+ influx","year":2006,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institutes of Health","keywords":"Haplotype; Receptor; Transfection; Biology; Null allele; Cystic fibrosis; Molecular biology; Single-nucleotide polymorphism; Nonsynonymous substitution; Gene; Internal medicine; Endocrinology; Allele; Genotype; Genetics; Medicine; Genome","score_opus":0.006823673087335146,"score_gpt":0.2417929618242221,"score_spread":0.23496928873688697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1267412639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99946266,0.00018288066,0.00013243187,0.00001794785,0.000004278869,0.0000034040218,0.00007261584,0.0000019339345,0.00012187975],"genre_scores_gemma":[0.99965453,0.000044004697,0.00008822793,0.000007957251,0.000007072185,0.000004399695,0.000053550113,0.0000021159938,0.00013816124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996867,0.00010839786,0.0000300744,0.00008644605,0.000046197685,0.00004217389],"domain_scores_gemma":[0.99948585,0.00020157573,0.00016002044,0.000024190782,0.000028563081,0.000099731755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003666453,0.0003034368,0.00026796447,0.00042078353,0.00024132343,0.00023251429,0.00011394721,0.00038924708,0.0024898802],"category_scores_gemma":[0.0010571298,0.00011488045,0.0002175714,0.00033453427,0.00021350896,0.00015741105,0.00017146736,0.00021400524,0.00020758995],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025375173,0.00011251412,0.96223116,0.00003151009,0.0002514218,0.0016594091,0.0002913336,0.0002884597,0.027336318,0.00009846683,0.00016178733,0.0050001694],"study_design_scores_gemma":[0.00007215802,0.00061617047,0.99289715,0.000014645537,0.00010472371,0.0038524964,0.000124695,0.0006939492,0.0011479156,0.00011089704,0.00035574372,0.0000092746395],"about_ca_topic_score_codex":0.0007488357,"about_ca_topic_score_gemma":0.00055507396,"teacher_disagreement_score":0.0024898802,"about_ca_system_score_codex":0.0000763915,"about_ca_system_score_gemma":0.000077810306,"threshold_uncertainty_score":0.008329511},"labels":[],"label_agreement":null},{"id":"W1416439369","doi":"10.1097/fpc.0000000000000168","title":"ABCC5 and ABCG1 polymorphisms predict irinotecan-induced severe toxicity in metastatic colorectal cancer patients","year":2015,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université du Québec; Ottawa Hospital; Université Laval; University of Ottawa; Centre hospitalier universitaire de Québec","funders":"Canadian Institutes of Health Research","keywords":"Irinotecan; SLCO1B1; Medicine; Internal medicine; FOLFIRI; Oncology; Colorectal cancer; Pharmacogenetics; Pharmacology; Cancer; Genotype; Biology; Genetics; Gene","score_opus":0.028281651985763757,"score_gpt":0.282883618737136,"score_spread":0.25460196675137226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1416439369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99945885,0.00018108527,0.000040868774,0.000027716986,0.0000022239035,0.0000033119513,0.00012468036,0.0000017097017,0.00015949765],"genre_scores_gemma":[0.9996939,0.00003458647,0.00003811324,0.0000097331085,0.0000029511557,0.0000017377331,0.0001302519,6.3862007e-7,0.000088122084],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998636,0.00002900086,0.000012666758,0.000043460244,0.000028782173,0.000022566752],"domain_scores_gemma":[0.9996495,0.000053906777,0.0001448283,0.000019950132,0.000044130218,0.00008775898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019396645,0.0002401709,0.0002640832,0.00031024322,0.00029345314,0.0002599484,0.00014189706,0.00027207445,0.0018360871],"category_scores_gemma":[0.00095730304,0.000098878256,0.00028775528,0.0005078079,0.00014276158,0.000104008424,0.00016733508,0.00024839226,0.00018569524],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002986232,0.000017918861,0.9967945,0.00000926335,0.000059572987,0.00013130507,0.000022525135,0.00009119296,0.0011134344,0.000012942007,0.00009645703,0.0013521772],"study_design_scores_gemma":[0.00001405696,0.00009787502,0.9987686,0.000003754721,0.000046468533,0.0003425844,0.000037428927,0.00037781912,0.00014323188,0.000017528304,0.0001485679,0.0000020515904],"about_ca_topic_score_codex":0.008456067,"about_ca_topic_score_gemma":0.009926577,"teacher_disagreement_score":0.008456067,"about_ca_system_score_codex":0.00028575133,"about_ca_system_score_gemma":0.0002673724,"threshold_uncertainty_score":0.016813695},"labels":[],"label_agreement":null},{"id":"W1966620087","doi":"10.1097/fpc.0b013e328012d0bf","title":"A functional G300S variant of the cysteinyl leukotriene 1 receptor is associated with atopy in a Tristan da Cunha isolate","year":2007,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Atopy; Asthma; Population; Immunology; Leukotriene; Genetics; Receptor; Genetic association; Biology; Gene; Single-nucleotide polymorphism; Medicine; Genotype","score_opus":0.017642803490116047,"score_gpt":0.26148927864802024,"score_spread":0.2438464751579042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966620087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99908984,0.000120546545,0.00010559677,0.000030333256,0.000012226628,0.000024057103,0.00010174628,0.000006016117,0.00050967786],"genre_scores_gemma":[0.9991084,0.000108146036,0.0001313997,0.00004292765,0.000008410201,0.000014567907,0.00012765086,0.000005949842,0.0004524897],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997427,0.000024051138,0.000020975234,0.00010246217,0.000059123635,0.000050649025],"domain_scores_gemma":[0.99963486,0.00006626339,0.00007124526,0.000028619206,0.00005592115,0.0001430892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012777222,0.0009094636,0.0004477175,0.001596039,0.0015367036,0.00038409358,0.0005999305,0.00052538526,0.0033402184],"category_scores_gemma":[0.0005674728,0.0003066343,0.00038932133,0.00097389217,0.0005063192,0.0001380066,0.0006443657,0.0005768627,0.0002091013],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024449213,0.0007565798,0.63919556,0.00016086083,0.00040907547,0.068136975,0.0027572757,0.0001701432,0.26905945,0.00079748133,0.00090868137,0.015203048],"study_design_scores_gemma":[0.000051777948,0.00049049006,0.97028697,0.000030903902,0.00015337087,0.023435941,0.00088200776,0.00042830745,0.0029332514,0.000098631695,0.0011754385,0.000032959055],"about_ca_topic_score_codex":0.045955848,"about_ca_topic_score_gemma":0.046990663,"teacher_disagreement_score":0.045955848,"about_ca_system_score_codex":0.00057171605,"about_ca_system_score_gemma":0.00038763517,"threshold_uncertainty_score":0.09137666},"labels":[],"label_agreement":null},{"id":"W1966810565","doi":"10.1097/fpc.0b013e32830058aa","title":"Altered expression of methylenetetrahydrofolate reductase modifies response to methotrexate in mice","year":2008,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Children's Hospital; McGill University Health Centre","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Methylenetetrahydrofolate reductase; Methotrexate; Antifolate; Hyperhomocysteinemia; Chemistry; Dihydrofolate reductase; Homocysteine; Thymidylate synthase; Internal medicine; Endocrinology; Pharmacology; Antimetabolite; Biochemistry; Biology; Medicine; Chemotherapy; Fluorouracil","score_opus":0.058157279059581346,"score_gpt":0.35559511047765086,"score_spread":0.2974378314180695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966810565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991546,0.0012765311,0.002921861,0.00030524086,0.00005831866,0.00009702648,0.0021124461,0.00035226106,0.0013303579],"genre_scores_gemma":[0.98414296,0.0016701014,0.0044217994,0.00022677275,0.000036988862,0.00021683573,0.0019445892,0.00015540284,0.0071846507],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9992993,0.000119765944,0.00009603916,0.00019975034,0.0001441371,0.00014097389],"domain_scores_gemma":[0.99932146,0.00007277341,0.00031972578,0.00007058642,0.000043281114,0.00017221844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040937678,0.00080309773,0.00056710135,0.0012021908,0.00038111568,0.0005790954,0.0005703788,0.0011925646,0.0029968254],"category_scores_gemma":[0.00025572078,0.000490188,0.0007191443,0.00046080197,0.0006755244,0.00042853123,0.00029692086,0.0015168159,0.001032266],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006213323,0.00015040244,0.0006980376,0.000036481946,0.000017405433,0.00012272036,0.00003466181,0.00007712938,0.9969612,0.00010339069,0.000060834645,0.0011165044],"study_design_scores_gemma":[0.0002838178,0.0027940683,0.017324222,0.000048469676,0.00017875343,0.0013542064,0.00011835112,0.001353118,0.9718704,0.00016587155,0.00447914,0.00002959218],"about_ca_topic_score_codex":0.0010774425,"about_ca_topic_score_gemma":0.0014700566,"teacher_disagreement_score":0.0029968254,"about_ca_system_score_codex":0.0007192488,"about_ca_system_score_gemma":0.00034582394,"threshold_uncertainty_score":0.010025382},"labels":[],"label_agreement":null},{"id":"W1967971645","doi":"10.1097/01.fpc.0000167333.38528.ec","title":"Polymorphisms of MRP1 (ABCC1) and related ATP-dependent drug transporters","year":2005,"lang":"en","type":"review","venue":"Pharmacogenetics and Genomics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Multidrug resistance-associated protein 2; ATP-binding cassette transporter; Biology; ABCC1; Multidrug Resistance-Associated Proteins; Transporter; Pharmacogenomics; Mutagenesis; Subfamily; Genetics; Solute carrier family; Mutation; Biochemistry; Gene","score_opus":0.02459545008453529,"score_gpt":0.30346884519727435,"score_spread":0.27887339511273906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967971645","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7252665,0.22386439,0.007612449,0.0029025516,0.00040493347,0.000193962,0.030425167,0.00044322573,0.008886853],"genre_scores_gemma":[0.91912276,0.052769184,0.005735361,0.00050161604,0.0006176682,0.0001990672,0.017200228,0.00007071204,0.0037835233],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989895,0.00021182232,0.00015770299,0.0003608811,0.00023349104,0.00004659198],"domain_scores_gemma":[0.9986303,0.0005255051,0.00051122956,0.00008503486,0.00016590548,0.00008202201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005285675,0.0005017115,0.0006857197,0.002447912,0.00028908203,0.00057631807,0.000410587,0.00074547925,0.004699115],"category_scores_gemma":[0.002703559,0.00014557898,0.00038926382,0.0040102056,0.00021791602,0.00039301955,0.00029096808,0.00063007744,0.0010452877],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002249292,0.00032817406,0.48093435,0.004131674,0.001269077,0.008824761,0.00075892074,0.0010777185,0.04543658,0.0044186367,0.01600518,0.43456563],"study_design_scores_gemma":[0.00013320494,0.0005966263,0.8285048,0.00043551525,0.0011231829,0.027613359,0.00022402825,0.001237896,0.012757468,0.0021228113,0.12515262,0.000098513636],"about_ca_topic_score_codex":0.0014381455,"about_ca_topic_score_gemma":0.00059205166,"teacher_disagreement_score":0.004699115,"about_ca_system_score_codex":0.00033126917,"about_ca_system_score_gemma":0.00022978807,"threshold_uncertainty_score":0.01572007},"labels":[],"label_agreement":null},{"id":"W1968319279","doi":"10.1097/fpc.0000000000000031","title":"Variation in P450 oxidoreductase (POR) A503V and flavin-containing monooxygenase (FMO)-3 E158K is associated with minor alterations in nicotine metabolism, but does not alter cigarette consumption","year":2014,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Cancer Institute; National Institute on Drug Abuse; Canadian Institutes of Health Research","keywords":"CYP2A6; Nicotine; Monooxygenase; Metabolite; Metabolism; Chemistry; Cotinine; Cytochrome P450; Drug metabolism; Biochemistry; Pharmacology; Biology; Internal medicine; CYP1A2; Medicine","score_opus":0.04835469404427228,"score_gpt":0.3456313863337212,"score_spread":0.2972766922894489,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968319279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99921274,0.00008590821,0.00024889913,0.000015505837,0.0000034811708,0.0000047111967,0.00014604423,0.00000576759,0.00027698444],"genre_scores_gemma":[0.99959034,0.00002546332,0.00011968321,0.000011085657,0.0000036101992,0.0000028096613,0.0001117132,0.0000047665585,0.00013061405],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99945647,0.0001773312,0.000048387457,0.00018790613,0.000068250534,0.00006167244],"domain_scores_gemma":[0.99934036,0.00020835348,0.0002746688,0.00009257188,0.000027149224,0.000056823512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040200015,0.0003283375,0.00028019308,0.0003714488,0.00022140838,0.00023721061,0.00020152383,0.00038753726,0.002545393],"category_scores_gemma":[0.0011702157,0.00016393392,0.0004919795,0.00040897654,0.00034483758,0.0001495796,0.00020406787,0.00028358013,0.00024085611],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027958006,0.000115093244,0.9489225,0.000025427424,0.0004899486,0.0006713375,0.00010792621,0.00013840276,0.040143758,0.00015070559,0.00011207812,0.0063269394],"study_design_scores_gemma":[0.00001936699,0.00025861175,0.99679583,0.0000041757426,0.00008041593,0.000897499,0.00002377494,0.0002790604,0.0013751517,0.00008274877,0.00018022976,0.0000032086434],"about_ca_topic_score_codex":0.0018264506,"about_ca_topic_score_gemma":0.0016062052,"teacher_disagreement_score":0.002545393,"about_ca_system_score_codex":0.00013350222,"about_ca_system_score_gemma":0.00009252219,"threshold_uncertainty_score":0.008515179},"labels":[],"label_agreement":null},{"id":"W1968413239","doi":"10.1097/fpc.0b013e32801a3c10","title":"CYP2D6 genotype in relation to perphenazine concentration and pituitary pharmacodynamic tissue sensitivity in Asians: CYP2D6–serotonin–dopamine crosstalk revisited","year":2007,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; National Alliance for Research on Schizophrenia and Depression","keywords":"Perphenazine; Internal medicine; Endocrinology; CYP2D6; Dopaminergic; Serotonergic; Pharmacology; Prolactin; Dopamine; Pharmacodynamics; Medicine; Antipsychotic; Serotonin; Pharmacokinetics; Schizophrenia (object-oriented programming); Cytochrome P450; Psychiatry; Receptor; Hormone","score_opus":0.03873708750571099,"score_gpt":0.3915192264568302,"score_spread":0.3527821389511192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968413239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99821293,0.00084469863,0.00025675184,0.00010237682,0.000006574904,0.0000063941347,0.00014182957,0.0000063762873,0.00042204474],"genre_scores_gemma":[0.99951625,0.00016223344,0.00011663748,0.000025256857,0.0000088907655,0.0000022277336,0.000059038073,0.0000030599308,0.00010641457],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998024,0.00006428975,0.00002242079,0.00005371948,0.00003542317,0.000021845946],"domain_scores_gemma":[0.9994288,0.00012711625,0.0002465809,0.000060554965,0.00006100454,0.000075846096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000535526,0.00028994514,0.0004173072,0.00033241662,0.0001946943,0.00032779362,0.00018707932,0.0002766937,0.001840489],"category_scores_gemma":[0.00068300945,0.0001327287,0.00040342,0.00076419435,0.0003014156,0.00018013704,0.00014098374,0.00031705384,0.00017466338],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022170825,0.000068135145,0.97013086,0.00005693094,0.0003252856,0.0005941088,0.000268414,0.000098857825,0.017519843,0.000080089034,0.00013151026,0.008508795],"study_design_scores_gemma":[0.000014977908,0.00025275777,0.996917,0.0000057436646,0.00013648256,0.000904222,0.00016403354,0.00021814989,0.001064921,0.00004861954,0.0002687228,0.0000044901426],"about_ca_topic_score_codex":0.0038445867,"about_ca_topic_score_gemma":0.0032757279,"teacher_disagreement_score":0.0038445867,"about_ca_system_score_codex":0.00016282473,"about_ca_system_score_gemma":0.00016493392,"threshold_uncertainty_score":0.007644415},"labels":[],"label_agreement":null},{"id":"W1973442245","doi":"10.1097/fpc.0b013e328328d4d3","title":"Association of MAOA gene functional promoter polymorphism with CSF dopamine turnover and atypical depression","year":2009,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Neurotransmitter Receptor Influence on Behavior","field":"Neuroscience","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Sahlgrenska Universitetssjukhuset; Vetenskapsrådet; Stockholms Läns Landsting","keywords":"Homovanillic acid; Monoamine oxidase A; Monoamine oxidase; Internal medicine; Dopamine; Monoamine neurotransmitter; Endocrinology; 5-Hydroxyindoleacetic acid; Odds ratio; Medicine; Depression (economics); Serotonin; Biology; Enzyme; Biochemistry","score_opus":0.020861142432710127,"score_gpt":0.25638634233384905,"score_spread":0.23552519990113893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973442245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995334,0.00023104511,0.00004027318,0.000015082177,0.0000045495194,0.0000019844395,0.00007174604,0.0000017082712,0.00010023205],"genre_scores_gemma":[0.99975294,0.00005051717,0.000050317198,0.000005892314,0.000005090384,0.0000020855161,0.00007652004,6.765523e-7,0.000056035766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99979633,0.00005785256,0.00002995992,0.00005235957,0.00003332598,0.000030168503],"domain_scores_gemma":[0.99901617,0.00032810122,0.00037074607,0.000043244876,0.00009951952,0.00014223329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025421384,0.00027084842,0.00026367515,0.00045647012,0.00025104027,0.0003455759,0.00016772533,0.0004019764,0.0018925058],"category_scores_gemma":[0.0015275606,0.00016721165,0.0003033636,0.00039155828,0.0002081308,0.00010020552,0.00016162901,0.0002937448,0.00015303907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003206415,0.000018310442,0.99747235,0.000007730522,0.00006433087,0.00018046201,0.000029718856,0.000021518139,0.0010710767,0.000007507377,0.000027631339,0.0007787863],"study_design_scores_gemma":[0.00001550331,0.00016042055,0.9984107,0.000006505272,0.00004447658,0.00093094807,0.000046448913,0.0001754591,0.00013291444,0.000013142864,0.00006175433,0.0000017226572],"about_ca_topic_score_codex":0.002589006,"about_ca_topic_score_gemma":0.0024594748,"teacher_disagreement_score":0.002589006,"about_ca_system_score_codex":0.0001235481,"about_ca_system_score_gemma":0.0001649781,"threshold_uncertainty_score":0.006331086},"labels":[],"label_agreement":null},{"id":"W1977233361","doi":"10.1097/01.fpc.0000189799.88596.04","title":"A single nucleotide polymorphism in CHAT influences response to acetylcholinesterase inhibitors in Alzheimer's disease","year":2006,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Alzheimer Society","keywords":"Acetylcholinesterase; Choline acetyltransferase; Single-nucleotide polymorphism; Cholinergic; Alzheimer's disease; Cholinesterase; Donepezil; SNP; Aché; Internal medicine; Disease; Neurodegeneration; Polymorphism (computer science); Biology; Medicine; Pharmacology; Endocrinology; Psychology; Genetics; Allele; Gene; Dementia; Enzyme; Biochemistry; Genotype","score_opus":0.027485506712048646,"score_gpt":0.3015279755519796,"score_spread":0.27404246883993094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977233361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996062,0.00011817786,0.000082259234,0.000029907837,0.0000052998403,0.0000024465055,0.000040956784,0.00000283305,0.00011197021],"genre_scores_gemma":[0.9997774,0.000025498,0.00007217295,0.000013777786,0.000005713127,0.000002012048,0.000038266375,0.0000017750167,0.00006335872],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999474,0.00022859535,0.00005708467,0.00013678355,0.000056665398,0.000046921028],"domain_scores_gemma":[0.99840015,0.00092650484,0.0003253757,0.000072168856,0.000086708256,0.00018896858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065240473,0.00044296778,0.0004121617,0.00059291197,0.0003087581,0.0003515956,0.00025904537,0.0007031196,0.0018505404],"category_scores_gemma":[0.0025504294,0.0002023375,0.00043615475,0.0006324406,0.00033777248,0.00013649449,0.00014903744,0.00041517388,0.0002100144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026567671,0.00020732294,0.975047,0.000032951906,0.00067709584,0.00090645015,0.00023530348,0.0004099408,0.014758123,0.00007091296,0.00016891395,0.004829226],"study_design_scores_gemma":[0.000059592865,0.00035082357,0.99635726,0.000008957018,0.00024373659,0.00090141536,0.000054824497,0.0009765534,0.00083283766,0.0001063416,0.00010080576,0.0000066833613],"about_ca_topic_score_codex":0.0031937414,"about_ca_topic_score_gemma":0.0025267894,"teacher_disagreement_score":0.0031937414,"about_ca_system_score_codex":0.00018920528,"about_ca_system_score_gemma":0.00019714893,"threshold_uncertainty_score":0.006350279},"labels":[],"label_agreement":null},{"id":"W1977536805","doi":"10.1097/fpc.0b013e3283349eb0","title":"Polymorphic variants in the human bile salt export pump (BSEP; ABCB11): functional characterization and interindividual variability","year":2009,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of General Medical Sciences; National Institutes of Health; National Cancer Institute; National Eye Institute; Vanderbilt University Medical Center","keywords":"Bile Salt Export Pump; Nonsynonymous substitution; Biology; Cholestasis; Progressive familial intrahepatic cholestasis; Single-nucleotide polymorphism; Western blot; Genetics; Molecular biology; Gene; Genotype; Transporter; Internal medicine; Endocrinology; Medicine","score_opus":0.024355838738861907,"score_gpt":0.26852874665858445,"score_spread":0.24417290791972254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977536805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99807286,0.00021683735,0.0013153243,0.000013161028,0.000004276319,0.0000075569137,0.00019895266,0.000008093556,0.0001629064],"genre_scores_gemma":[0.99897194,0.00006353031,0.0005164926,0.000013159147,0.000006762072,0.000007983474,0.00028387472,0.000009316872,0.0001269266],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991999,0.00018524886,0.00010492116,0.00035771797,0.000116997784,0.000035162993],"domain_scores_gemma":[0.99891865,0.00053199823,0.00026311618,0.000141868,0.00009285105,0.000051500694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006402542,0.0002630291,0.0003533867,0.00055339857,0.00017305453,0.00028221885,0.00018355637,0.00033801165,0.0009813261],"category_scores_gemma":[0.0013705179,0.00012754774,0.00022383918,0.000522814,0.00030062956,0.00014545146,0.00020787299,0.000252249,0.00018051256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001329267,0.00011755478,0.760897,0.0001052255,0.0008316639,0.0016362251,0.0006555541,0.00072981545,0.21668455,0.00025147447,0.0002495032,0.016512133],"study_design_scores_gemma":[0.00002410373,0.000246397,0.9784943,0.0000089035775,0.00017029683,0.005747656,0.00012589528,0.0014691962,0.01283783,0.00018247547,0.0006772613,0.000015802865],"about_ca_topic_score_codex":0.00043769582,"about_ca_topic_score_gemma":0.0004123228,"teacher_disagreement_score":0.0009813261,"about_ca_system_score_codex":0.00007617988,"about_ca_system_score_gemma":0.00004871458,"threshold_uncertainty_score":0.0033860207},"labels":[],"label_agreement":null},{"id":"W1977808352","doi":"10.1097/fpc.0b013e3283476a01","title":"Variation in the glucocorticoid receptor gene (NR3C1) may be associated with corticosteroid dependency and resistance in children with Crohn's disease","year":2011,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; McGill University Health Centre; Children's Hospital of Eastern Ontario; Centre Hospitalier Universitaire Sainte-Justine","funders":"Canadian Institutes of Health Research","keywords":"Single-nucleotide polymorphism; Odds ratio; Corticosteroid; Haplotype; Internal medicine; Medicine; Gastroenterology; Glucocorticoid receptor; Genotype; Glucocorticoid; Allele; Endocrinology; Immunology; Biology; Genetics; Gene","score_opus":0.00904682290305552,"score_gpt":0.21954113273286266,"score_spread":0.21049430982980713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977808352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990145,0.0004566577,0.00008738431,0.00004409907,0.0000036680792,0.000004016582,0.0002339092,0.0000039650386,0.00015170056],"genre_scores_gemma":[0.9993529,0.00017505013,0.0001658282,0.000018630906,0.0000054040934,0.0000037100683,0.00017847835,0.0000027791475,0.000097366625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994436,0.00010223739,0.00005716018,0.00018361377,0.00013556879,0.000077767574],"domain_scores_gemma":[0.99872476,0.00031983273,0.00065639935,0.00005901051,0.000113851325,0.00012618442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004242209,0.00041187205,0.0003985038,0.00062553654,0.00040986427,0.00039838106,0.0004119215,0.00044104207,0.0019686185],"category_scores_gemma":[0.0017370377,0.00018758069,0.00042072538,0.0012656383,0.00045939043,0.00016144109,0.00023392764,0.0004704451,0.00015979228],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016722038,0.000010287163,0.99586076,0.000019499928,0.00008056368,0.00031282977,0.000087947345,0.000046001926,0.002035602,0.000020664396,0.000055530152,0.0013030705],"study_design_scores_gemma":[0.0000072593775,0.000037853275,0.9987594,0.0000076199103,0.000044765184,0.00070969755,0.000060406353,0.00006736541,0.00015791885,0.000012986354,0.00013255481,0.000002353516],"about_ca_topic_score_codex":0.027082274,"about_ca_topic_score_gemma":0.0251333,"teacher_disagreement_score":0.027082274,"about_ca_system_score_codex":0.00045420788,"about_ca_system_score_gemma":0.00051290944,"threshold_uncertainty_score":0.05384928},"labels":[],"label_agreement":null},{"id":"W1979374480","doi":"10.1097/01.fpc.0000174786.85238.63","title":"No evidence that polymorphisms in CYP2C8, CYP2C9, UGT1A6, PPARδ and PPARγ act as modifiers of the protective effect of regular NSAID use on the risk of colorectal carcinoma","year":2005,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bishop's University","funders":"","keywords":"Odds ratio; Colorectal cancer; Peroxisome proliferator-activated receptor; CYP2C9; Cytochrome P450; Internal medicine; Confidence interval; Case-control study; Medicine; CYP2C8; Pharmacology; Gastroenterology; Oncology; Endocrinology; Receptor; Cancer; Metabolism","score_opus":0.018083678097104268,"score_gpt":0.2575863891985746,"score_spread":0.2395027111014703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979374480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913386,0.006031831,0.0006116584,0.00033881454,0.000041342082,0.000014111928,0.00018017193,0.000015972362,0.0014275518],"genre_scores_gemma":[0.99821967,0.0009955518,0.00032253665,0.00010526942,0.00004696146,0.0000040028513,0.00012861937,0.0000039174483,0.00017355596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852604,0.000470355,0.00014383436,0.00042295974,0.0003531163,0.000083681116],"domain_scores_gemma":[0.98745126,0.00671387,0.002953218,0.001403465,0.0009445234,0.00053369545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024065408,0.00032765084,0.0005444117,0.0009389861,0.00030875727,0.0006423569,0.000668631,0.0009527731,0.0039145704],"category_scores_gemma":[0.009977605,0.0003015349,0.00080566393,0.0011184019,0.0012025263,0.00026497274,0.00030769993,0.0005370977,0.00028214997],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002872113,0.000083193336,0.9793229,0.00031022416,0.0018980828,0.0005631965,0.00016637676,0.000085037005,0.0059166765,0.00017274973,0.00013436325,0.008475053],"study_design_scores_gemma":[0.00013546714,0.00082729093,0.99231815,0.0000656031,0.0015279347,0.002172928,0.000104354556,0.0001956706,0.0015657395,0.00014986997,0.00092766335,0.000009360855],"about_ca_topic_score_codex":0.002186475,"about_ca_topic_score_gemma":0.001882373,"teacher_disagreement_score":0.0039145704,"about_ca_system_score_codex":0.0002458022,"about_ca_system_score_gemma":0.00039688795,"threshold_uncertainty_score":0.013095498},"labels":[],"label_agreement":null},{"id":"W1979694104","doi":"10.1097/fpc.0b013e32832f3010","title":"Cisplatin pharmacogenetics, DNA repair polymorphisms, and esophageal cancer outcomes","year":2009,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto","funders":"National Cancer Institute","keywords":"ERCC1; Nucleotide excision repair; Cisplatin; DNA repair; Single-nucleotide polymorphism; Hazard ratio; Pharmacogenetics; Biology; Cancer research; Haplotype; Internal medicine; Allele; Oncology; Genetics; Chemotherapy; Confidence interval; Genotype; Medicine; DNA; Gene","score_opus":0.011623152398093767,"score_gpt":0.28286531329898007,"score_spread":0.2712421609008863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979694104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99851745,0.00076333806,0.000117190364,0.0000638101,0.0000041623257,0.000004672667,0.00015995157,0.0000047451913,0.00036473857],"genre_scores_gemma":[0.9996352,0.00010515051,0.000039746847,0.000013531686,0.000004117472,0.0000032855949,0.00011038211,0.0000011601211,0.000087333356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996772,0.00011307252,0.00003436462,0.00008891515,0.00005599418,0.000030474152],"domain_scores_gemma":[0.99890256,0.00041066363,0.00047804037,0.000057917656,0.00005372838,0.000097135446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005547844,0.00017975683,0.0003084839,0.00023871075,0.00012263739,0.00031175715,0.00013915278,0.00030732702,0.0014507856],"category_scores_gemma":[0.0018198738,0.00007565754,0.00037143132,0.00036937406,0.0001712223,0.00016695354,0.00019905706,0.000335519,0.00014578679],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002558543,0.0001013341,0.98603445,0.00003638775,0.0005477182,0.00012535189,0.000018602846,0.00080346095,0.002160261,0.000036874237,0.000098304,0.0074787242],"study_design_scores_gemma":[0.000062611165,0.00057073834,0.99703383,0.000008934578,0.0003200042,0.00033654942,0.000016745737,0.00063915085,0.000664749,0.00009220262,0.00025081896,0.0000036991016],"about_ca_topic_score_codex":0.0006581644,"about_ca_topic_score_gemma":0.00086025905,"teacher_disagreement_score":0.0014507856,"about_ca_system_score_codex":0.00019764392,"about_ca_system_score_gemma":0.00016474955,"threshold_uncertainty_score":0.004853308},"labels":[],"label_agreement":null},{"id":"W1982264959","doi":"10.1097/fpc.0b013e3283331637","title":"A pharmacogenetics study of the human glucuronosyltransferase UGT1A4","year":2009,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Institute of General Medical Sciences; Canadian Institutes of Health Research","keywords":"Biology; Genetics; Coding region; Promoter; Linkage disequilibrium; Gene; Genetic variation; Haplotype; Allele; Gene expression","score_opus":0.0951563878583701,"score_gpt":0.42852828229794054,"score_spread":0.33337189443957044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982264959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927569,0.0032136727,0.0021595587,0.0004916935,0.000024171542,0.000034449473,0.00015568407,0.000015694006,0.0011483612],"genre_scores_gemma":[0.99678683,0.000883797,0.001611005,0.00016379016,0.000067950896,0.000015697911,0.00013645836,0.000006404656,0.0003280613],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99959534,0.00016826949,0.00002275875,0.000116939096,0.00006812657,0.00002851341],"domain_scores_gemma":[0.99939644,0.00030383584,0.0001191712,0.00003885569,0.00006956049,0.00007213142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009670398,0.00039823848,0.00037121924,0.00049901416,0.00025871905,0.00031549888,0.00020005486,0.00038416206,0.00108445],"category_scores_gemma":[0.001367794,0.00011649512,0.00043865605,0.00083037216,0.0002565371,0.0001281021,0.00016651554,0.00044930514,0.00015779847],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004213504,0.00054290856,0.8243684,0.000246938,0.001728259,0.0028255326,0.00029681317,0.0027552142,0.06921031,0.0010304883,0.0008164092,0.09196528],"study_design_scores_gemma":[0.00033584784,0.00399071,0.9435887,0.00006198221,0.0020678607,0.007438504,0.00012199023,0.005667741,0.02487415,0.0011804196,0.010646969,0.000025150446],"about_ca_topic_score_codex":0.0016746034,"about_ca_topic_score_gemma":0.0006136724,"teacher_disagreement_score":0.0016746034,"about_ca_system_score_codex":0.0004348603,"about_ca_system_score_gemma":0.00049220206,"threshold_uncertainty_score":0.0051142573},"labels":[],"label_agreement":null},{"id":"W1982839620","doi":"10.1097/fpc.0b013e32832e2ced","title":"A systems biology network model for genetic association studies of nicotine addiction and treatment","year":2009,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Biomedical Text Mining and Ontologies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"National Institute on Drug Abuse","keywords":"Ontology; Computer science; Genome-wide association study; Data science; Systems biology; Genetic association; Leverage (statistics); Bioinformatics; Artificial intelligence; Biology; Genetics","score_opus":0.04373480546693839,"score_gpt":0.3357536298030357,"score_spread":0.29201882433609727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982839620","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010310625,0.0005926359,0.96660924,0.0042434516,0.00014860324,0.00020484473,0.003657641,0.00045590347,0.01377707],"genre_scores_gemma":[0.33270854,0.0023465778,0.64061916,0.0009694628,0.00020783431,0.0021147407,0.004951633,0.00013176363,0.015950324],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9988574,0.0005442895,0.00007084627,0.0002780176,0.00019219537,0.000057334055],"domain_scores_gemma":[0.99742585,0.001834886,0.00022978966,0.00013398757,0.00026889125,0.00010657632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020740593,0.0008494079,0.0005346345,0.0020673848,0.0009894557,0.0022375751,0.0018370505,0.0014797138,0.006596255],"category_scores_gemma":[0.0062322184,0.00040058073,0.002038592,0.002261142,0.0011510963,0.002398654,0.0014936371,0.0016870905,0.0007790984],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007709702,0.00007284858,0.0031795746,0.00022784014,0.00016793609,0.00033976958,0.00045851464,0.42514107,0.0009912435,0.5410608,0.00510916,0.02317419],"study_design_scores_gemma":[0.00003735441,0.000021552498,0.00049571693,0.00004437901,0.00008294419,0.00010337852,0.000079270314,0.7340136,0.00013720659,0.2464418,0.018526271,0.00001644846],"about_ca_topic_score_codex":0.020181859,"about_ca_topic_score_gemma":0.024742667,"teacher_disagreement_score":0.020181859,"about_ca_system_score_codex":0.0033402517,"about_ca_system_score_gemma":0.003199977,"threshold_uncertainty_score":0.040128767},"labels":[],"label_agreement":null},{"id":"W1986975701","doi":"10.1097/fpc.0b013e328348c6f2","title":"PharmGKB summary","year":2011,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of General Medical Sciences; National Institute of Mental Health; U.S. Department of Veterans Affairs","keywords":"Biology; Computational biology","score_opus":0.06969703173788677,"score_gpt":0.2948409967919357,"score_spread":0.22514396505404893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986975701","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016369636,0.037178952,0.0021619855,0.0682962,0.020799622,0.0011550332,0.065356955,0.003579857,0.7998345],"genre_scores_gemma":[0.01176366,0.04993568,0.0019367187,0.02550898,0.015029765,0.0007101042,0.05410509,0.001025827,0.8399841],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99907994,0.00015540051,0.000082878374,0.00014580258,0.00038670684,0.00014926319],"domain_scores_gemma":[0.9983411,0.00015086679,0.00015812664,0.0000848519,0.00055377686,0.0007112588],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012269901,0.0011659347,0.0014080838,0.0014124621,0.00055427756,0.0031147597,0.0015752615,0.0024157164,0.590679],"category_scores_gemma":[0.003828082,0.00036729057,0.00082165125,0.0014988597,0.00024745998,0.0011624868,0.0010188931,0.0023129785,0.49090752],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023704504,0.0000273803,0.000085452084,0.0002811194,0.000010993439,0.00006959447,0.0000038847525,0.000044969405,0.00014557948,0.0004169194,0.9286165,0.07006049],"study_design_scores_gemma":[0.00023087661,0.00007794029,0.00033446515,0.0002047776,0.000013152538,0.00014320588,0.0000057752823,0.00004702457,0.00012189303,0.0003819441,0.99843305,0.000005845076],"about_ca_topic_score_codex":0.0014945534,"about_ca_topic_score_gemma":0.0023967035,"teacher_disagreement_score":0.590679,"about_ca_system_score_codex":0.001175257,"about_ca_system_score_gemma":0.002206535,"threshold_uncertainty_score":0.5838467},"labels":[],"label_agreement":null},{"id":"W1987967354","doi":"10.1097/fpc.0b013e328323f66c","title":"Genetic variations in UGT1A1 and UGT2B7 and endometrial cancer risk","year":2009,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Neonatal Health and Biochemistry","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Toronto Centre for Phenogenomics","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute; National Heart, Lung, and Blood Institute; Health Canada; National Institutes of Health","keywords":"Endometrial cancer; Pharmacogenetics; Biology; UGT2B7; Oncology; Genetics; Internal medicine; Medicine; Cancer; Genotype; Gene","score_opus":0.014605694198228467,"score_gpt":0.32141796823521585,"score_spread":0.30681227403698735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987967354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990017,0.0005213191,0.00010940903,0.000044072272,0.0000027826413,0.0000041053454,0.00007099022,0.0000018848415,0.00024381733],"genre_scores_gemma":[0.99933666,0.00018586247,0.0002143011,0.000017070302,0.0000057308607,0.0000051517204,0.00009099652,0.0000016244314,0.00014255273],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99941623,0.00027574715,0.00004138624,0.000097588105,0.000109203786,0.000059875383],"domain_scores_gemma":[0.9990995,0.0004043974,0.00025034513,0.00006410012,0.0000664532,0.000115189796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006380283,0.00021714115,0.00030751165,0.00068581157,0.0002358217,0.00029654772,0.00020161705,0.00034658238,0.0013525216],"category_scores_gemma":[0.003809453,0.00019502966,0.00025404472,0.00064754207,0.0002802329,0.00014737288,0.0001980463,0.00026820373,0.00012588273],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037867023,0.0000350654,0.992385,0.000015802549,0.0001444118,0.0002839568,0.0001428895,0.00012529042,0.002167854,0.00012981633,0.00008095639,0.004110252],"study_design_scores_gemma":[0.000024192652,0.00016064077,0.99700975,0.000011975832,0.00011224485,0.0008076243,0.000073274095,0.00047273908,0.0007084074,0.00018692539,0.00042738547,0.000004797604],"about_ca_topic_score_codex":0.0051634824,"about_ca_topic_score_gemma":0.0042760214,"teacher_disagreement_score":0.0051634824,"about_ca_system_score_codex":0.00024717866,"about_ca_system_score_gemma":0.00020423779,"threshold_uncertainty_score":0.0102669},"labels":[],"label_agreement":null},{"id":"W1991546902","doi":"10.1097/fpc.0b013e32833bba25","title":"Evolution of detoxifying systems: the role of environment and population history in shaping genetic diversity at human CYP2D6 locus","year":2010,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Children's & Women's Health Centre of British Columbia; Child and Family Research Institute","funders":"","keywords":"Biology; Locus (genetics); Genetic variation; Genetics; Allele; Population; Genetic diversity; Confounding; Evolutionary biology; Gene; Demography","score_opus":0.0648848010729666,"score_gpt":0.3244512909148713,"score_spread":0.25956648984190467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991546902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99726284,0.00092639646,0.0011208248,0.00012078806,0.000004788148,0.0000047062917,0.00009798353,0.0000052211426,0.00045650415],"genre_scores_gemma":[0.99929905,0.00020126953,0.0003125966,0.000022533564,0.000008514567,0.000002313977,0.000051916708,0.0000030655392,0.00009872564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99956244,0.000194067,0.000022811695,0.00014550953,0.000041365383,0.00003386095],"domain_scores_gemma":[0.9995479,0.00020921319,0.00011667846,0.000041069226,0.00003079615,0.000054366184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071082276,0.00018310921,0.00024367667,0.0005757536,0.00028681115,0.000377691,0.00018815554,0.00041788383,0.0013174126],"category_scores_gemma":[0.0010773742,0.00012865601,0.0002543855,0.0006553281,0.00051495316,0.00032455433,0.00027937815,0.00033022638,0.00014203448],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049850706,0.000056813242,0.9309561,0.000052125466,0.00040615626,0.0004491883,0.0005235607,0.0008864169,0.04225832,0.0005791473,0.000093060975,0.023240447],"study_design_scores_gemma":[0.000009805403,0.00009462262,0.9956974,0.000008962146,0.000067989815,0.0005584868,0.00015424733,0.0010871731,0.0013827974,0.00043582622,0.0004928542,0.000009838825],"about_ca_topic_score_codex":0.00091117877,"about_ca_topic_score_gemma":0.0012478973,"teacher_disagreement_score":0.0013174126,"about_ca_system_score_codex":0.00015727092,"about_ca_system_score_gemma":0.00010580726,"threshold_uncertainty_score":0.0044071674},"labels":[],"label_agreement":null},{"id":"W1995013829","doi":"10.1097/fpc.0b013e32835d9b0b","title":"The LCS6 polymorphism in the binding site of let-7 microRNA to the KRAS 3′-untranslated region","year":2013,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saint Paul University","funders":"","keywords":"KRAS; Colorectal cancer; Internal medicine; Genotype; Medicine; Oncology; Allele; Pharmacogenetics; Chemotherapy; Single-nucleotide polymorphism; Cancer; Biology; Genetics; Gene","score_opus":0.02180236331550997,"score_gpt":0.2787751533284489,"score_spread":0.25697279001293893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995013829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977307,0.00047242042,0.00077071914,0.000075063115,0.000041081796,0.000024829578,0.00030457237,0.000021640908,0.00055898266],"genre_scores_gemma":[0.998796,0.00005925067,0.0004820269,0.000045947385,0.000022944998,0.00001415466,0.00019897362,0.0000072410025,0.0003733457],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996197,0.00011045718,0.000051560928,0.000103832324,0.00008195699,0.000032431857],"domain_scores_gemma":[0.99948126,0.00020567523,0.00017429049,0.00003690801,0.000037153062,0.000064711545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002492304,0.00034635945,0.00035608062,0.0004550469,0.0002704111,0.00021734124,0.00016022955,0.00052302785,0.003696999],"category_scores_gemma":[0.00084902154,0.00014750924,0.000482286,0.00036126288,0.00024580242,0.000106507956,0.00014037473,0.00038589764,0.00059564604],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010276618,0.0005484944,0.6430319,0.00022219936,0.0008157094,0.0032913836,0.0003907458,0.0010148976,0.30975363,0.00090129144,0.0010873864,0.028665805],"study_design_scores_gemma":[0.0003468833,0.0036052035,0.93269217,0.000095340794,0.0006322805,0.0125409085,0.00018795868,0.004407793,0.03876747,0.00072945445,0.005944965,0.000049669048],"about_ca_topic_score_codex":0.0005022364,"about_ca_topic_score_gemma":0.0006083043,"teacher_disagreement_score":0.003696999,"about_ca_system_score_codex":0.0001466813,"about_ca_system_score_gemma":0.00014514569,"threshold_uncertainty_score":0.012367725},"labels":[],"label_agreement":null},{"id":"W1995565483","doi":"10.1097/01213011-200502000-00007","title":"Nicotine metabolism: the impact of CYP2A6 on estimates of additive genetic influence","year":2005,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"CYP2A6; Cotinine; Zygosity; Nicotine; Pharmacogenetics; Metabolite; Heritability; Genotype; Genetic variation; Biology; Drug metabolism; Pharmacokinetics; Pharmacology; Genetics; Metabolism; Internal medicine; Medicine; Endocrinology; Gene; CYP1A2; Cytochrome P450","score_opus":0.052108970261283416,"score_gpt":0.4206246086507744,"score_spread":0.368515638389491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995565483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95314294,0.0023708502,0.041776735,0.00031818758,0.00007582691,0.000061723964,0.00047215837,0.00007310613,0.0017085006],"genre_scores_gemma":[0.99209106,0.00028143075,0.006959333,0.00006358653,0.000030978073,0.000029561399,0.00019457605,0.000046319554,0.00030315766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9811396,0.014305947,0.0005522408,0.0019478664,0.0017539861,0.0003003618],"domain_scores_gemma":[0.9670156,0.026120054,0.0014183989,0.0041716504,0.0009049401,0.0003693536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014120663,0.0008837639,0.0014194159,0.0007662347,0.0006612946,0.0008017833,0.0008300949,0.0007016604,0.00096250506],"category_scores_gemma":[0.05606059,0.00037402342,0.0016082673,0.0013971739,0.00071747025,0.000678355,0.0009947148,0.0012792898,0.00022672709],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013960496,0.000074212505,0.94876176,0.00007909303,0.003710482,0.0010414618,0.00038480695,0.004412067,0.008390114,0.0012139059,0.00032287423,0.03021318],"study_design_scores_gemma":[0.000044117234,0.00044982994,0.9664437,0.00002594426,0.0019824763,0.0022562637,0.00012863634,0.023597246,0.0022467892,0.0020158056,0.00076546567,0.000043706663],"about_ca_topic_score_codex":0.009951939,"about_ca_topic_score_gemma":0.009929005,"teacher_disagreement_score":0.014120663,"about_ca_system_score_codex":0.00032505134,"about_ca_system_score_gemma":0.0004635376,"threshold_uncertainty_score":0.07467812},"labels":[],"label_agreement":null},{"id":"W1999429952","doi":"10.1097/fpc.0b013e32833a6d4a","title":"A single-nucleotide polymorphism of alanine to threonine at position 163 of the human angiotensin II type 1 receptor impairs Losartan affinity","year":2010,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Renin-Angiotensin System Studies","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"Canadian Institutes of Health Research; Health Canada","keywords":"Losartan; Alanine; Threonine; Angiotensin II; Single-nucleotide polymorphism; Pharmacogenetics; Pharmacology; Receptor; Polymorphism (computer science); Chemistry; Biology; Genetics; Biochemistry; Genotype; Gene; Amino acid; Serine; Phosphorylation","score_opus":0.022185034797605883,"score_gpt":0.2756456542692869,"score_spread":0.253460619471681,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999429952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978021,0.00015976535,0.0013047336,0.000067069916,0.0000412845,0.000023616212,0.00018757432,0.000047267506,0.00036658577],"genre_scores_gemma":[0.9983164,0.00009275772,0.000742954,0.00005665161,0.000013973491,0.00001794124,0.0001395986,0.000026829372,0.00059287576],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99968743,0.00007411905,0.000050275245,0.00007603885,0.000064887194,0.00004731506],"domain_scores_gemma":[0.9996705,0.0000833754,0.000118658776,0.000026800175,0.00001306287,0.00008756804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022549352,0.00052724086,0.00042922012,0.00020444862,0.00016928464,0.00022856225,0.00026650022,0.00046177045,0.0044316147],"category_scores_gemma":[0.00026888144,0.00019062131,0.00044052541,0.00015706022,0.00039147784,0.00010231146,0.00023060871,0.00079266826,0.0007891772],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009168956,0.00021684937,0.001013546,0.000035965586,0.00004318934,0.00079465,0.00003134731,0.0001473959,0.9947983,0.00011613233,0.000103679464,0.0017820268],"study_design_scores_gemma":[0.00052476133,0.005778682,0.08702043,0.000060828435,0.0003324287,0.013618344,0.00020090649,0.0074485317,0.88029766,0.00040524398,0.004230563,0.00008161641],"about_ca_topic_score_codex":0.0005823719,"about_ca_topic_score_gemma":0.00050757756,"teacher_disagreement_score":0.0044316147,"about_ca_system_score_codex":0.00017805675,"about_ca_system_score_gemma":0.00019289895,"threshold_uncertainty_score":0.014825225},"labels":[],"label_agreement":null},{"id":"W2003227063","doi":"10.1097/fpc.0b013e3283527c1c","title":"CYP2A6 and CYP2B6 genetic variation and its association with nicotine metabolism in South Western Alaska Native people","year":2012,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; Centre for Addiction and Mental Health; University of Toronto","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institute on Drug Abuse; U.S. Public Health Service","keywords":"CYP2A6; Cotinine; Nicotine; CYP2B6; Population; Medicine; Nicotine replacement therapy; Genotype; Demography; Physiology; Metabolism; Pharmacology; Internal medicine; Genetics; Biology; Environmental health; Gene; Cytochrome P450","score_opus":0.042490101905294606,"score_gpt":0.34686930900466045,"score_spread":0.30437920709936583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003227063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99945706,0.00017729781,0.000038177543,0.000015160495,0.0000027626459,0.000002045455,0.00007179422,0.0000013058329,0.00023446651],"genre_scores_gemma":[0.9996203,0.000075522024,0.00006500051,0.0000061664177,0.00000384683,0.0000021759377,0.000049811388,6.2858595e-7,0.00017661187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999871,0.000031347558,0.000016485703,0.000036143912,0.000031563668,0.000013478227],"domain_scores_gemma":[0.999814,0.000032841002,0.00007135281,0.000012606755,0.000027472259,0.00004181978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022276228,0.0001481348,0.00014000766,0.00030848949,0.00034074674,0.00024958278,0.00009999704,0.0002082942,0.0015753807],"category_scores_gemma":[0.0004835148,0.00011063301,0.00017104346,0.00045730107,0.00013413308,0.00010683162,0.0001243881,0.00018781246,0.00012237257],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015864782,0.00003445509,0.9967451,0.000010505424,0.00006351068,0.00011255491,0.00016764732,0.00004425902,0.0008647186,0.000021264466,0.000057619978,0.0017196416],"study_design_scores_gemma":[0.0000038561348,0.00004387326,0.99930215,0.0000032998591,0.000022323484,0.00022474604,0.00011977519,0.0001001015,0.000056431007,0.000020118006,0.00010209968,0.0000012931422],"about_ca_topic_score_codex":0.011493491,"about_ca_topic_score_gemma":0.00858394,"teacher_disagreement_score":0.011493491,"about_ca_system_score_codex":0.000102807106,"about_ca_system_score_gemma":0.00009027565,"threshold_uncertainty_score":0.022853196},"labels":[],"label_agreement":null},{"id":"W2003529763","doi":"10.1097/fpc.0b013e3280119d50","title":"Polymorphisms predicted to alter function in Prostaglandin E2 synthase and Prostaglandin E2 receptors","year":2007,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada)","funders":"National Cancer Institute","keywords":"Prostaglandin E2 receptor; Prostaglandin E2; Prostaglandin; Biology; Receptor; Pharmacogenetics; Genetics; Gene; Pharmacology; Endocrinology; Genotype","score_opus":0.011150872605943073,"score_gpt":0.26682917204319945,"score_spread":0.2556782994372564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003529763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99727196,0.0003417971,0.0012041865,0.000077325196,0.00001753577,0.000026430213,0.0004959724,0.00001714768,0.0005475425],"genre_scores_gemma":[0.99808025,0.00007755536,0.0011868936,0.000053722873,0.000017522056,0.000017152039,0.00033844323,0.000006766676,0.00022175538],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996705,0.00012774156,0.00004369669,0.00006608388,0.00005277547,0.000039148883],"domain_scores_gemma":[0.99933064,0.0003956758,0.0001589194,0.000027740241,0.000033625674,0.00005343697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039574775,0.00051424635,0.0003125389,0.0005776123,0.00028507566,0.0002126127,0.00018486986,0.00045346247,0.0035105625],"category_scores_gemma":[0.0011275327,0.00009696401,0.00037151948,0.0005774508,0.00031075385,0.000121930876,0.00014019161,0.0003296215,0.00030669218],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049660024,0.0004447121,0.80052274,0.00029003393,0.00094231556,0.0075571826,0.00041548014,0.0035119955,0.14424022,0.0012429619,0.001029408,0.034837],"study_design_scores_gemma":[0.00035198126,0.0011002251,0.9332983,0.00009360015,0.0009418492,0.015388308,0.0002258798,0.006753137,0.03594205,0.0012912727,0.004568521,0.000045011424],"about_ca_topic_score_codex":0.00079499173,"about_ca_topic_score_gemma":0.0009767282,"teacher_disagreement_score":0.0035105625,"about_ca_system_score_codex":0.00013131498,"about_ca_system_score_gemma":0.00019576708,"threshold_uncertainty_score":0.011744022},"labels":[],"label_agreement":null},{"id":"W2003590529","doi":"10.1097/fpc.0b013e3282f63f29","title":"Synergistic effect of apolipoprotein E ε4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease","year":2008,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Butyrylcholinesterase; Apolipoprotein E; Rivastigmine; Internal medicine; Allele; Placebo; Psychology; Cognitive decline; Alzheimer's disease; Dementia; Oncology; Medicine; Gastroenterology; Endocrinology; Acetylcholinesterase; Disease; Pathology; Genetics; Donepezil; Biology; Biochemistry","score_opus":0.032236499766970954,"score_gpt":0.3360214035230987,"score_spread":0.30378490375612777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003590529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99784064,0.0016255663,0.000050519408,0.000035258647,0.0000104972005,0.000019054654,0.000039795465,0.0000058830237,0.00037279958],"genre_scores_gemma":[0.99918073,0.0003552647,0.0001705094,0.000030339053,0.000016727374,0.00001669155,0.00005317758,0.0000013750332,0.00017517844],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99933064,0.00037963004,0.00004497802,0.0000922764,0.00007511963,0.000077233904],"domain_scores_gemma":[0.99800235,0.0008882728,0.0005051259,0.000106192005,0.00009244617,0.00040561],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015055793,0.0005248987,0.0009828587,0.00021281064,0.00023449752,0.00042115818,0.0003071384,0.0004956817,0.0016173519],"category_scores_gemma":[0.0026392546,0.00023730064,0.00087585906,0.00016521882,0.0002856312,0.00023131141,0.00041293824,0.000410988,0.00012278388],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.49345124,0.007050783,0.34221113,0.0011160566,0.008787382,0.00095253764,0.00029272572,0.0017675159,0.045002356,0.00016376481,0.0005411808,0.098663345],"study_design_scores_gemma":[0.010067847,0.15962355,0.80841136,0.000101198864,0.00766809,0.0012215886,0.00018859866,0.0012587593,0.009429525,0.00027671733,0.0017155433,0.00003715648],"about_ca_topic_score_codex":0.00040072642,"about_ca_topic_score_gemma":0.0010008432,"teacher_disagreement_score":0.0016173519,"about_ca_system_score_codex":0.00018881456,"about_ca_system_score_gemma":0.00032674684,"threshold_uncertainty_score":0.007962406},"labels":[],"label_agreement":null},{"id":"W2004256112","doi":"10.1097/01213011-200503000-00008","title":"Ethnic variation in CYP2A6*7, CYP2A6*8 and CYP2A6*10 as assessed with a novel haplotyping method","year":2005,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canada Research Chairs; Centre for Addiction and Mental Health; University of Toronto","funders":"National Institute on Alcohol Abuse and Alcoholism; University of Toronto","keywords":"CYP2A6; Haplotype; Allele; Genetics; Single-nucleotide polymorphism; Biology; Allele frequency; SNP; Genotype; Gene","score_opus":0.1199717370528832,"score_gpt":0.45728655851368316,"score_spread":0.33731482146079994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004256112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9740484,0.0006681782,0.0207938,0.00012718204,0.000021404734,0.00018776166,0.0021223687,0.000105897634,0.0019251241],"genre_scores_gemma":[0.9728617,0.00036047597,0.022835642,0.00009614787,0.000014904083,0.00014138619,0.0015603163,0.000026973064,0.0021024325],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991091,0.00017483546,0.000046919016,0.0003038632,0.00028545552,0.00007982168],"domain_scores_gemma":[0.9996099,0.00007117625,0.000108248416,0.00006388369,0.0001006498,0.000046186207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005824887,0.00034302144,0.00033404093,0.0007881461,0.00045155417,0.00027988205,0.00032278927,0.000277935,0.0010951177],"category_scores_gemma":[0.0008257688,0.00012743092,0.0002328091,0.0007995428,0.00030648464,0.00007670904,0.0002791207,0.0003415916,0.00024282504],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010387473,0.00022126595,0.41980767,0.00015697739,0.00064571475,0.00065240543,0.0015044047,0.0010349349,0.49014854,0.00076272024,0.0013995472,0.082627036],"study_design_scores_gemma":[0.00007690845,0.00032275927,0.920229,0.000016417333,0.0003070772,0.0023078183,0.00022013902,0.0026483263,0.0656245,0.00019383099,0.0079937745,0.000059334594],"about_ca_topic_score_codex":0.028862024,"about_ca_topic_score_gemma":0.060068518,"teacher_disagreement_score":0.028862024,"about_ca_system_score_codex":0.00039392823,"about_ca_system_score_gemma":0.00046319907,"threshold_uncertainty_score":0.057388067},"labels":[],"label_agreement":null},{"id":"W2005144917","doi":"10.1097/01213011-200503000-00006","title":"Identification and functional characterization of variants in human concentrative nucleoside transporter 3, hCNT3 (SLC28A3), arising from single nucleotide polymorphisms in coding regions of the hCNT3 gene","year":2005,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Biology; Biochemistry; Nucleoside; Gene; Molecular biology; Uridine; Genetics; RNA","score_opus":0.016983959394940924,"score_gpt":0.2384452742649581,"score_spread":0.22146131487001716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005144917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999376,0.0000944641,0.00028914202,0.000011761983,0.0000030374442,0.00000458762,0.0001513984,0.0000033569988,0.00006636891],"genre_scores_gemma":[0.9984022,0.00006533134,0.00076045055,0.000037596037,0.0000057069997,0.000008015315,0.00047923636,0.000008763765,0.00023270462],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998721,0.000016205078,0.000016161308,0.000051248,0.0000295388,0.000014683904],"domain_scores_gemma":[0.99982315,0.00005057191,0.000053431144,0.000016224758,0.000026647926,0.000029983905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015363563,0.0002672376,0.00019085848,0.0001686119,0.00013226364,0.00020733832,0.00013546807,0.00037715185,0.0008770194],"category_scores_gemma":[0.0003775058,0.00007878587,0.00024147051,0.00018215129,0.00020758955,0.00007554558,0.00009658335,0.00019639937,0.00023688268],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010390147,0.00008831085,0.08602329,0.00006332127,0.0001021238,0.0023043316,0.00023658441,0.00022526912,0.9040553,0.00012917182,0.00012868934,0.0056045693],"study_design_scores_gemma":[0.00018174399,0.0012718874,0.6638933,0.000028695149,0.00024727057,0.023451718,0.0003005619,0.0038856817,0.30304515,0.00016427517,0.0034987065,0.000031018273],"about_ca_topic_score_codex":0.0015760792,"about_ca_topic_score_gemma":0.0016874912,"teacher_disagreement_score":0.0015760792,"about_ca_system_score_codex":0.00017166253,"about_ca_system_score_gemma":0.00010599539,"threshold_uncertainty_score":0.0031337738},"labels":[],"label_agreement":null},{"id":"W2006042795","doi":"10.1097/fpc.0b013e328337ce3e","title":"Influence of serotonin 3A and 3B receptor genes on clozapine treatment response in schizophrenia","year":2010,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research","keywords":"Clozapine; Schizophrenia (object-oriented programming); Antipsychotic; Haplotype; Pharmacogenetics; Internal medicine; Medicine; Pharmacology; Allele; Genotype; Gene; Biology; Genetics; Psychiatry","score_opus":0.01794174555324397,"score_gpt":0.3135962388660124,"score_spread":0.29565449331276844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006042795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99965215,0.00010345613,0.000030061286,0.000030507672,0.0000021936653,0.0000018349783,0.00004710121,0.0000024903375,0.00013020125],"genre_scores_gemma":[0.9997807,0.000034905937,0.00003612542,0.000022214283,0.0000023960417,0.0000017903883,0.000048334055,0.0000023218672,0.00007109655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994362,0.0002916392,0.000052309075,0.0000732497,0.00009729556,0.000049232094],"domain_scores_gemma":[0.9993174,0.00030230946,0.00021089816,0.00003947733,0.00003151901,0.00009840551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042252845,0.00023936598,0.00035373287,0.00040198216,0.00018376303,0.00032769522,0.000089683446,0.00029647534,0.0011897157],"category_scores_gemma":[0.0015613486,0.00013872645,0.00040322373,0.0004335623,0.00021064292,0.00008394359,0.00010940066,0.00023343881,0.00018716336],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0102293,0.00024775122,0.8966455,0.00003698373,0.0008616505,0.0011716015,0.00034330323,0.0006110667,0.07192212,0.0000725194,0.0002227645,0.017635386],"study_design_scores_gemma":[0.000033201635,0.00024374411,0.9983132,0.0000024295525,0.00006208765,0.00026731813,0.00003889617,0.00026446165,0.00067783037,0.000022420918,0.00007046512,0.000004017293],"about_ca_topic_score_codex":0.0039952616,"about_ca_topic_score_gemma":0.0070216297,"teacher_disagreement_score":0.0039952616,"about_ca_system_score_codex":0.00034143968,"about_ca_system_score_gemma":0.00020401379,"threshold_uncertainty_score":0.007944047},"labels":[],"label_agreement":null},{"id":"W2008263103","doi":"10.1097/fpc.0000000000000008","title":"Expression of UGT2B7 is driven by two mutually exclusive promoters and alternative splicing in human tissues","year":2013,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Exon; UGT2B7; Biology; Promoter; Alternative splicing; Glucuronidation; Molecular biology; Kidney; Gene expression; Gene; Genetics; Enzyme; Biochemistry","score_opus":0.05437189203628639,"score_gpt":0.40985482682499225,"score_spread":0.35548293478870585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008263103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98516756,0.0022092254,0.010323413,0.00008209337,0.000016859885,0.000040642804,0.0007357781,0.00010919128,0.0013151797],"genre_scores_gemma":[0.9815307,0.001305027,0.011456207,0.000052527823,0.000027713657,0.0000828736,0.0037134236,0.000050074716,0.0017813278],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996222,0.000045793884,0.000022332038,0.00012998334,0.00013851497,0.000041213967],"domain_scores_gemma":[0.9997099,0.00006293057,0.00009959613,0.00002575879,0.000060621234,0.000041056694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022976704,0.0002644831,0.00023143471,0.00049681525,0.00017740193,0.00047311612,0.0001481259,0.00023802304,0.0010641366],"category_scores_gemma":[0.00038205672,0.0002388863,0.00025934956,0.00034489774,0.00029265686,0.00010934998,0.00027425482,0.0002740337,0.00064863963],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024829383,0.000020147592,0.0049839607,0.00007512658,0.000017616032,0.0002179425,0.00010977299,0.00010222595,0.9878493,0.00029600546,0.00009643869,0.0059830826],"study_design_scores_gemma":[0.00007786757,0.0005129946,0.08442292,0.00006254055,0.00011799067,0.0061677205,0.00022041773,0.0030541227,0.891662,0.0004452694,0.013228993,0.000027064838],"about_ca_topic_score_codex":0.00068763294,"about_ca_topic_score_gemma":0.0008738417,"teacher_disagreement_score":0.0010641366,"about_ca_system_score_codex":0.00028385225,"about_ca_system_score_gemma":0.00031786558,"threshold_uncertainty_score":0.003559947},"labels":[],"label_agreement":null},{"id":"W2009516154","doi":"10.1097/01.fpc.0000197468.16126.cd","title":"A sensitive and rapid alternative to HLA typing as a genetic screening test for abacavir hypersensitivity syndrome","year":2006,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital","funders":"National Medical Research Council; National Health and Medical Research Council","keywords":"Abacavir; Human leukocyte antigen; Typing; Pharmacogenetics; Genetics; Allele; Biology; Medicine; Genotype; Gene; Antigen; Virus","score_opus":0.02290837751607754,"score_gpt":0.29340124132038037,"score_spread":0.2704928638043028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009516154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96506375,0.0018538367,0.02729364,0.0003223106,0.00013573763,0.00046868218,0.0009442704,0.0002648283,0.0036528378],"genre_scores_gemma":[0.9638901,0.0005368154,0.033608377,0.00038556106,0.00006804422,0.00026674583,0.00055153656,0.000014935076,0.0006778971],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99914336,0.0002855236,0.00007457951,0.00017703894,0.00023205178,0.00008741951],"domain_scores_gemma":[0.9989189,0.0005438493,0.00017108244,0.00008204328,0.00020244268,0.00008168269],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008551324,0.0005446884,0.0003729122,0.0016638237,0.00021931218,0.00046283915,0.0003929068,0.0006886261,0.0022063158],"category_scores_gemma":[0.0016985178,0.0002251938,0.00022920973,0.00040205114,0.00040767298,0.00030353662,0.00031515674,0.00065467943,0.0006633827],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013529778,0.00075076707,0.42261156,0.00024030423,0.000103160164,0.0019589553,0.00032251526,0.0005978147,0.459259,0.00054949825,0.0017092455,0.11054423],"study_design_scores_gemma":[0.0005063926,0.0044670757,0.6729131,0.00025545608,0.00036748877,0.030367907,0.0006050138,0.01827438,0.25848484,0.0010285027,0.012626065,0.00010381231],"about_ca_topic_score_codex":0.00047205505,"about_ca_topic_score_gemma":0.00048254008,"teacher_disagreement_score":0.0022063158,"about_ca_system_score_codex":0.00019152295,"about_ca_system_score_gemma":0.00019248354,"threshold_uncertainty_score":0.007380903},"labels":[],"label_agreement":null},{"id":"W2011198655","doi":"10.1097/fpc.0b013e328341041c","title":"Identification of genetic factors associated with susceptibility to angiotensin-converting enzyme inhibitors-induced cough","year":2010,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Respiratory and Cough-Related Research","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nexen (Canada)","funders":"","keywords":"Medicine; Angiotensin-converting enzyme; Internal medicine; Odds ratio; Haplotype; Sildenafil; Pharmacogenetics; Etiology; Pharmacology; Endocrinology; Bioinformatics; Genotype; Genetics; Biology; Gene; Blood pressure","score_opus":0.036273462862751044,"score_gpt":0.3104170856852762,"score_spread":0.27414362282252513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011198655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99809617,0.00062937476,0.0005922237,0.00006798865,0.000013041178,0.000008950471,0.00023498591,0.000008558039,0.00034870362],"genre_scores_gemma":[0.9991737,0.00010330854,0.00034650372,0.000018555065,0.000014259902,0.000005362917,0.00015565704,0.0000031760298,0.00017936084],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99962187,0.0001293583,0.000042864966,0.000116077186,0.00004148557,0.000048269903],"domain_scores_gemma":[0.9990042,0.0003908369,0.000333688,0.000072932584,0.000053643373,0.00014477484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043560812,0.0003713362,0.0003295188,0.0005812797,0.00027686098,0.00034233977,0.00025194063,0.00041544923,0.0029670082],"category_scores_gemma":[0.0014944688,0.00012386081,0.0006590918,0.0007342394,0.0002113833,0.00015413848,0.0002350159,0.00041542805,0.00019838347],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006140149,0.00007370024,0.9889742,0.000035977147,0.0003446776,0.0007294042,0.00006558098,0.00009832131,0.005848262,0.0000798108,0.00011560579,0.0030204721],"study_design_scores_gemma":[0.000016349419,0.00013453161,0.9974554,0.000009561339,0.0001702765,0.0010453974,0.00004871474,0.0004453094,0.0004098585,0.00008342496,0.00017704217,0.000004158874],"about_ca_topic_score_codex":0.0009539842,"about_ca_topic_score_gemma":0.00088543317,"teacher_disagreement_score":0.0029670082,"about_ca_system_score_codex":0.00009856459,"about_ca_system_score_gemma":0.0001723144,"threshold_uncertainty_score":0.009925604},"labels":[],"label_agreement":null},{"id":"W2011669229","doi":"10.1097/fpc.0b013e328343dd93","title":"PharmGKB summary","year":2011,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute of General Medical Sciences","keywords":"Marsh; Philosophy; Environmental ethics; Humanities; Biology; Ecology","score_opus":0.05132108746965449,"score_gpt":0.3047934739915415,"score_spread":0.253472386521887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011669229","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01313341,0.052996673,0.009964993,0.05158592,0.007222584,0.0010309746,0.055950712,0.0068113464,0.8013034],"genre_scores_gemma":[0.06377864,0.045557212,0.009508921,0.01750689,0.0034849853,0.0006257471,0.065312296,0.0012553799,0.79296994],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99944335,0.00009594078,0.000041479354,0.00010495232,0.0002146017,0.00009971278],"domain_scores_gemma":[0.99933076,0.00006880775,0.00008162344,0.000057266392,0.00017754272,0.00028403004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008441741,0.00077730045,0.00063517306,0.0008051118,0.0005426991,0.0018481603,0.0012715571,0.0015370783,0.24789262],"category_scores_gemma":[0.0016739586,0.00025147529,0.0004530313,0.0010769325,0.00028642913,0.00093607325,0.0011167326,0.0015693511,0.1712224],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001485232,0.00014925702,0.0009833097,0.0011378375,0.000052469393,0.000753067,0.000058548074,0.0002973016,0.009680949,0.010300966,0.54069436,0.43440667],"study_design_scores_gemma":[0.00010832264,0.00010645476,0.00048787537,0.00006614833,0.000016271555,0.00033152985,0.000011436858,0.000056183384,0.0015411499,0.0008777428,0.99639076,0.000006176869],"about_ca_topic_score_codex":0.0015311139,"about_ca_topic_score_gemma":0.0015311394,"teacher_disagreement_score":0.24789262,"about_ca_system_score_codex":0.001309557,"about_ca_system_score_gemma":0.001827254,"threshold_uncertainty_score":0.8292834},"labels":[],"label_agreement":null},{"id":"W2012727770","doi":"10.1097/fpc.0b013e328342f5b1","title":"Identification of novel functional organic anion-transporting polypeptide 1B3 polymorphisms and assessment of substrate specificity","year":2011,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Institute of General Medical Sciences; Canadian Institutes of Health Research","keywords":"Nonsynonymous substitution; Organic anion-transporting polypeptide; Solute carrier family; Organic anion transporter 1; Biology; Chemistry; Molecular biology; Biochemistry; Gene; Transporter","score_opus":0.04942673290203325,"score_gpt":0.28087099431090223,"score_spread":0.23144426140886898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012727770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983895,0.00017780263,0.0009806757,0.000032167096,0.000004766716,0.000011459669,0.00023575159,0.000009219974,0.0001586441],"genre_scores_gemma":[0.998004,0.00007240033,0.0013459836,0.000029636629,0.000005247595,0.00001255981,0.00029599952,0.000010812704,0.00022333545],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997867,0.000051178125,0.000023738086,0.00007862088,0.000037843347,0.00002197153],"domain_scores_gemma":[0.9997985,0.00006368743,0.00007419178,0.0000139772565,0.000022316217,0.00002747152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002675966,0.00041140232,0.00019912445,0.00029885033,0.00015208406,0.0002035591,0.00014074211,0.0003931222,0.0013448443],"category_scores_gemma":[0.0004273362,0.0000963035,0.00026702546,0.0003078279,0.00020826321,0.00006340678,0.00009669652,0.00028963434,0.00029763565],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012299843,0.000089435605,0.09366294,0.00006670751,0.00009050279,0.0013715775,0.00013909006,0.00024305785,0.89771116,0.00010358034,0.00009002418,0.0052018794],"study_design_scores_gemma":[0.00017768041,0.0011865775,0.66979367,0.000046836467,0.00029742977,0.014947319,0.00021913691,0.004899466,0.30465654,0.00027144444,0.0034734616,0.00003035498],"about_ca_topic_score_codex":0.0010009306,"about_ca_topic_score_gemma":0.00076498935,"teacher_disagreement_score":0.0013448443,"about_ca_system_score_codex":0.00015492135,"about_ca_system_score_gemma":0.0001049475,"threshold_uncertainty_score":0.004498899},"labels":[],"label_agreement":null},{"id":"W2013483031","doi":"10.1097/fpc.0b013e32833c6107","title":"PharmGKB summary","year":2010,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute of General Medical Sciences","keywords":"Computational biology; Biology","score_opus":0.01848995321924366,"score_gpt":0.3294989531607356,"score_spread":0.3110089999414919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013483031","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019589614,0.038926408,0.0022341402,0.050077148,0.016316164,0.0009622755,0.05326954,0.0029669555,0.83328825],"genre_scores_gemma":[0.01137331,0.040679924,0.0016816303,0.016096031,0.009611962,0.00055665505,0.036214106,0.00068585546,0.8831005],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994467,0.000095756,0.000045420522,0.00010786124,0.00020243975,0.00010184903],"domain_scores_gemma":[0.999008,0.0001001958,0.00009004477,0.00005645939,0.00027776617,0.0004676697],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008670845,0.0010466524,0.0012097463,0.0010159981,0.0004932292,0.0023954236,0.0013466593,0.0021095513,0.60759115],"category_scores_gemma":[0.0026337875,0.00035184843,0.00057494943,0.0011119616,0.00021274328,0.00093635236,0.0008735271,0.0019987072,0.5096366],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032066926,0.000035959725,0.00010776222,0.00028084512,0.000013171227,0.00009108242,0.0000042005768,0.000050098744,0.00021684216,0.00058677816,0.89456284,0.10372973],"study_design_scores_gemma":[0.00024891162,0.000082854975,0.00038697186,0.00013917555,0.000011463491,0.00015314203,0.0000050806398,0.000051542123,0.00014168996,0.00040359117,0.99837023,0.0000054205707],"about_ca_topic_score_codex":0.0013325524,"about_ca_topic_score_gemma":0.002040138,"teacher_disagreement_score":0.60759115,"about_ca_system_score_codex":0.00085632806,"about_ca_system_score_gemma":0.001651684,"threshold_uncertainty_score":0.5597236},"labels":[],"label_agreement":null},{"id":"W2014966268","doi":"10.1097/fpc.0b013e32831a9abe","title":"Associations between common variants in the MDR1 (ABCB1) gene and ulcerative colitis among North Indians","year":2008,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; McGill University Health Centre; Université de Montréal","funders":"","keywords":"Ulcerative colitis; Genetics; Pharmacogenetics; Gene; Biology; Medicine; Internal medicine; Genotype; Disease","score_opus":0.02668482936993595,"score_gpt":0.2689964332201752,"score_spread":0.24231160385023925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014966268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99958533,0.00017044786,0.000029911036,0.000025887177,0.0000023896957,0.0000018869789,0.000038315182,0.0000030596639,0.000142796],"genre_scores_gemma":[0.9996525,0.00011575354,0.0000585964,0.0000134770935,0.000009167452,0.0000026314608,0.000060477207,0.0000015934336,0.00008581505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996991,0.00007819758,0.000036498044,0.00008187061,0.00005095562,0.00005332388],"domain_scores_gemma":[0.99912184,0.00017647397,0.00041587927,0.00006157101,0.00008662673,0.00013760988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000247481,0.00025433407,0.00029315054,0.00050096295,0.00046871504,0.00039573698,0.00021427927,0.00029428158,0.0017809989],"category_scores_gemma":[0.0008198227,0.00018928737,0.00022863875,0.0006308871,0.00043074947,0.00016319107,0.00021916624,0.0002957591,0.00016892506],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000213879,0.000039732084,0.9950388,0.00002232859,0.000066218905,0.0005296255,0.00020817705,0.000032383196,0.0015173417,0.000021860265,0.00007317305,0.0022365376],"study_design_scores_gemma":[0.000008200516,0.000059268255,0.9984428,0.000005627523,0.000044204793,0.0010259298,0.00015982038,0.000049371512,0.00007991686,0.000020254243,0.000102060534,0.0000025508357],"about_ca_topic_score_codex":0.0051567233,"about_ca_topic_score_gemma":0.0048830025,"teacher_disagreement_score":0.0051567233,"about_ca_system_score_codex":0.0001460116,"about_ca_system_score_gemma":0.00015888675,"threshold_uncertainty_score":0.010253429},"labels":[],"label_agreement":null},{"id":"W2016545633","doi":"10.1097/fpc.0b013e3282f3606e","title":"A novel CYP2A6 allele, CYP2A6*23, impairs enzyme function in vitro and in vivo and decreases smoking in a population of Black-African descent","year":2008,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research","keywords":"CYP2A6; Pharmacogenetics; Allele; In vivo; Genetics; Allele frequency; Biology; Population; Descent (aeronautics); Enzyme; In vitro; Gene; Medicine; Genotype; Geography; Environmental health; Biochemistry","score_opus":0.0661402791490691,"score_gpt":0.34489303013547035,"score_spread":0.27875275098640123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016545633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99889994,0.000260936,0.0005192714,0.000039348102,0.0000092286555,0.000009385884,0.00010493998,0.000016927863,0.00013993752],"genre_scores_gemma":[0.9977029,0.00023500065,0.001149711,0.000046253812,0.00001412266,0.000015915677,0.0002375106,0.000014323871,0.00058426405],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997725,0.00006019594,0.000013851945,0.00007172591,0.00005619902,0.000025478987],"domain_scores_gemma":[0.9997112,0.000045367517,0.00014349358,0.000021007525,0.000021922402,0.000056973768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029529168,0.00041763118,0.00034325075,0.00020369209,0.00018186512,0.00018896548,0.0001469826,0.0003236046,0.0020746754],"category_scores_gemma":[0.00049699954,0.0000921471,0.00025450584,0.00021339317,0.00020005122,0.000066445034,0.000100169396,0.00038523547,0.00026729086],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014052159,0.00031624944,0.062351767,0.000075851196,0.0001982861,0.0007435889,0.0000951545,0.0001196105,0.9244725,0.00008952349,0.00022956272,0.009902664],"study_design_scores_gemma":[0.0002648547,0.0050008344,0.71324885,0.000040680865,0.0004725384,0.018839521,0.00014161774,0.0018707177,0.255208,0.0001535678,0.004726811,0.000031991312],"about_ca_topic_score_codex":0.0011206367,"about_ca_topic_score_gemma":0.0010442466,"teacher_disagreement_score":0.0020746754,"about_ca_system_score_codex":0.0001474357,"about_ca_system_score_gemma":0.00014641508,"threshold_uncertainty_score":0.0069405437},"labels":[],"label_agreement":null},{"id":"W2019098660","doi":"10.1097/fpc.0b013e328354455c","title":"Very important pharmacogene summary for VDR","year":2012,"lang":"en","type":"review","venue":"Pharmacogenetics and Genomics","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Christie (Canada); Université du Québec à Montréal; McGill University Health Centre; Université du Québec à Chicoutimi","funders":"National Institute of General Medical Sciences","keywords":"Philosophy; Library science; Computer science","score_opus":0.1265502516405605,"score_gpt":0.4148175827277482,"score_spread":0.2882673310871877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019098660","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00040780645,0.96465963,0.0016256986,0.012364604,0.0060546966,0.000047935202,0.001788377,0.00013079928,0.012920387],"genre_scores_gemma":[0.0033438227,0.96032655,0.0014647775,0.006187182,0.0044366033,0.00004457265,0.0032832483,0.00003597496,0.020877289],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99975413,0.00005210959,0.000038242757,0.000045988392,0.00008512878,0.000024392964],"domain_scores_gemma":[0.9994099,0.00026617348,0.0000886539,0.00003806221,0.00014295228,0.000054264983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048465247,0.00071302435,0.0011406988,0.0025276514,0.00030143603,0.0011359319,0.0008387747,0.0013436902,0.032006826],"category_scores_gemma":[0.0018391265,0.00023972482,0.00089955184,0.0022135063,0.00043756687,0.0012304719,0.00063770334,0.0015978621,0.016592829],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010984567,0.000030624004,0.00027986907,0.008799504,0.00011175685,0.0006630129,0.00004776621,0.00015584148,0.0017399447,0.0059918053,0.30966517,0.672405],"study_design_scores_gemma":[0.000017819584,0.000020923242,0.00045845908,0.0021479614,0.00008767803,0.0016883606,0.000019876567,0.000025857757,0.00041939353,0.0019429909,0.99316156,0.000009205125],"about_ca_topic_score_codex":0.0015342736,"about_ca_topic_score_gemma":0.0022238449,"teacher_disagreement_score":0.032006826,"about_ca_system_score_codex":0.0006316006,"about_ca_system_score_gemma":0.0013478389,"threshold_uncertainty_score":0.107073486},"labels":[],"label_agreement":null},{"id":"W2019147684","doi":"10.1097/01.fpc.0000220573.05714.ac","title":"Effect of butyrylcholinesterase genotype on the response to rivastigmine or donepezil in younger patients with Alzheimer's disease","year":2006,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Rivastigmine; Butyrylcholinesterase; Donepezil; Tolerability; Acetylcholinesterase; Medicine; Internal medicine; Cholinesterase; Retrospective cohort study; Adverse effect; Oncology; Gastroenterology; Psychology; Disease; Dementia; Aché; Biology","score_opus":0.014354491201338205,"score_gpt":0.2880520142942587,"score_spread":0.2736975230929205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019147684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998401,0.0011637653,0.0000557204,0.00003659663,0.000025858577,0.00006674573,0.00009520086,0.0000064911283,0.0001486722],"genre_scores_gemma":[0.999006,0.0003652894,0.00011552895,0.00011882566,0.000041118583,0.00007407411,0.00016537192,0.0000017310314,0.000112043934],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99947494,0.00023422019,0.00007734826,0.0000925598,0.000054881984,0.00006601961],"domain_scores_gemma":[0.998976,0.00030096946,0.000364279,0.00006248403,0.000046843157,0.00024944678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010720479,0.0005469793,0.0016891115,0.00021272057,0.00025289005,0.00034941992,0.0002943029,0.00069138006,0.00084717904],"category_scores_gemma":[0.0017664051,0.00027509336,0.0010402957,0.00021496211,0.00029331102,0.00027679052,0.00016600665,0.00055945356,0.00016974207],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8895716,0.0061107585,0.053501848,0.0003787201,0.0022167566,0.00026505423,0.00013194216,0.00039944603,0.013124096,0.00005578413,0.00036388522,0.033880096],"study_design_scores_gemma":[0.3111187,0.3169106,0.361769,0.000067038214,0.002567471,0.00076815253,0.00008259378,0.001377866,0.0037518844,0.00018652708,0.0013400204,0.00006021842],"about_ca_topic_score_codex":0.00060210755,"about_ca_topic_score_gemma":0.0009929177,"teacher_disagreement_score":0.0016891115,"about_ca_system_score_codex":0.0003140545,"about_ca_system_score_gemma":0.00032678078,"threshold_uncertainty_score":0.005669594},"labels":[],"label_agreement":null},{"id":"W2019651109","doi":"10.1097/fpc.0b013e32835d9ab0","title":"Influence of CYP2B6 genetic variants on plasma and urine concentrations of bupropion and metabolites at steady state","year":2013,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Poisoning and overdose treatments","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Center for Research Resources; National Institute on Drug Abuse; U.S. Public Health Service","keywords":"Bupropion; CYP2B6; Active metabolite; Pharmacology; Metabolite; Pharmacogenetics; Urine; Pharmacokinetics; Genotype; CYP2D6; Medicine; Chemistry; Internal medicine; Cytochrome P450; Metabolism; CYP3A4; Smoking cessation; Biochemistry; Gene","score_opus":0.013116080143748909,"score_gpt":0.26386803599150876,"score_spread":0.25075195584775983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019651109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990428,0.00018458035,0.00029047235,0.000026143507,0.0000049046125,0.000007724418,0.00016448792,0.000007386171,0.00027158528],"genre_scores_gemma":[0.999595,0.000026856022,0.00015191427,0.00001379819,0.0000036466533,0.0000042669,0.000082163126,0.0000062811378,0.000116007235],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999395,0.0002473151,0.000047118472,0.00015010365,0.000109363114,0.00005109426],"domain_scores_gemma":[0.9988965,0.00047486433,0.0003262691,0.0001283439,0.0000818563,0.00009216932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050519546,0.00025852007,0.0003660444,0.0002383296,0.00015944269,0.00033437103,0.00012048444,0.00031388088,0.0017942471],"category_scores_gemma":[0.0017613037,0.00016390765,0.00036183815,0.00026499396,0.0002659393,0.00012557354,0.00012314644,0.00028708638,0.0002067658],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013775282,0.00037770378,0.8923524,0.000042208012,0.00078713056,0.00085815735,0.00020690904,0.00058301986,0.07864731,0.00017378929,0.00026509335,0.011930958],"study_design_scores_gemma":[0.000081570775,0.0014209768,0.9902198,0.0000034422092,0.00019953218,0.0011559111,0.000033927638,0.00085129874,0.0056936783,0.000088771085,0.0002437577,0.0000073904434],"about_ca_topic_score_codex":0.0009118371,"about_ca_topic_score_gemma":0.00057148805,"teacher_disagreement_score":0.0017942471,"about_ca_system_score_codex":0.00013190469,"about_ca_system_score_gemma":0.00006852473,"threshold_uncertainty_score":0.0060023665},"labels":[],"label_agreement":null},{"id":"W2022663382","doi":"10.1097/fpc.0b013e3280ef698f","title":"Effect of drug transporter genotypes on pravastatin disposition in European- and African-American participants","year":2007,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":202,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Center for Research Resources; National Institute of General Medical Sciences; Bristol-Myers Squibb","keywords":"SLCO1B1; Pravastatin; Cmax; Pharmacokinetics; Abcg2; Pharmacology; Internal medicine; Organic anion-transporting polypeptide; Multidrug resistance-associated protein 2; Medicine; Genotype; Pharmacogenetics; Biology; Transporter; Cholesterol; ATP-binding cassette transporter; Genetics","score_opus":0.0087329902029027,"score_gpt":0.28675502814453196,"score_spread":0.2780220379416293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022663382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996376,0.000100072095,0.000042124953,0.000013359651,0.0000019155668,0.0000041391795,0.00005731846,8.407016e-7,0.00014259973],"genre_scores_gemma":[0.9997013,0.000038124905,0.00007331485,0.000018434135,0.0000034200452,0.000007655794,0.00006222155,0.0000012052432,0.000094299954],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995828,0.00017312531,0.000031328127,0.000099621844,0.000053961558,0.000059144855],"domain_scores_gemma":[0.9994498,0.00015572469,0.00020861092,0.000040200433,0.000052725587,0.00009289474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062416267,0.0002674841,0.00031738047,0.00029004138,0.00039140842,0.00028035606,0.00015775439,0.00040223572,0.0018063302],"category_scores_gemma":[0.0014463457,0.00014992073,0.00029315168,0.00034445184,0.00021057886,0.00026889733,0.00021138956,0.00023510758,0.00020969388],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018771392,0.000183631,0.9926645,0.000014543548,0.0001640643,0.0001213265,0.0002458677,0.000039722687,0.0021356826,0.000038859802,0.000063018386,0.0024515104],"study_design_scores_gemma":[0.00004330575,0.0004883948,0.9983524,0.0000058636138,0.00008449391,0.0002653411,0.0001961457,0.00016896422,0.00019978253,0.000038255006,0.0001526843,0.000004466634],"about_ca_topic_score_codex":0.0021025273,"about_ca_topic_score_gemma":0.0022612002,"teacher_disagreement_score":0.0021025273,"about_ca_system_score_codex":0.00012229558,"about_ca_system_score_gemma":0.00013852897,"threshold_uncertainty_score":0.006042719},"labels":[],"label_agreement":null},{"id":"W2024278415","doi":"10.1097/fpc.0000000000000061","title":"Cancer patients’ acceptance, understanding, and willingness-to-pay for pharmacogenomic testing","year":2014,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Pharmacogenomics; Medicine; Willingness to pay; Cancer; Genetic testing; Oncology; Intensive care medicine; Internal medicine; Pharmacology","score_opus":0.16242019437257235,"score_gpt":0.4190787767134464,"score_spread":0.256658582340874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024278415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969259,0.00021452937,0.00015224339,0.0007804796,0.0000058737364,0.000017436283,0.000046608988,0.0000029175878,0.0018541171],"genre_scores_gemma":[0.9995704,0.00007231991,0.00008988075,0.00015920815,0.000004294482,0.000007894228,0.000022028851,8.229653e-7,0.00007315397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99603456,0.0022002968,0.0002751351,0.00017610996,0.000887363,0.00042663366],"domain_scores_gemma":[0.97642696,0.014512361,0.005590731,0.0005032207,0.001338328,0.0016283218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048023495,0.00018394779,0.00027711582,0.0006994678,0.00048183248,0.0017970633,0.0003280437,0.0010228193,0.0042647016],"category_scores_gemma":[0.026806664,0.00014948734,0.00069817883,0.00044749628,0.0008708664,0.0008985213,0.000731722,0.0011828775,0.00029161823],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003809762,0.00029886572,0.96745425,0.000077828794,0.00015189085,0.00044592845,0.007108107,0.0008076154,0.0005022457,0.00042607597,0.0007924831,0.021553826],"study_design_scores_gemma":[0.000104911895,0.0018025563,0.9389798,0.0002106156,0.00016056596,0.0039521907,0.04147786,0.0063247927,0.00069073384,0.0020299705,0.0041455314,0.000120445315],"about_ca_topic_score_codex":0.0015610133,"about_ca_topic_score_gemma":0.0010639537,"teacher_disagreement_score":0.0048023495,"about_ca_system_score_codex":0.0006937988,"about_ca_system_score_gemma":0.0006790157,"threshold_uncertainty_score":0.02539754},"labels":[],"label_agreement":null},{"id":"W2025045247","doi":"10.1097/fpc.0b013e32835f834d","title":"CYP2A6 slow nicotine metabolism is associated with increased quitting by adolescent smokers","year":2013,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Canada Research Chairs; University of New Brunswick; Université de Montréal; Centre for Addiction and Mental Health","funders":"National Institute on Drug Abuse; Canadian Institutes of Health Research","keywords":"CYP2A6; Odds ratio; Smoking cessation; Nicotine; Confidence interval; Medicine; Pharmacogenetics; Internal medicine; Physiology; Cohort; Logistic regression; Abstinence; Endocrinology; Metabolism; Genotype; Genetics; Biology; Psychiatry; Gene; Cytochrome P450; Pathology","score_opus":0.01673320161291944,"score_gpt":0.2627025914740785,"score_spread":0.24596938986115904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025045247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994272,0.00019744883,0.00009213346,0.000042075255,0.000002582493,0.0000035314451,0.000053462933,0.000003139609,0.00017848022],"genre_scores_gemma":[0.99957997,0.00011111585,0.000107762105,0.000019554656,0.0000072040602,0.0000030506385,0.000062041116,0.0000027386982,0.00010661964],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99956816,0.00016000005,0.000038854138,0.000106487816,0.00008140772,0.00004513022],"domain_scores_gemma":[0.9977818,0.0005153696,0.0012198786,0.00010868791,0.00014418582,0.00023010877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005241577,0.000223469,0.00035247844,0.00052107545,0.00023437034,0.00043393043,0.00017599443,0.00036093997,0.001658415],"category_scores_gemma":[0.002342916,0.00031095598,0.00038641138,0.00052206055,0.00024088367,0.00020741347,0.00019815039,0.0006866048,0.00013474302],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009324412,0.000022329727,0.99785006,0.0000051198017,0.000032756623,0.000060781902,0.000037437003,0.000010161182,0.00071559224,0.000011743139,0.000026526312,0.0011342043],"study_design_scores_gemma":[0.0000029305797,0.000048187252,0.999355,0.000003014025,0.000026037478,0.00028546344,0.000027019285,0.000090929134,0.00010555925,0.000013512716,0.000041352025,0.0000010504026],"about_ca_topic_score_codex":0.0024293396,"about_ca_topic_score_gemma":0.0026322107,"teacher_disagreement_score":0.0024293396,"about_ca_system_score_codex":0.0001301797,"about_ca_system_score_gemma":0.00015612089,"threshold_uncertainty_score":0.0055479407},"labels":[],"label_agreement":null},{"id":"W2028722229","doi":"10.1097/01.fpc.0000175597.60066.3d","title":"St. John's wort and its constituent hyperforin concordantly regulate expression of genes encoding enzymes involved in basic cellular pathways","year":2005,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Natural Compound Pharmacology Studies","field":"Agricultural and Biological Sciences","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biology; Endoplasmic reticulum; Gene expression; Biochemistry; Cell biology; Gene","score_opus":0.03558154012873604,"score_gpt":0.24412180585835558,"score_spread":0.20854026572961953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028722229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99514633,0.002074111,0.0011580008,0.0001275886,0.000029422159,0.000029401486,0.00029323206,0.00004184672,0.0011000078],"genre_scores_gemma":[0.99327457,0.0008447644,0.0020517753,0.00014926863,0.000021352878,0.00003871532,0.00055205415,0.000019170135,0.0030483764],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998036,0.00003392135,0.000014652445,0.000048896152,0.000059078764,0.000039853716],"domain_scores_gemma":[0.9997663,0.000049224924,0.00008700428,0.000019829351,0.0000309458,0.000046700163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000107106716,0.0003290752,0.00031572726,0.00025792795,0.00011909374,0.00026371362,0.000105758736,0.00028295704,0.0017534421],"category_scores_gemma":[0.00017109582,0.00011682606,0.00022242442,0.0001997975,0.0002914951,0.00016946682,0.00015662637,0.00030007688,0.0001570108],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030007272,0.000010936582,0.00019479291,0.000026686692,0.0000061417154,0.000039200946,0.00000791327,0.00001345904,0.9986028,0.000016019829,0.000016370037,0.0007655395],"study_design_scores_gemma":[0.000028992854,0.0007242154,0.016111515,0.00000487919,0.00003425893,0.00036280561,0.00003596806,0.00013517622,0.98087007,0.000028455463,0.0016587396,0.000004859176],"about_ca_topic_score_codex":0.00066444225,"about_ca_topic_score_gemma":0.0015566221,"teacher_disagreement_score":0.0017534421,"about_ca_system_score_codex":0.00042072058,"about_ca_system_score_gemma":0.00027070256,"threshold_uncertainty_score":0.005865872},"labels":[],"label_agreement":null},{"id":"W2030018298","doi":"10.1097/fpc.0b013e3283349e84","title":"Cytochrome P450 2C9-CYP2C9","year":2010,"lang":"en","type":"review","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":239,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"National Institute of General Medical Sciences; National Institutes of Health; Mashhad University of Medical Sciences","keywords":"CYP2C9; Cytochrome P450; Biology; Biochemistry; Metabolism","score_opus":0.21651714893957597,"score_gpt":0.504793880293876,"score_spread":0.2882767313543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030018298","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00047577536,0.9700586,0.002949658,0.0026903972,0.0020417357,0.00015570711,0.0010488062,0.00020498314,0.020374343],"genre_scores_gemma":[0.003623256,0.9657024,0.001939402,0.000978051,0.0015270057,0.000075993106,0.0012818414,0.000020621215,0.024851456],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99958855,0.000069494025,0.00003785545,0.00008818426,0.00018175867,0.000034157336],"domain_scores_gemma":[0.9996321,0.00010128313,0.000070125534,0.000022205726,0.00013132485,0.000043020453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044931308,0.0010924522,0.0015837476,0.0022146462,0.00026845108,0.0009221429,0.00096291135,0.0011203447,0.030259537],"category_scores_gemma":[0.0011054997,0.00026884733,0.0006332962,0.003039781,0.00038712833,0.0010559658,0.00050121057,0.0012591832,0.030646153],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008795502,0.00006145417,0.00029392948,0.0053901,0.000055268705,0.00038413508,0.00001170375,0.00018493086,0.0020499225,0.0012634856,0.14611691,0.84410024],"study_design_scores_gemma":[0.0000557579,0.00007174732,0.0009881807,0.0011190339,0.00007381891,0.0026622675,0.0000107377255,0.000081425766,0.0013460204,0.0011896039,0.9923878,0.000013671282],"about_ca_topic_score_codex":0.0016285846,"about_ca_topic_score_gemma":0.0023479324,"teacher_disagreement_score":0.030259537,"about_ca_system_score_codex":0.00049185526,"about_ca_system_score_gemma":0.0009445489,"threshold_uncertainty_score":0.1012283},"labels":[],"label_agreement":null},{"id":"W2034756313","doi":"10.1097/fpc.0b013e32835f1cc0","title":"Nomenclature for alleles of the thiopurine methyltransferase gene","year":2013,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"National Center for Research Resources; National Institute of General Medical Sciences; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Thiopurine methyltransferase; Pharmacogenomics; Azathioprine; Gene nomenclature; Genetics; Allele; Computational biology; Biology; Pharmacogenetics; Gene; Medicine; Bioinformatics; Nomenclature; Genotype; Internal medicine","score_opus":0.015595956298392968,"score_gpt":0.2826222173214928,"score_spread":0.26702626102309984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034756313","genre_codex":"other","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04915042,0.13783659,0.19879729,0.05315801,0.079012424,0.0030516682,0.06461235,0.005285769,0.4090955],"genre_scores_gemma":[0.14363657,0.08204153,0.48408136,0.031648204,0.016204525,0.005042583,0.10816618,0.003694516,0.12548457],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99381196,0.0024140116,0.0015666892,0.00079850864,0.0009768811,0.0004319032],"domain_scores_gemma":[0.9926369,0.0024449178,0.0015482735,0.0006505455,0.0020402255,0.0006791059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042431364,0.0014039295,0.0012305686,0.006705804,0.0012525957,0.0025136624,0.0018411084,0.0016145125,0.021561317],"category_scores_gemma":[0.009190219,0.00027062543,0.0012500611,0.0061993673,0.0022352876,0.0022502022,0.0017557414,0.00385747,0.020339863],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010702154,0.00014794325,0.012757654,0.0022472793,0.00014908737,0.0020290022,0.0025506513,0.0005397394,0.010306051,0.14056319,0.46089378,0.3667454],"study_design_scores_gemma":[0.000034088378,0.00009260263,0.00253402,0.0002856598,0.000030440604,0.0018277675,0.00020118256,0.00015314185,0.00049236056,0.00992798,0.9843908,0.000030024792],"about_ca_topic_score_codex":0.0016262679,"about_ca_topic_score_gemma":0.0015378519,"teacher_disagreement_score":0.021561317,"about_ca_system_score_codex":0.0009720515,"about_ca_system_score_gemma":0.0026292084,"threshold_uncertainty_score":0.072129846},"labels":[],"label_agreement":null},{"id":"W2035435860","doi":"10.1097/fpc.0b013e32806d87a4","title":"A pharmacogenomics study of the human estrogen glucuronosyltransferase UGT1A3","year":2007,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Canadian Institutes of Health Research; Canada Research Chairs","keywords":"Estrone; Chemistry; Hepatocyte nuclear factors; Hepatocyte nuclear factor 4; Phenotype; Biology; Biochemistry; Molecular biology; Genetics; Transcription factor; Gene; Hormone; Nuclear receptor","score_opus":0.016461816648895344,"score_gpt":0.29948432765097743,"score_spread":0.2830225110020821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035435860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99882096,0.0002878147,0.00062697055,0.000031609434,0.0000019344038,0.0000056447125,0.00008834457,0.000005186819,0.00013140851],"genre_scores_gemma":[0.9988411,0.00020145992,0.00044334246,0.000025383739,0.0000049000882,0.0000039244774,0.00020406242,0.000004936453,0.00027085334],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998963,0.000032872882,0.000004620078,0.0000367581,0.000017869455,0.000011580368],"domain_scores_gemma":[0.9999019,0.000025928191,0.000023989562,0.00001135702,0.0000151865215,0.000021663733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023617364,0.0002211653,0.00028617855,0.00020692578,0.00014757636,0.00018759698,0.0000705385,0.00018780817,0.0004901584],"category_scores_gemma":[0.00040588377,0.00010681023,0.0003520709,0.0003242791,0.00016456319,0.00006498886,0.0000842615,0.00024621031,0.00012592379],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004807391,0.00037936898,0.18117587,0.00007085636,0.00039675942,0.0009016016,0.00021030197,0.0013298785,0.78234017,0.00026463595,0.00021558274,0.027907608],"study_design_scores_gemma":[0.00012260205,0.003782284,0.7939683,0.000008656965,0.000479126,0.0040114857,0.00012087879,0.005384355,0.18885377,0.00019965268,0.0030492053,0.000019650515],"about_ca_topic_score_codex":0.0030415286,"about_ca_topic_score_gemma":0.0011245662,"teacher_disagreement_score":0.0030415286,"about_ca_system_score_codex":0.00025190774,"about_ca_system_score_gemma":0.00018282679,"threshold_uncertainty_score":0.006047666},"labels":[],"label_agreement":null},{"id":"W2038045293","doi":"10.1097/01.fpc.0000220560.59972.33","title":"Gene–gene interactions between CYP2B6 and CYP2A6 in nicotine metabolism","year":2007,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Nicotinic Acetylcholine Receptors Study","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Center for Research Resources; Canada Research Chairs; National Institute on Drug Abuse; Health Canada; NIH Clinical Center; National Institutes of Health; Centre for Addiction and Mental Health","keywords":"CYP2A6; Nicotine; Cotinine; CYP2B6; Genotype; Pharmacogenetics; Metabolite; Pharmacology; Haplotype; Biology; Metabolism; Genetics; Medicine; Gene; Endocrinology; Internal medicine; Cytochrome P450; CYP3A4","score_opus":0.014737306789117891,"score_gpt":0.3076562995420746,"score_spread":0.2929189927529567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038045293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948179,0.0023285479,0.0016675965,0.00021255489,0.000019833911,0.000021254466,0.00024931793,0.000021123884,0.000661819],"genre_scores_gemma":[0.99756646,0.00045909628,0.0012357999,0.000035844052,0.000033249624,0.00001196442,0.00015895673,0.000012388603,0.00048613487],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99915874,0.00045682315,0.000037142952,0.00015249739,0.00012363427,0.000071100374],"domain_scores_gemma":[0.999019,0.00045472523,0.00023230563,0.000054260312,0.00010546309,0.00013413122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006910566,0.00038806186,0.00043627783,0.0004841187,0.00025841384,0.0003657802,0.00021456835,0.00044948788,0.0030355828],"category_scores_gemma":[0.0013395101,0.00015238325,0.00059820537,0.0006791791,0.00033622453,0.00013940751,0.00017752327,0.00037758067,0.0003779869],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004033074,0.000316958,0.8867113,0.0001111802,0.0011716286,0.001444751,0.00020550459,0.0008182176,0.08604465,0.0004615491,0.00038877863,0.018292429],"study_design_scores_gemma":[0.00007403193,0.0004262405,0.99137324,0.000012244724,0.0002849612,0.0012249409,0.00004199956,0.0014966496,0.0038637181,0.00023444761,0.0009576639,0.0000099064855],"about_ca_topic_score_codex":0.0020921354,"about_ca_topic_score_gemma":0.0017113668,"teacher_disagreement_score":0.0030355828,"about_ca_system_score_codex":0.00018546273,"about_ca_system_score_gemma":0.00021785162,"threshold_uncertainty_score":0.010155022},"labels":[],"label_agreement":null},{"id":"W2040475315","doi":"10.1097/01213011-200506000-00001","title":"Polymorphisms of human nuclear receptors that control expression of drug-metabolizing enzymes","year":2005,"lang":"en","type":"review","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Aryl hydrocarbon receptor; Biology; Nuclear receptor; Receptor; Drug metabolism; Gene; Xenobiotic; Single-nucleotide polymorphism; Transcription factor; Phenotype; Genetics; Function (biology); Enzyme; Cell biology; Biochemistry; Genotype","score_opus":0.13710172867479412,"score_gpt":0.43579132939100107,"score_spread":0.298689600716207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040475315","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025746558,0.9976464,0.00020840597,0.00021594932,0.000079446494,0.0000039030087,0.000027131264,0.000010323185,0.0015509365],"genre_scores_gemma":[0.0014624735,0.9969164,0.0002627203,0.000113177506,0.00007595401,0.000005707753,0.000054710752,0.0000011907799,0.0011076397],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999846,0.000028783805,0.000017490993,0.000037701466,0.000056222398,0.0000137716115],"domain_scores_gemma":[0.9997843,0.0000839611,0.000044066437,0.000007907717,0.00006130552,0.000018505049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045912556,0.0006786463,0.0012235262,0.001381514,0.00014728043,0.000515166,0.00064303074,0.0005954777,0.0036456594],"category_scores_gemma":[0.0005056226,0.00017760132,0.00027016603,0.0017178571,0.0003349948,0.00061343214,0.00025576563,0.0006246378,0.0036045725],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007432944,0.00003262976,0.00048568033,0.0054749153,0.00006402357,0.00027351457,0.000029835091,0.0003173085,0.0030692157,0.0018144994,0.01731438,0.9710497],"study_design_scores_gemma":[0.00003471408,0.000095407624,0.0030776847,0.0014438353,0.00010149369,0.002951782,0.00006224696,0.0000810274,0.0014768195,0.0021070621,0.9885484,0.000019513769],"about_ca_topic_score_codex":0.0010151834,"about_ca_topic_score_gemma":0.001737218,"teacher_disagreement_score":0.0036456594,"about_ca_system_score_codex":0.00048707926,"about_ca_system_score_gemma":0.0005828959,"threshold_uncertainty_score":0.012195945},"labels":[],"label_agreement":null},{"id":"W2040718125","doi":"10.1097/01.fpc.0000230413.97596.fa","title":"Multilocus genetic interactions and response to efavirenz-containing regimens: an Adult AIDS Clinical Trials Group study","year":2006,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Center for Research Resources; ACT Government; National Institute of Neurological Disorders and Stroke; National Institute of General Medical Sciences; National Heart, Lung, and Blood Institute; National Institute of Allergy and Infectious Diseases","keywords":"Efavirenz; CYP2B6; Pharmacogenetics; Pharmacology; Nelfinavir; Single-nucleotide polymorphism; Biology; Medicine; Internal medicine; Genotype; Oncology; CYP3A4; Viral load; Virology; Genetics; Gene; Cytochrome P450; Human immunodeficiency virus (HIV); Antiretroviral therapy","score_opus":0.08553449737478164,"score_gpt":0.4370506260796645,"score_spread":0.35151612870488286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040718125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998041,0.0007024053,0.00026171436,0.0001848959,0.000018912782,0.00013236828,0.00031690823,0.000008002281,0.00033381293],"genre_scores_gemma":[0.9982803,0.0001891444,0.0005155599,0.0001228135,0.000058361977,0.00015691467,0.00042442238,0.0000027202914,0.00024974038],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99650085,0.0028110915,0.00015288735,0.00026916835,0.0001638158,0.00010221322],"domain_scores_gemma":[0.99349374,0.0031673482,0.001738955,0.00060329324,0.0003207073,0.00067599636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0062166094,0.00086888624,0.0011216428,0.00029860114,0.0004566699,0.0006846916,0.00042667554,0.0010667559,0.0020189793],"category_scores_gemma":[0.008349262,0.0003824609,0.0009940488,0.00047918875,0.0003593219,0.0005426304,0.0003160507,0.0010332444,0.00028344578],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3740061,0.005668119,0.5721242,0.0003699814,0.0115037495,0.0003506435,0.0003765152,0.0024313603,0.0020541502,0.0002518549,0.0017529943,0.029110359],"study_design_scores_gemma":[0.12853584,0.06981363,0.77451736,0.00013976374,0.008068077,0.0008527253,0.00020924093,0.013811779,0.0006760161,0.000781106,0.0025006097,0.00009393742],"about_ca_topic_score_codex":0.00062078104,"about_ca_topic_score_gemma":0.00079426175,"teacher_disagreement_score":0.0062166094,"about_ca_system_score_codex":0.0002430006,"about_ca_system_score_gemma":0.00043817965,"threshold_uncertainty_score":0.03287697},"labels":[],"label_agreement":null},{"id":"W2041631632","doi":"10.1097/fpc.0b013e3283498ecf","title":"Genetic epidemiology of induced CYP3A4 activity","year":2011,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"CYP3A4; Pharmacogenetics; Genetic variation; Population; Biology; Drug metabolism; Heritability; Genetic variability; Twin study; Pharmacology; Genetics; Cytochrome P450; Drug; Medicine; Metabolism; Environmental health; Biochemistry; Gene; Genotype","score_opus":0.3375756093859221,"score_gpt":0.4534916952181803,"score_spread":0.11591608583225815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041631632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974317,0.00057049387,0.0012648742,0.00005735567,0.000006315942,0.000013314759,0.00029968825,0.000012009934,0.0003442952],"genre_scores_gemma":[0.9990125,0.00017582155,0.000547232,0.000009949195,0.000008258154,0.000007000614,0.00016380339,0.0000046439227,0.00007090608],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980153,0.000890741,0.0001507609,0.00058027194,0.00026454416,0.000098409706],"domain_scores_gemma":[0.9979752,0.00067792373,0.0007371583,0.00025351156,0.00019508046,0.00016120121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012380495,0.00034370396,0.0004507964,0.0008788991,0.00042261824,0.00039785696,0.0003881771,0.00050228066,0.0015339945],"category_scores_gemma":[0.0035305377,0.00022861935,0.00042129893,0.0012357144,0.0006073224,0.00020124426,0.0005682327,0.00046078087,0.00015411762],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029209195,0.000039329545,0.9917679,0.000022242059,0.00022735415,0.00024130393,0.00010847488,0.00024494083,0.0033263569,0.0003259239,0.000068241185,0.0033357171],"study_design_scores_gemma":[0.000007844419,0.00018240517,0.997001,0.00001025072,0.00010769832,0.0010604191,0.0000709473,0.0006547074,0.00046700845,0.00024939058,0.00018222503,0.0000061410283],"about_ca_topic_score_codex":0.0034236396,"about_ca_topic_score_gemma":0.0018252261,"teacher_disagreement_score":0.0034236396,"about_ca_system_score_codex":0.00024952498,"about_ca_system_score_gemma":0.00021616758,"threshold_uncertainty_score":0.006807387},"labels":[],"label_agreement":null},{"id":"W2041731718","doi":"10.1097/fpc.0b013e3282f55ab2","title":"Quantitative trait locus and computational mapping identifies Kcnj9 (GIRK3) as a candidate gene affecting analgesia from multiple drug classes","year":2008,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute on Drug Abuse; National Institute of Neurological Disorders and Stroke; National Institute of Mental Health; National Institutes of Health","keywords":"Quantitative trait locus; Computational biology; Biology; Locus (genetics); Candidate gene; Genetics; Trait; Pharmacogenetics; Gene; Bioinformatics; Computer science; Genotype","score_opus":0.03316275995170153,"score_gpt":0.29745685224959295,"score_spread":0.2642940922978914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041731718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9733661,0.00013676456,0.02530212,0.00007900258,0.000007044815,0.000020608071,0.0006429321,0.000114755734,0.00033068267],"genre_scores_gemma":[0.9792726,0.00009995854,0.019455025,0.000045643876,0.0000070188867,0.000027319142,0.00078420615,0.000031779284,0.00027635993],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99977976,0.000051861105,0.00001149883,0.00008075101,0.000053227483,0.00002292252],"domain_scores_gemma":[0.99973685,0.00014815363,0.00006709918,0.0000123351965,0.000008715215,0.000026881693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004012268,0.00039648448,0.00039813432,0.0005212518,0.00016278049,0.00026794866,0.00045113536,0.00023503607,0.0013959124],"category_scores_gemma":[0.00040561185,0.00012316252,0.00049559947,0.00049291475,0.00031293728,0.000061201026,0.00021485068,0.00040623778,0.00014124169],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017092921,0.0003264205,0.045983043,0.0001733445,0.00040549156,0.0010535028,0.00007489888,0.012671866,0.9108952,0.0019111926,0.0002659312,0.024529856],"study_design_scores_gemma":[0.0008437022,0.001017005,0.61583674,0.000050424824,0.00089875725,0.004506088,0.00011007336,0.23067781,0.13878071,0.0042537022,0.0029116555,0.00011328319],"about_ca_topic_score_codex":0.0018823685,"about_ca_topic_score_gemma":0.0019263137,"teacher_disagreement_score":0.0018823685,"about_ca_system_score_codex":0.00025261726,"about_ca_system_score_gemma":0.00027789103,"threshold_uncertainty_score":0.0046697855},"labels":[],"label_agreement":null},{"id":"W2044174461","doi":"10.1097/fpc.0b013e32831367f0","title":"Confirmation of provisional quantitative trait loci for voluntary alcohol consumption: genetic analysis in chromosome substitution strains and F2 crosses derived from A/J and C57BL/6J progenitors","year":2008,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Neurotransmitter Receptor Influence on Behavior","field":"Neuroscience","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Quantitative trait locus; Biology; Genetics; Congenic; Chromosome; Allele; Chromosome 9; Chromosome 15; Gene","score_opus":0.08937623914260931,"score_gpt":0.3408272254194886,"score_spread":0.25145098627687934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044174461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940527,0.0001799334,0.0038458013,0.00002617877,0.000011098169,0.00009443723,0.0012733833,0.000059654558,0.00045666276],"genre_scores_gemma":[0.97883314,0.00029707776,0.011966464,0.00010417555,0.000016532367,0.0003315261,0.0035525016,0.00025690036,0.004641493],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99908984,0.00012156154,0.00010370892,0.00026765393,0.00028684805,0.00013045008],"domain_scores_gemma":[0.99834,0.00034555412,0.00064835494,0.00015697854,0.00012301638,0.0003859687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064854196,0.0010729715,0.000516674,0.0016682644,0.0006284362,0.0004897742,0.0007216326,0.0005924273,0.0032526874],"category_scores_gemma":[0.0004098006,0.00048246302,0.0006770781,0.0006363819,0.0005751462,0.00022135518,0.0006369602,0.0010142955,0.0004607774],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035640097,0.00012092569,0.0018625349,0.000023539831,0.000024494131,0.000059351627,0.00004579345,0.000035922723,0.99681973,0.000050633844,0.000012849333,0.0005879497],"study_design_scores_gemma":[0.0002182814,0.0018324961,0.20862672,0.00003710223,0.00027993225,0.0016789482,0.00020469807,0.0017874986,0.7829728,0.00007662427,0.0022228593,0.00006192223],"about_ca_topic_score_codex":0.003077274,"about_ca_topic_score_gemma":0.007671731,"teacher_disagreement_score":0.0032526874,"about_ca_system_score_codex":0.00045189328,"about_ca_system_score_gemma":0.0003858568,"threshold_uncertainty_score":0.010881305},"labels":[],"label_agreement":null},{"id":"W2044893269","doi":"10.1097/fpc.0b013e3283369347","title":"Chrna4 A529 knock-in mice exhibit altered nicotine sensitivity","year":2010,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Nicotinic Acetylcholine Receptors Study","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; National Institute on Drug Abuse; National Institute on Alcohol Abuse and Alcoholism","keywords":"Nicotine; Gene knockin; Nicotinic agonist; Biology; Nicotinic acetylcholine receptor; Acetylcholine receptor; Genetics; Conditioned place preference; Endocrinology; Pharmacology; Receptor; Internal medicine; Gene; Medicine; Neuroscience","score_opus":0.0074675665202372996,"score_gpt":0.26587207609449365,"score_spread":0.25840450957425637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044893269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894357,0.0006693601,0.004418594,0.00041688164,0.00019232654,0.000060344926,0.0023947,0.0004849954,0.0019270576],"genre_scores_gemma":[0.97957695,0.0008167021,0.0045994227,0.00038133338,0.0000660773,0.00016327128,0.0019474206,0.00045089438,0.011997854],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99906737,0.0000953602,0.00015508884,0.00032616715,0.00019479918,0.00016120798],"domain_scores_gemma":[0.9986695,0.00017803273,0.0005339355,0.0001129161,0.00007139101,0.00043413264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003832704,0.0012771009,0.00068194175,0.0013022609,0.0005149475,0.000815493,0.0006885306,0.0016765377,0.008729075],"category_scores_gemma":[0.00040061263,0.00068155647,0.0007476898,0.0004236424,0.0010192813,0.00043048465,0.0005003824,0.0017768431,0.0018736048],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003722711,0.00008573217,0.00029769193,0.00003463661,0.000023369796,0.00027939738,0.00002910216,0.00008746754,0.9978796,0.00013791265,0.000087017164,0.00068581547],"study_design_scores_gemma":[0.00033815295,0.001521364,0.027408902,0.00008752916,0.00020605313,0.003876556,0.00024935973,0.002988326,0.9579119,0.00043784536,0.0049013025,0.000072828785],"about_ca_topic_score_codex":0.0015166989,"about_ca_topic_score_gemma":0.0022866598,"teacher_disagreement_score":0.008729075,"about_ca_system_score_codex":0.00052923756,"about_ca_system_score_gemma":0.0003354203,"threshold_uncertainty_score":0.029201627},"labels":[],"label_agreement":null},{"id":"W2047017658","doi":"10.1097/fpc.0b013e32832a404f","title":"Genetic and environmental influences on the ratio of 3′hydroxycotinine to cotinine in plasma and urine","year":2009,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Nicotinic Acetylcholine Receptors Study","field":"Biochemistry, Genetics and Molecular Biology","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Center for Research Resources; National Institute on Drug Abuse","keywords":"Cotinine; Urine; Plasma concentration; Pharmacogenetics; Chemistry; Chromatography; Biology; Medicine; Pharmacology; Internal medicine; Genetics; Biochemistry; Genotype","score_opus":0.008232799267443911,"score_gpt":0.25039659575720036,"score_spread":0.24216379648975644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047017658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990631,0.00017393667,0.00047151206,0.00000915678,0.0000035586672,0.00000671042,0.00010530231,0.0000038097892,0.0001628913],"genre_scores_gemma":[0.99932086,0.00006346346,0.00039180453,0.000004439111,0.000003351542,0.0000054653565,0.000091467344,0.000003616296,0.000115563824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865204,0.0005270323,0.000081137565,0.00040215516,0.00026885312,0.000068835936],"domain_scores_gemma":[0.9983032,0.0006874125,0.0005139313,0.00020092385,0.00015523481,0.00013937366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000883574,0.00034625214,0.00032769458,0.00059454027,0.00023596588,0.0003840782,0.00021962207,0.00025119373,0.0010261626],"category_scores_gemma":[0.0035341075,0.0002810334,0.00034999003,0.0005038528,0.0004081855,0.0001512212,0.00028686313,0.00027023815,0.00013325142],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008983244,0.000072648385,0.9737519,0.000022090066,0.0004598956,0.00030444824,0.00021903898,0.00021763246,0.019099414,0.00009640845,0.000046921872,0.004811274],"study_design_scores_gemma":[0.0000038010915,0.00010052881,0.9985196,0.0000019066083,0.00005605183,0.00034420364,0.000029528142,0.0002827009,0.00059521256,0.000022099637,0.000041867374,0.0000025381023],"about_ca_topic_score_codex":0.0031451285,"about_ca_topic_score_gemma":0.0024562762,"teacher_disagreement_score":0.0031451285,"about_ca_system_score_codex":0.00015779711,"about_ca_system_score_gemma":0.00015170097,"threshold_uncertainty_score":0.0062536597},"labels":[],"label_agreement":null},{"id":"W2052300490","doi":"10.1097/fpc.0b013e3283498147","title":"Transcriptional diversity at the UGT2B7 locus is dictated by extensive pre-mRNA splicing mechanisms that give rise to multiple mRNA splice variants","year":2011,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval","funders":"Canadian Institutes of Health Research","keywords":"UGT2B7; Exon; Alternative splicing; Biology; Glucuronidation; RNA splicing; Gene isoform; Exon skipping; Messenger RNA; Locus (genetics); Genetics; Gene; Molecular biology; RNA","score_opus":0.10904525793029503,"score_gpt":0.34436475449878223,"score_spread":0.23531949656848722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052300490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887056,0.0026012314,0.0064979736,0.00009901396,0.0000159679,0.000024821356,0.00065131334,0.00008935548,0.001314725],"genre_scores_gemma":[0.9886458,0.0011890944,0.0049042543,0.0000685557,0.000035082918,0.000052335596,0.0036475542,0.000051604067,0.001405707],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996941,0.00004155906,0.000015060538,0.00011769997,0.00008750682,0.00004413766],"domain_scores_gemma":[0.99972314,0.00007244563,0.0000717061,0.000025446261,0.00006443171,0.00004278599],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020783019,0.00029264542,0.00035952614,0.0005604559,0.00019975599,0.00055216305,0.0001407005,0.0002897984,0.0010294626],"category_scores_gemma":[0.0002591748,0.00017652282,0.0004592805,0.00045316646,0.0003633444,0.00011789626,0.00024477782,0.00030165247,0.0006730462],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000124056,0.000012187584,0.0068955277,0.00005101586,0.000024981771,0.00017586269,0.00005890291,0.000088023844,0.98851776,0.00016986516,0.00004743298,0.0038343375],"study_design_scores_gemma":[0.00005071615,0.0004760935,0.21788466,0.00007474068,0.00017957011,0.0036773204,0.00027746276,0.0030225918,0.7635903,0.00082257,0.009910905,0.000033093722],"about_ca_topic_score_codex":0.00054729014,"about_ca_topic_score_gemma":0.0008637065,"teacher_disagreement_score":0.0010294626,"about_ca_system_score_codex":0.00024609882,"about_ca_system_score_gemma":0.00021960384,"threshold_uncertainty_score":0.0034438968},"labels":[],"label_agreement":null},{"id":"W2053419614","doi":"10.1097/fpc.0b013e3282f60db0","title":"Changes in consensus arylamine N-acetyltransferase gene nomenclature","year":2008,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Mass Spectrometry Techniques and Applications","field":"Chemistry","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; Wellcome Trust","keywords":"Arylamine N-acetyltransferase; Nat; Nomenclature; Gene nomenclature; Allele; Biology; Hamster; Genetics; Gene; Molecular biology; Zoology; Taxonomy (biology); Computer science","score_opus":0.020611292833785388,"score_gpt":0.26077561662073895,"score_spread":0.24016432378695357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053419614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29778388,0.03103727,0.22519983,0.04754685,0.07566029,0.0007451787,0.04479627,0.009338247,0.26789212],"genre_scores_gemma":[0.30332968,0.02824011,0.35846627,0.028884044,0.004298691,0.0011030827,0.1010552,0.004499785,0.17012313],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969003,0.0006269799,0.00068617193,0.00060290436,0.0009668643,0.00021675721],"domain_scores_gemma":[0.9943545,0.0006827469,0.0007111401,0.0008745959,0.0028360644,0.0005410153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00364286,0.00065602886,0.00071993115,0.0016377994,0.0006329152,0.0012073318,0.0014490188,0.0010722665,0.011071659],"category_scores_gemma":[0.0055801473,0.00027574695,0.0006983195,0.0020665978,0.00055427675,0.0008085654,0.0007762601,0.002757465,0.0099860355],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001252389,0.00029418967,0.014256813,0.00084601477,0.00017995172,0.0017437154,0.00092480227,0.0014674917,0.2203864,0.034700725,0.26310518,0.46084234],"study_design_scores_gemma":[0.000056691224,0.0002746607,0.010453623,0.00026932234,0.00008000075,0.0025820276,0.0002810044,0.0006113206,0.025825312,0.004361065,0.95512176,0.00008324079],"about_ca_topic_score_codex":0.0025992736,"about_ca_topic_score_gemma":0.0038603535,"teacher_disagreement_score":0.011071659,"about_ca_system_score_codex":0.0013971652,"about_ca_system_score_gemma":0.0019830565,"threshold_uncertainty_score":0.037038386},"labels":[],"label_agreement":null},{"id":"W2055253331","doi":"10.1097/fpc.0b013e328363c137","title":"Genetic variants associated with angiotensin-converting enzyme inhibitor-associated angioedema","year":2013,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute; McMaster University","funders":"National Center for Research Resources; National Institute of General Medical Sciences; National Heart, Lung, and Blood Institute; National Institutes of Health; Vanderbilt University","keywords":"Angioedema; Angiotensin-converting enzyme; Pharmacogenetics; Genetic variants; Genetics; Enzyme; Biology; Pharmacology; Computational biology; Medicine; Internal medicine; Immunology; Gene; Biochemistry; Genotype","score_opus":0.015489563182125807,"score_gpt":0.23714980731696197,"score_spread":0.22166024413483618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055253331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991567,0.00018583822,0.00015703504,0.000035963873,0.0000036991166,0.000008866191,0.00019908117,0.0000036808567,0.00024910268],"genre_scores_gemma":[0.9994518,0.000042806325,0.00022878985,0.000027492704,0.0000072042567,0.0000031227187,0.00010519661,0.0000019428383,0.00013161219],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99965906,0.00007976042,0.000036954345,0.000109909844,0.00006809908,0.000046324614],"domain_scores_gemma":[0.999302,0.00022410606,0.00032405366,0.000034324737,0.000046866582,0.00006868461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039611312,0.00037201017,0.00024164162,0.0004841642,0.00027975533,0.00035420174,0.00025190774,0.00033728368,0.0024244736],"category_scores_gemma":[0.0010918379,0.00011509108,0.00029180205,0.0006982866,0.00027473556,0.0001372533,0.00018226473,0.00027440576,0.00014383023],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064387114,0.000089957684,0.98349667,0.000036837355,0.00027800977,0.0012983999,0.000110420144,0.00015775845,0.010554195,0.00008057298,0.00017135168,0.0030818724],"study_design_scores_gemma":[0.000044954002,0.00012208454,0.9966428,0.000011554681,0.00013733078,0.0016044765,0.000047582835,0.00025410097,0.00080034806,0.000054479173,0.00027518132,0.000005085012],"about_ca_topic_score_codex":0.004002074,"about_ca_topic_score_gemma":0.004835537,"teacher_disagreement_score":0.004002074,"about_ca_system_score_codex":0.00016890414,"about_ca_system_score_gemma":0.00021119758,"threshold_uncertainty_score":0.008110702},"labels":[],"label_agreement":null},{"id":"W2056568858","doi":"10.1097/fpc.0b013e328340095e","title":"Comparison of the efficacy of fibrates on hypertriglyceridemic phenotypes with different genetic and clinical characteristics","year":2010,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; Université de Montréal; Cégep de Chicoutimi; Université du Québec à Chicoutimi","funders":"Canadian Institutes of Health Research","keywords":"Hypertriglyceridemia; Internal medicine; Triglyceride; Endocrinology; Medicine; Fibrate; Fenofibrate; Gastroenterology; Cholesterol","score_opus":0.026526117734047446,"score_gpt":0.33561607977631536,"score_spread":0.3090899620422679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056568858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99916136,0.00052904815,0.000047300982,0.000010502757,0.0000067160295,0.0000073401798,0.000037983133,0.000003098327,0.00019663123],"genre_scores_gemma":[0.99954444,0.00011831749,0.00008375505,0.000023814546,0.000013752551,0.000009564145,0.000115797215,0.0000014330678,0.000089137655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995647,0.00018697277,0.00006927004,0.00007274906,0.000059000802,0.00004733132],"domain_scores_gemma":[0.9987675,0.0005367595,0.00027661238,0.00008260322,0.00012581515,0.00021076601],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076278043,0.0003013906,0.0006890935,0.00023464848,0.00013806358,0.00020114893,0.000095545656,0.000251441,0.0006319905],"category_scores_gemma":[0.0012759197,0.00008859847,0.00046795615,0.00015186872,0.00013504452,0.00013033708,0.00011546339,0.00022295056,0.000117815456],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17530319,0.0036598444,0.67031384,0.0003403926,0.0022875676,0.00069769396,0.00031025216,0.00090508064,0.06627387,0.000050053008,0.00029559035,0.07956251],"study_design_scores_gemma":[0.0013536188,0.050499875,0.93451524,0.00002113127,0.0007236498,0.000933753,0.00014645953,0.0006498064,0.010632441,0.000039335715,0.00046407717,0.000020520036],"about_ca_topic_score_codex":0.00018378388,"about_ca_topic_score_gemma":0.00039072527,"teacher_disagreement_score":0.00076278043,"about_ca_system_score_codex":0.00010467006,"about_ca_system_score_gemma":0.00009189175,"threshold_uncertainty_score":0.0040339828},"labels":[],"label_agreement":null},{"id":"W2058506110","doi":"10.1097/01.fpc.0000172244.65417.7a","title":"Influence of the eNOS gene on development of blood pressure and left ventricular mass: Longitudinal findings in multiethnic youth","year":2005,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Nitric Oxide and Endothelin Effects","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"National Heart, Lung, and Blood Institute; American Heart Association","keywords":"Enos; Blood pressure; Internal medicine; Cardiology; Medicine; Biology; Nitric oxide","score_opus":0.016256280630623288,"score_gpt":0.2596652068018319,"score_spread":0.24340892617120863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058506110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997242,0.00009771831,0.000044541124,0.000011551034,0.0000013824348,0.0000011745693,0.000055379172,0.0000015948735,0.000062451676],"genre_scores_gemma":[0.9995963,0.00007657068,0.00008037413,0.000007214739,0.0000028541062,0.0000033684832,0.0001024367,0.0000018642704,0.000129013],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99971634,0.000084341395,0.000021389167,0.000072642026,0.000057147165,0.00004806096],"domain_scores_gemma":[0.99918026,0.00011059314,0.0003320651,0.000060664686,0.00012541181,0.00019099543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007068645,0.00020308704,0.00022731998,0.00042696384,0.00037618092,0.00038392772,0.00021166244,0.00031991498,0.0006081377],"category_scores_gemma":[0.0013076987,0.00022382106,0.00033648525,0.0003730806,0.0001816696,0.000285717,0.00037558234,0.0003731009,0.00011736637],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000070370625,0.000034871187,0.99786574,0.0000027487936,0.00004035088,0.00007588191,0.00013968536,0.000021769452,0.0005771318,0.000008768367,0.000019392271,0.001143386],"study_design_scores_gemma":[0.0000013891278,0.00006654609,0.999511,0.0000028794377,0.000018397348,0.00012737852,0.000074680844,0.000064689215,0.000077918856,0.000006844338,0.000047184785,0.0000011052387],"about_ca_topic_score_codex":0.004778591,"about_ca_topic_score_gemma":0.005311487,"teacher_disagreement_score":0.004778591,"about_ca_system_score_codex":0.00014236111,"about_ca_system_score_gemma":0.00022635752,"threshold_uncertainty_score":0.009501576},"labels":[],"label_agreement":null},{"id":"W2059633613","doi":"10.1097/01.fpc.0000173484.51807.48","title":"Functional characterization of non-synonymous single nucleotide polymorphisms in the gene encoding human multidrug resistance protein 1 (MRP1/ABCC1)","year":2005,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"ABCC1; Single-nucleotide polymorphism; Biology; Genetics; Mutant; Gene; Efflux; ATP-binding cassette transporter; Mutagenesis; Wild type; Multidrug Resistance-Associated Proteins; Transporter; Genotype","score_opus":0.020803948752786686,"score_gpt":0.2486905487021202,"score_spread":0.22788659994933352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059633613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99815375,0.00031055245,0.0008358115,0.000040269017,0.000014101151,0.000016691545,0.00038226772,0.000013453693,0.0002329824],"genre_scores_gemma":[0.9978381,0.00016327882,0.0011403592,0.000047166897,0.000011903844,0.000015627978,0.0004918024,0.0000144712285,0.00027739006],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997961,0.0000585542,0.000032375396,0.000049741957,0.00004765306,0.000015535868],"domain_scores_gemma":[0.9996933,0.00011650082,0.000102105456,0.00002393705,0.00003198723,0.000032297197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021666776,0.00033350603,0.00022044657,0.00025677108,0.00013058264,0.00016474813,0.00014099934,0.00035543455,0.0008589145],"category_scores_gemma":[0.0004364012,0.00012180619,0.00028157947,0.00024104174,0.00019644227,0.000056385816,0.00007288366,0.00029081057,0.0002810996],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006519448,0.0001452214,0.020551208,0.00010179272,0.00012130868,0.0021558134,0.00013158566,0.00050350715,0.96731967,0.0001961702,0.00014546329,0.007976267],"study_design_scores_gemma":[0.000304429,0.0021022316,0.40923664,0.000040333693,0.0006092875,0.0230377,0.00021395084,0.008843773,0.54785657,0.0003796011,0.007298354,0.00007713197],"about_ca_topic_score_codex":0.00060688664,"about_ca_topic_score_gemma":0.0006673695,"teacher_disagreement_score":0.0008589145,"about_ca_system_score_codex":0.00013706104,"about_ca_system_score_gemma":0.000116794086,"threshold_uncertainty_score":0.0028733015},"labels":[],"label_agreement":null},{"id":"W2060079516","doi":"10.1097/fpc.0b013e328336ef1c","title":"Extensive splicing of transcripts encoding the bile acid-conjugating enzyme UGT2B4 modulates glucuronidation","year":2010,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Université Laval; Centre hospitalier universitaire de Québec","funders":"Canadian Institutes of Health Research; Canada Research Chairs","keywords":"Exon; Biology; Glucuronidation; Alternative splicing; Gene; RNA splicing; Gene isoform; Molecular biology; Genetics; Biochemistry; Enzyme; RNA; Microsome","score_opus":0.0675290214685342,"score_gpt":0.38030536502945145,"score_spread":0.3127763435609172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060079516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99329764,0.000656764,0.004704585,0.000054409786,0.000022636901,0.000012156047,0.00032463597,0.000059432194,0.0008677036],"genre_scores_gemma":[0.99559313,0.00043291523,0.0020228443,0.000031016174,0.0000126710465,0.000018841905,0.0006260357,0.000031362455,0.0012311214],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987197,0.000017662187,0.0000106238695,0.000049636878,0.000028869394,0.000021254458],"domain_scores_gemma":[0.9998005,0.000039397586,0.00007382815,0.000022476966,0.000025665588,0.000038243033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013809808,0.00033865162,0.00017535457,0.00017955931,0.00011044929,0.0002592675,0.00014033754,0.00022106389,0.0015177925],"category_scores_gemma":[0.0001860756,0.00012732465,0.00027960198,0.00015481473,0.0002697231,0.00009611717,0.00020854558,0.00032598575,0.00038434265],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060901348,0.0000056591084,0.0016896533,0.00001782623,0.000006228078,0.0001175755,0.000018110699,0.00003306835,0.9966247,0.00006247277,0.00002600153,0.0013377785],"study_design_scores_gemma":[0.000019786054,0.00023205698,0.05077085,0.000013047686,0.000064111584,0.0014359814,0.00006670213,0.0011703937,0.9436394,0.0001537772,0.002426071,0.000007799008],"about_ca_topic_score_codex":0.00031913663,"about_ca_topic_score_gemma":0.00030284375,"teacher_disagreement_score":0.0015177925,"about_ca_system_score_codex":0.00018796779,"about_ca_system_score_gemma":0.00012927101,"threshold_uncertainty_score":0.005077541},"labels":[],"label_agreement":null},{"id":"W2061587734","doi":"10.1097/01.fpc.0000173483.13689.56","title":"Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily","year":2005,"lang":"en","type":"review","venue":"Pharmacogenetics and Genomics","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":818,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Canadian Institutes of Health Research","funders":"National Institute of Environmental Health Sciences","keywords":"Exon; Tandem exon duplication; Gene; Genetics; Biology; Gene duplication; Gene nomenclature; Genome; Gene family; Nomenclature; Taxonomy (biology)","score_opus":0.053841218278205184,"score_gpt":0.3431138725821247,"score_spread":0.2892726543039195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061587734","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007312632,0.77967954,0.07054496,0.021431908,0.056088414,0.0003614291,0.007350238,0.001902577,0.055328332],"genre_scores_gemma":[0.023050955,0.724623,0.14186859,0.01683993,0.01902143,0.0010538315,0.03403869,0.0011000521,0.03840352],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997387,0.0006672892,0.0006125855,0.00037111915,0.00082770095,0.00013444173],"domain_scores_gemma":[0.99700505,0.00038986586,0.00038524444,0.00018068479,0.0018338505,0.00020527723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002377791,0.0013709383,0.0018849478,0.0044710743,0.0010319263,0.0018949701,0.0020729771,0.0014325652,0.008252668],"category_scores_gemma":[0.003957846,0.00035170355,0.0015904495,0.0050471425,0.001468442,0.0027174654,0.0013164212,0.003917026,0.008799436],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027207626,0.00008696694,0.0019701088,0.004617403,0.00015699198,0.0010324896,0.00080803497,0.0005300264,0.012207653,0.025314678,0.3739842,0.57901937],"study_design_scores_gemma":[0.0000058086334,0.00003427857,0.00040541674,0.0003192548,0.000038261885,0.0008290215,0.00004737156,0.00004778546,0.00033282617,0.0010705952,0.99685645,0.000012716039],"about_ca_topic_score_codex":0.0029526255,"about_ca_topic_score_gemma":0.0024330448,"teacher_disagreement_score":0.008252668,"about_ca_system_score_codex":0.0014737331,"about_ca_system_score_gemma":0.004552791,"threshold_uncertainty_score":0.027607977},"labels":[],"label_agreement":null},{"id":"W2065073682","doi":"10.1097/fpc.0b013e328344c5c6","title":"Bioavailability of testosterone enanthate dependent on genetic variation in the phosphodiesterase 7B but not on the uridine 5′-diphospho-glucuronosyltransferase (UGT2B17) gene.","year":2011,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Stockholms Läns Landsting; Canadian Institutes of Health Research; World Anti-Doping Agency; Canada Research Chairs","keywords":"Androgen; Testosterone (patch); Endocrinology; Internal medicine; Glucuronosyltransferase; Biology; Genetic variation; Allele; Genotype; Single-nucleotide polymorphism; Gene; Chemistry; Genetics; Medicine; Hormone; Microsome; In vitro","score_opus":0.05571974258801401,"score_gpt":0.26050481088941985,"score_spread":0.20478506830140583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065073682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99762243,0.0008778619,0.0007388402,0.00005015594,0.000018855711,0.000012656797,0.0001775082,0.000008902086,0.00049269473],"genre_scores_gemma":[0.9989248,0.00011271728,0.00021411269,0.000025021078,0.000007677065,0.000006564462,0.00014675835,0.00001135456,0.00055110117],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9996327,0.00015251357,0.00001845227,0.000101744,0.00006440978,0.000030035313],"domain_scores_gemma":[0.99945015,0.00019500339,0.00018298058,0.00006044375,0.000027777925,0.000083669154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002931145,0.00024226609,0.00029002034,0.00023977556,0.00012891232,0.00028225005,0.000145372,0.0002696948,0.0026985365],"category_scores_gemma":[0.0006697592,0.00021728883,0.0003365987,0.00019205986,0.00030784754,0.0001227229,0.00012914473,0.00030453372,0.0003024089],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077857343,0.0004471118,0.30893016,0.000121042,0.00079220685,0.0011040841,0.00038958527,0.00023007026,0.66484255,0.0002352999,0.00036486602,0.014757269],"study_design_scores_gemma":[0.000084314204,0.0008284946,0.979353,0.00000840647,0.00016090031,0.0016626284,0.00006438366,0.00048981817,0.01660129,0.00008627276,0.00065179577,0.000008732564],"about_ca_topic_score_codex":0.000985027,"about_ca_topic_score_gemma":0.0007080947,"teacher_disagreement_score":0.0026985365,"about_ca_system_score_codex":0.00015212946,"about_ca_system_score_gemma":0.00012045377,"threshold_uncertainty_score":0.009027541},"labels":[],"label_agreement":null},{"id":"W2068212056","doi":"10.1097/fpc.0b013e3283539062","title":"DRD1 associations with smoking abstinence across slow and normal nicotine metabolizers","year":2012,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"National Cancer Institute; National Institute on Drug Abuse","keywords":"Nicotine; Smoking cessation; Abstinence; Odds ratio; CYP2A6; Nicotinic agonist; Bonferroni correction; Medicine; Internal medicine; Pharmacology; Psychology; Psychiatry; Receptor; Metabolism; Pathology","score_opus":0.02997270005820581,"score_gpt":0.3222851463178931,"score_spread":0.29231244625968733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068212056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991659,0.0002430156,0.00019498325,0.000047131398,0.0000030374283,0.0000063643224,0.0001296804,0.0000038825674,0.00020588307],"genre_scores_gemma":[0.9993825,0.00006214545,0.00019683593,0.000024156283,0.0000052065657,0.0000066309335,0.00012751174,0.000003853202,0.00019105595],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99940455,0.00022987626,0.00008020979,0.00017701666,0.000053853288,0.000054560365],"domain_scores_gemma":[0.9986708,0.00059095543,0.0003799645,0.00014505927,0.00006439581,0.00014881126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011675818,0.00047476555,0.00069771253,0.0007247833,0.00030695865,0.00045853556,0.00028155986,0.00045084214,0.0025035895],"category_scores_gemma":[0.0029611783,0.00026895734,0.0006292954,0.0005260996,0.00038872426,0.00024120312,0.00050165487,0.0006745231,0.0001273788],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058265408,0.00011222819,0.9742507,0.000038466904,0.00053550163,0.0002993174,0.00018578183,0.00023923891,0.008749698,0.0002089911,0.00014011157,0.009413475],"study_design_scores_gemma":[0.00011046478,0.00049933774,0.99671656,0.0000071920676,0.00025312084,0.0004601159,0.00007714854,0.00056083244,0.00073564256,0.00034952766,0.00022316544,0.0000069547614],"about_ca_topic_score_codex":0.0015388144,"about_ca_topic_score_gemma":0.0017024892,"teacher_disagreement_score":0.0025035895,"about_ca_system_score_codex":0.00015635508,"about_ca_system_score_gemma":0.000111415815,"threshold_uncertainty_score":0.008375406},"labels":[],"label_agreement":null},{"id":"W2070001149","doi":"10.1097/fpc.0b013e3282f1f118","title":"Genetic diversity at the UGT1 locus is amplified by a novel 3′ alternative splicing mechanism leading to nine additional UGT1A proteins that act as regulators of glucuronidation activity","year":2007,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Exon; Alternative splicing; Gene isoform; Biology; Gene; Genetics; Exon skipping; Glucuronidation; Locus (genetics); RNA splicing; Microsome; RNA","score_opus":0.08133985469911617,"score_gpt":0.37645900795841075,"score_spread":0.2951191532592946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070001149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949763,0.00028535904,0.0036839037,0.000029086752,0.000007681877,0.00002201244,0.00024398907,0.00008603667,0.0006656132],"genre_scores_gemma":[0.9936935,0.00028452728,0.0033550826,0.0000329726,0.000021917198,0.00004194421,0.0016522171,0.000044880893,0.00087307766],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997801,0.000030383986,0.00001685485,0.00009094882,0.00004720415,0.000034563334],"domain_scores_gemma":[0.9997092,0.000057301902,0.00013325136,0.000032220614,0.000017355826,0.000050675833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001342037,0.000544576,0.00025915183,0.0005831556,0.00018123223,0.00029445166,0.00028189563,0.00026199865,0.0013995944],"category_scores_gemma":[0.0002013024,0.0001959839,0.0005590544,0.0003963626,0.0002531308,0.00009176618,0.00031387157,0.00049009296,0.00044914676],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001683783,0.000026257763,0.0044941516,0.000027270211,0.000028560271,0.00045895547,0.00003745151,0.000106352774,0.9907141,0.00014418706,0.000044215234,0.0037500765],"study_design_scores_gemma":[0.0001191069,0.0010330059,0.18313627,0.000045907324,0.000416611,0.020741846,0.00010730109,0.0042679766,0.7811074,0.00056396984,0.008402714,0.000057832898],"about_ca_topic_score_codex":0.00027158644,"about_ca_topic_score_gemma":0.00029059825,"teacher_disagreement_score":0.0013995944,"about_ca_system_score_codex":0.0002626111,"about_ca_system_score_gemma":0.00015537108,"threshold_uncertainty_score":0.0046821237},"labels":[],"label_agreement":null},{"id":"W2071101196","doi":"10.1097/fpc.0b013e3282f01aa3","title":"CYP2D6 and DRD2 genes differentially impact pharmacodynamic sensitivity and time course of prolactin response to perphenazine","year":2007,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of Toronto","funders":"","keywords":"Perphenazine; Pharmacogenetics; Pharmacodynamics; CYP2D6; Pharmacology; Gene; Medicine; Biology; Pharmacokinetics; Genetics; Genotype","score_opus":0.035398069190745,"score_gpt":0.4098867385297899,"score_spread":0.3744886693390449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071101196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991073,0.00021830123,0.00015075383,0.000058200978,0.0000032163632,0.0000070280107,0.00021496373,0.0000040946434,0.00023611421],"genre_scores_gemma":[0.99934274,0.00006615514,0.00015601258,0.000023155342,0.000004211239,0.000003055749,0.00012843196,0.0000029819266,0.00027328177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99974734,0.00005186699,0.000014584091,0.00007255524,0.00006500827,0.000048802747],"domain_scores_gemma":[0.9996306,0.0000939476,0.00014202247,0.00002492559,0.000048295562,0.000060235856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022772868,0.00028307553,0.0002679425,0.00028207066,0.00018952668,0.00030923064,0.00017293214,0.0002492943,0.0015610899],"category_scores_gemma":[0.0006859782,0.00012885848,0.0003550632,0.00052862725,0.00027362045,0.0000880951,0.000104578176,0.00032701172,0.000119024044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026933646,0.00011272192,0.9360488,0.00003715551,0.00027439758,0.000651783,0.0002246762,0.0002884319,0.049488325,0.00007981838,0.000223439,0.009877221],"study_design_scores_gemma":[0.00002575114,0.0000991833,0.99701405,0.0000015833974,0.00005007189,0.0005337201,0.000040560553,0.00026458286,0.0017485077,0.000021227708,0.00019706508,0.000003752907],"about_ca_topic_score_codex":0.030619498,"about_ca_topic_score_gemma":0.024420595,"teacher_disagreement_score":0.030619498,"about_ca_system_score_codex":0.00057408976,"about_ca_system_score_gemma":0.00044285212,"threshold_uncertainty_score":0.06088257},"labels":[],"label_agreement":null},{"id":"W2075089790","doi":"10.1097/fpc.0b013e3283330767","title":"Human UDP-glucuronosyltransferase UGT2A2: cDNA construction, expression, and functional characterization in comparison with UGT2A1 and UGT2A3","year":2009,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Drug Research and Development","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of General Medical Sciences; National Institute of Environmental Health Sciences; National Institute on Deafness and Other Communication Disorders; National Institutes of Health","keywords":"Glucuronidation; Complementary DNA; Molecular biology; Recombinant DNA; Biology; genomic DNA; Exon; Glucuronosyltransferase; UGT2B7; Chemistry; Biochemistry; Gene; Enzyme; Microsome","score_opus":0.05646111701490544,"score_gpt":0.36415622683245163,"score_spread":0.3076951098175462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075089790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9245778,0.012483227,0.043572973,0.001174836,0.00039874786,0.0005653131,0.011201311,0.00060254993,0.005423255],"genre_scores_gemma":[0.8241007,0.011896271,0.08897986,0.0004446764,0.00037899494,0.000701619,0.05055974,0.00038360214,0.02255461],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99974746,0.000034465138,0.000021412567,0.00008023738,0.000082267245,0.000034200355],"domain_scores_gemma":[0.9998753,0.000019459661,0.000023720233,0.000017078624,0.000035382196,0.000029071367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033322824,0.0004841397,0.00045020398,0.0003630309,0.00028945875,0.00049136556,0.0002940794,0.00054466084,0.0018312443],"category_scores_gemma":[0.00033565224,0.00021619789,0.0005677214,0.000745322,0.0002961482,0.00029545615,0.00017570067,0.0005933676,0.0013462706],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002173649,0.00004360527,0.00065175735,0.00012875165,0.000018172526,0.00014522702,0.000029208622,0.00020168565,0.9936215,0.0001888362,0.0003882842,0.0043657073],"study_design_scores_gemma":[0.00011366009,0.000396975,0.015639551,0.00002512891,0.00014377071,0.0033598216,0.00004802035,0.004682197,0.9276226,0.00022097767,0.047715012,0.000032222248],"about_ca_topic_score_codex":0.0012163422,"about_ca_topic_score_gemma":0.0012256089,"teacher_disagreement_score":0.0018312443,"about_ca_system_score_codex":0.00042268148,"about_ca_system_score_gemma":0.00044047544,"threshold_uncertainty_score":0.006126106},"labels":[],"label_agreement":null},{"id":"W2081207967","doi":"10.1097/fpc.0b013e3282f974dc","title":"Breast cancer resistance protein (ABCG2) and drug disposition: intestinal expression, polymorphisms and sulfasalazine as an in vivo probe","year":2008,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"National Institute of General Medical Sciences; U.S. Public Health Service; Health Research Board; Vanderbilt University; Pfizer","keywords":"Abcg2; Sulfasalazine; Single-nucleotide polymorphism; Pharmacology; Genotype; Pharmacogenetics; Biology; In vivo; Medicine; Internal medicine; ATP-binding cassette transporter; Ulcerative colitis; Transporter; Genetics; Gene","score_opus":0.011128831756733674,"score_gpt":0.25464161126477963,"score_spread":0.24351277950804595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081207967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985551,0.000500053,0.0005326385,0.000035778095,0.000001942699,0.000005206762,0.00005736822,0.0000058523333,0.00030616566],"genre_scores_gemma":[0.9985727,0.00017551387,0.00062531367,0.000031688523,0.0000029192151,0.000012435254,0.000103901475,0.000002884878,0.0004726034],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998466,0.0000830394,0.000004798118,0.000032476422,0.000017241488,0.000015789992],"domain_scores_gemma":[0.99992585,0.00002647852,0.000019403604,0.000008642307,0.000008576386,0.000010962796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015750069,0.00019724746,0.00018669193,0.00013391174,0.000111028494,0.00018223729,0.00006523854,0.00033306755,0.0010692761],"category_scores_gemma":[0.00021148776,0.00012917464,0.000104251696,0.00021075661,0.0001650697,0.00011129295,0.00008497012,0.00027633016,0.00015486404],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016062381,0.00010471501,0.035576366,0.00004890881,0.000033833843,0.00021508143,0.00008506923,0.00012988492,0.9569921,0.00005255097,0.00005051956,0.0051045874],"study_design_scores_gemma":[0.00012692863,0.0029060587,0.5220595,0.000008350218,0.0001154839,0.0029797722,0.00018621491,0.0024419434,0.46713483,0.00010213008,0.001926964,0.000011892049],"about_ca_topic_score_codex":0.0005677395,"about_ca_topic_score_gemma":0.0007216797,"teacher_disagreement_score":0.0010692761,"about_ca_system_score_codex":0.00015177795,"about_ca_system_score_gemma":0.000047593603,"threshold_uncertainty_score":0.0035771132},"labels":[],"label_agreement":null},{"id":"W2082177471","doi":"10.1097/fpc.0b013e3283510a35","title":"PRKCB is associated with calcineurin inhibitor-induced renal dysfunction in heart transplant recipients","year":2012,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Transplantation: Methods and Outcomes","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Montreal Heart Institute; Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Calcineurin; Renal function; Single-nucleotide polymorphism; Internal medicine; Medicine; Nephrotoxicity; Transplantation; Heart transplantation; Biology; Endocrinology; Pharmacology; Kidney; Gene; Genotype; Genetics","score_opus":0.0439905346409824,"score_gpt":0.32063186303166935,"score_spread":0.27664132839068695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082177471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99925095,0.0003164807,0.000112437854,0.00003759593,0.0000049928767,0.0000024822498,0.000072255236,0.000005149943,0.00019761894],"genre_scores_gemma":[0.99963164,0.000078868885,0.00006836973,0.00001591571,0.000010375659,0.0000027286435,0.00007407654,0.0000025878492,0.0001154889],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99963975,0.00007325051,0.00005176688,0.00010999895,0.00007600708,0.000049262322],"domain_scores_gemma":[0.9989975,0.00013338504,0.0006188905,0.000061272,0.000058068068,0.00013082099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036188628,0.00028722984,0.0002797321,0.0005087032,0.00035763998,0.00041160965,0.00036433572,0.0003994535,0.0024961377],"category_scores_gemma":[0.0012513412,0.00019307726,0.00046731866,0.0007856382,0.00022721314,0.00016506482,0.0002494591,0.0005136479,0.00028997083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054043607,0.00004500111,0.9929658,0.000026910397,0.00013707016,0.00048390674,0.000044903794,0.00006066104,0.0034602373,0.00002494258,0.000077202625,0.002132981],"study_design_scores_gemma":[0.000026583553,0.0001282381,0.9960515,0.000009466896,0.000108309105,0.0028459525,0.00005425207,0.0002519862,0.00031081826,0.000031386204,0.00017724726,0.000004191641],"about_ca_topic_score_codex":0.0015799882,"about_ca_topic_score_gemma":0.00082511094,"teacher_disagreement_score":0.0024961377,"about_ca_system_score_codex":0.00015554954,"about_ca_system_score_gemma":0.00019625411,"threshold_uncertainty_score":0.008350372},"labels":[],"label_agreement":null},{"id":"W2083377767","doi":"10.1097/fpc.0000000000000135","title":"Genetic and phenotypic variation in UGT2B17, a testosterone-metabolizing enzyme, is associated with BMI in males","year":2015,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto; Centre for Addiction and Mental Health","funders":"National Cancer Institute; National Institute on Minority Health and Health Disparities; Canadian Institutes of Health Research; National Institute on Drug Abuse; U.S. Public Health Service","keywords":"Testosterone (patch); Biology; Genotype; Internal medicine; Phenotype; Endocrinology; Genetics; Body mass index; Gene; Medicine","score_opus":0.0377897331096415,"score_gpt":0.2797763342787374,"score_spread":0.24198660116909587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083377767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99907696,0.00027734909,0.0002561166,0.000023085624,0.000003775798,0.0000021365347,0.00016497979,0.000008355862,0.0001871428],"genre_scores_gemma":[0.999276,0.000091392,0.00020009458,0.000009586119,0.000007737295,0.0000029438852,0.00019962304,0.0000037879627,0.00020882543],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99981123,0.000043828302,0.000014315029,0.00006277241,0.00004918617,0.00001865816],"domain_scores_gemma":[0.9995653,0.000062909654,0.00024566433,0.000030192385,0.000033904762,0.000061944964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023328482,0.00031899186,0.00020383277,0.0004959043,0.00020500552,0.00019231549,0.00014397499,0.00018984517,0.0022400867],"category_scores_gemma":[0.0005472528,0.00013117482,0.00022082943,0.0004319645,0.00020970886,0.00007187253,0.00016108957,0.00024915935,0.00020915712],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036549833,0.00003772053,0.97774625,0.000016709979,0.00013421885,0.00018901176,0.00009242611,0.00005259149,0.018382028,0.000049944145,0.00007542635,0.0028581244],"study_design_scores_gemma":[0.0000024035862,0.000042967495,0.998811,0.0000022455397,0.000021656118,0.0004608557,0.000022689228,0.00005189066,0.00047756644,0.000011532385,0.00009409357,0.0000010357294],"about_ca_topic_score_codex":0.0013809379,"about_ca_topic_score_gemma":0.00093546556,"teacher_disagreement_score":0.0022400867,"about_ca_system_score_codex":0.000088347144,"about_ca_system_score_gemma":0.000067692876,"threshold_uncertainty_score":0.0074938536},"labels":[],"label_agreement":null},{"id":"W2084109130","doi":"10.1097/fpc.0b013e3283307cf1","title":"Weight loss and body fat reduction under sibutramine therapy in obesity with the C825T polymorphism in the GNB3 gene","year":2009,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"","keywords":"Sibutramine; Weight loss; Endocrinology; Internal medicine; Obesity; Single-nucleotide polymorphism; Polymorphism (computer science); Medicine; Body mass index; Pharmacogenetics; Allele; Pharmacology; Genotype; Biology; Genetics; Gene","score_opus":0.01550771285781099,"score_gpt":0.27714940053489795,"score_spread":0.26164168767708695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084109130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99966633,0.00015061391,0.00005536926,0.000031887077,0.0000032966354,0.0000026296157,0.000013523721,0.0000028998581,0.000073352276],"genre_scores_gemma":[0.9996531,0.000065353895,0.00011249029,0.00003681072,0.000006491569,0.000005007726,0.000037985774,0.0000018876577,0.00008087958],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99967575,0.00016658884,0.000027004719,0.000051122795,0.00005413405,0.000025394584],"domain_scores_gemma":[0.99953246,0.00016101668,0.00018437464,0.00004089331,0.000023503888,0.000057811205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005040421,0.0003024614,0.0005877998,0.00030170972,0.00017429555,0.00023778893,0.0001393566,0.000409014,0.0008701095],"category_scores_gemma":[0.0011557363,0.00020663023,0.0004274833,0.00025812624,0.0003310024,0.00010893326,0.0001690809,0.0005058689,0.00011913009],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022553902,0.00084558316,0.8715066,0.000106967746,0.00164217,0.0008427928,0.0001924309,0.00047597638,0.07596686,0.000050529048,0.00014747871,0.025668712],"study_design_scores_gemma":[0.0003993224,0.003024676,0.9915609,0.0000079774845,0.00040750174,0.0006783837,0.00005171572,0.00073505624,0.002982269,0.00004433083,0.00010169274,0.0000061580877],"about_ca_topic_score_codex":0.0012781797,"about_ca_topic_score_gemma":0.0015154097,"teacher_disagreement_score":0.0012781797,"about_ca_system_score_codex":0.00021194578,"about_ca_system_score_gemma":0.00018427485,"threshold_uncertainty_score":0.0029107928},"labels":[],"label_agreement":null},{"id":"W2084835385","doi":"10.1097/fpc.0000000000000123","title":"VDR gene polymorphisms impact on anemia at 2 weeks of anti-HCV therapy","year":2015,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"123 Certification (Canada)","funders":"","keywords":"Calcitriol receptor; ITPA; Internal medicine; Calcitriol; Ribavirin; Endocrinology; Vitamin D and neurology; Anemia; Medicine; Pharmacology; Hepatitis C virus; Immunology; Virus","score_opus":0.05875356388997557,"score_gpt":0.36253693322274516,"score_spread":0.3037833693327696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084835385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991322,0.00042415148,0.00008190499,0.000018742885,0.0000047094736,0.0000049649157,0.00007816636,0.0000031288077,0.0002519896],"genre_scores_gemma":[0.99965465,0.00003576254,0.000052115836,0.000008708067,0.0000043516657,0.0000031859395,0.00006717938,0.0000016711949,0.00017227257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996362,0.00012785466,0.000035298755,0.00009510797,0.000056006782,0.000049610506],"domain_scores_gemma":[0.9988319,0.0003662179,0.0005346516,0.000051984127,0.00007990593,0.00013530647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042329018,0.00026365602,0.0003555342,0.00033055933,0.00018150789,0.00041193957,0.00017057033,0.00041954292,0.00195384],"category_scores_gemma":[0.0015586428,0.00017648496,0.0004547195,0.00030623053,0.00015473003,0.00018345595,0.00013846888,0.00045300258,0.00022012877],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017427244,0.0000429788,0.9922202,0.000012654907,0.00012460856,0.00016363342,0.000060288436,0.00016219582,0.0021516315,0.000018465642,0.00005366702,0.0032468042],"study_design_scores_gemma":[0.000018204157,0.00022042467,0.9985875,0.0000073115043,0.00006836981,0.00035303028,0.0000342742,0.0003331044,0.00024378831,0.000016308768,0.00011343936,0.0000043211126],"about_ca_topic_score_codex":0.0012303799,"about_ca_topic_score_gemma":0.0012563601,"teacher_disagreement_score":0.00195384,"about_ca_system_score_codex":0.00025620713,"about_ca_system_score_gemma":0.00017043961,"threshold_uncertainty_score":0.0065362453},"labels":[],"label_agreement":null},{"id":"W2086552186","doi":"10.1097/fpc.0b013e32832a06bf","title":"IgG1 heavy chain-coding gene polymorphism (G1m allotypes) and development of antibodies-to-infliximab","year":2009,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nautical Research Society","funders":"","keywords":"Allotype; Genotyping; Biology; Immunogenetics; Antibody; Infliximab; Genetics; Immunology; Gene polymorphism; Allele; Population; Genotype; Gene; Tumor necrosis factor alpha; Medicine","score_opus":0.012295324395455231,"score_gpt":0.25874301589228843,"score_spread":0.2464476914968332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086552186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996561,0.00012342114,0.00003321467,0.000016077733,0.0000028909426,0.0000015895629,0.00002997012,0.0000016571344,0.00013515531],"genre_scores_gemma":[0.99980205,0.000026120819,0.000030196885,0.000013249436,0.000005289597,0.0000015670353,0.000039223283,7.6093994e-7,0.00008169691],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997484,0.00007014707,0.000027578553,0.00007539287,0.000040511684,0.00003795188],"domain_scores_gemma":[0.99921775,0.00024272062,0.00030698243,0.000045914654,0.000049184593,0.00013745847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027018148,0.0002785903,0.00019956999,0.0005672427,0.00025986068,0.0002707986,0.00020247819,0.0005862226,0.0026716487],"category_scores_gemma":[0.0011190658,0.0001658815,0.00017888361,0.0003625536,0.00021707574,0.00015963694,0.00015075631,0.0003494228,0.00027018378],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005719295,0.000069471505,0.99478734,0.000011902563,0.00005394326,0.0003078586,0.000056580266,0.000027708196,0.0025926926,0.00002114494,0.00005561432,0.0014438079],"study_design_scores_gemma":[0.000019767253,0.00022505877,0.997223,0.0000050056287,0.0000390106,0.0017159526,0.000038255006,0.00013143997,0.0004744677,0.00002325636,0.000102596794,0.0000020752595],"about_ca_topic_score_codex":0.00069541665,"about_ca_topic_score_gemma":0.00063306716,"teacher_disagreement_score":0.0026716487,"about_ca_system_score_codex":0.0001651366,"about_ca_system_score_gemma":0.00011409562,"threshold_uncertainty_score":0.008937597},"labels":[],"label_agreement":null},{"id":"W2086912092","doi":"10.1097/fpc.0b013e32832c484b","title":"Induction of 1C aldoketoreductases and other drug dose-dependent genes upon acquisition of anthracycline resistance","year":2009,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Aldose Reductase and Taurine","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Laurentian University; University of Ottawa; Sudbury Regional Hospital","funders":"Cancer Care Ontario","keywords":"Anthracycline; Doxorubicin; Biology; Drug resistance; Epirubicin; ABCC1; Cancer research; Gene; ATP-binding cassette transporter; Biochemistry; Microbiology; Genetics; Cancer; Chemotherapy","score_opus":0.011838435524183242,"score_gpt":0.27842003419250555,"score_spread":0.2665815986683223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086912092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98973304,0.00094611663,0.005795429,0.00012831151,0.00002428977,0.00008719847,0.0017336947,0.00024399528,0.0013078665],"genre_scores_gemma":[0.98629504,0.00042565758,0.0070055267,0.00009908786,0.000013268675,0.00018165495,0.002759461,0.00005674801,0.003163516],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995523,0.000048644826,0.000038439084,0.00015613028,0.00012736252,0.00007700037],"domain_scores_gemma":[0.9993259,0.00021000119,0.00019453393,0.00009110217,0.00010768418,0.00007086293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024767264,0.00032127294,0.00043710892,0.00041207703,0.00013075757,0.0003885342,0.00017233411,0.00032004184,0.001899831],"category_scores_gemma":[0.00049777376,0.00015772265,0.00037046673,0.0003107444,0.00030427196,0.00021887179,0.00023049244,0.0006673145,0.00042862195],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007925622,0.000017185372,0.0004890347,0.00001898878,0.0000025564955,0.000010754988,0.000010149189,0.00005960569,0.9986228,0.000024747715,0.000015846696,0.00064912083],"study_design_scores_gemma":[0.000007160816,0.00022510474,0.036810916,0.000004825468,0.000010485032,0.000106022504,0.000028656244,0.0015398528,0.9604397,0.00003587179,0.0007816063,0.000009748848],"about_ca_topic_score_codex":0.00064227125,"about_ca_topic_score_gemma":0.00071691733,"teacher_disagreement_score":0.001899831,"about_ca_system_score_codex":0.0005827922,"about_ca_system_score_gemma":0.0002072233,"threshold_uncertainty_score":0.0063555837},"labels":[],"label_agreement":null},{"id":"W2087253029","doi":"10.1097/fpc.0b013e3282f4711d","title":"Genetic analysis of a relationship between macrocyclic lactone and benzimidazole anthelmintic selection on Haemonchus contortus","year":2008,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Helminth infection and control","field":"Veterinary","cited_by":143,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Haemonchus contortus; Biology; Anthelmintic; Isotype; Single-nucleotide polymorphism; Genetics; Molecular biology; Gene; Nematode; Genotype; Antibody","score_opus":0.09622153296992626,"score_gpt":0.3451034460874899,"score_spread":0.24888191311756364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087253029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99980754,0.000028116376,0.000036386442,0.0000037827665,5.1417834e-7,0.0000023582245,0.000033745408,0.0000013047384,0.00008641907],"genre_scores_gemma":[0.9995834,0.000025443456,0.00009526744,0.000008123637,0.0000013594952,0.000004336504,0.000122655,0.0000013983948,0.00015804297],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998833,0.000027670112,0.000007445478,0.000030185,0.00003179066,0.000019650168],"domain_scores_gemma":[0.99967086,0.00008171143,0.00014152373,0.000012555808,0.000035553574,0.000057790105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009694007,0.00019435394,0.0001134514,0.0004069269,0.00011777547,0.000101076046,0.00010754095,0.00016355015,0.00074118795],"category_scores_gemma":[0.00030064845,0.0000886616,0.00009797058,0.0002229663,0.00014771025,0.000055874425,0.00008307463,0.00019459464,0.000071575145],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040389277,0.00010984913,0.117009856,0.000038987353,0.00008194361,0.00040652964,0.000130411,0.00010906675,0.87901115,0.000023997432,0.000039772807,0.0026347053],"study_design_scores_gemma":[0.000007835184,0.00039482303,0.9812397,0.0000043097284,0.00003392218,0.0006740122,0.000070893395,0.00037287967,0.016974118,0.000009480792,0.00021410953,0.0000039958527],"about_ca_topic_score_codex":0.0014856021,"about_ca_topic_score_gemma":0.0033480679,"teacher_disagreement_score":0.0014856021,"about_ca_system_score_codex":0.00018379421,"about_ca_system_score_gemma":0.00010572567,"threshold_uncertainty_score":0.002953887},"labels":[],"label_agreement":null},{"id":"W2088250393","doi":"10.1097/01.fpc.0000220571.20961.dd","title":"Cyp3A4, Cyp3A5, and MDR-1 genetic influences on tacrolimus pharmacokinetics in renal transplant recipients","year":2006,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; Université de Montréal","funders":"","keywords":"Tacrolimus; CYP3A5; Pharmacokinetics; CYP3A4; Transplantation; Pharmacogenetics; Pharmacology; Kidney transplantation; Medicine; Genotype; Calcineurin; Gastroenterology; Internal medicine; Biology; Cytochrome P450; Metabolism; Genetics","score_opus":0.016537846780318628,"score_gpt":0.2929732151675874,"score_spread":0.2764353683872688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088250393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996356,0.00018624014,0.00004941023,0.000011897592,0.000001546924,0.0000011995384,0.000017657607,0.0000017271738,0.00009470669],"genre_scores_gemma":[0.99979645,0.000055757693,0.000037999514,0.000006668427,0.000005907797,0.0000014768564,0.000024080939,0.0000012868024,0.00007033949],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999759,0.00008207252,0.000019539646,0.000037744518,0.000051502353,0.00005009319],"domain_scores_gemma":[0.999456,0.00017568184,0.0002057846,0.00003512886,0.00003698646,0.00009048381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003551003,0.00017970883,0.00022858295,0.0002941161,0.00022363738,0.0002860318,0.00010664912,0.00022044488,0.0016979956],"category_scores_gemma":[0.0011320529,0.00011316141,0.00031914123,0.00031774983,0.00020005942,0.00014621668,0.00011866966,0.0002443898,0.0001981959],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011333353,0.00008521969,0.9878818,0.000010609671,0.0001013972,0.0003054799,0.00007990776,0.00013051958,0.0045652376,0.000036127334,0.00006113304,0.0056091296],"study_design_scores_gemma":[0.000013580692,0.0002154398,0.9982317,0.0000029646656,0.000059569447,0.0006931797,0.00003973744,0.00022185544,0.00040162855,0.000031290678,0.00008631117,0.0000027914168],"about_ca_topic_score_codex":0.00094199064,"about_ca_topic_score_gemma":0.00064525864,"teacher_disagreement_score":0.0016979956,"about_ca_system_score_codex":0.00014826085,"about_ca_system_score_gemma":0.00012588706,"threshold_uncertainty_score":0.0056803226},"labels":[],"label_agreement":null},{"id":"W2090453855","doi":"10.1097/fpc.0b013e32835001e7","title":"Pharmacogenomic analysis of ATP-sensitive potassium channels coexpressing the common type 2 diabetes risk variants E23K and S1369A","year":2011,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Cardiac Ischemia and Reperfusion","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Gliclazide; Glimepiride; Glibenclamide; Pharmacology; Haplotype; Tolbutamide; Sulfonylurea; Glipizide; Chemistry; Internal medicine; Biology; Endocrinology; Type 2 diabetes; Diabetes mellitus; Medicine; Biochemistry; Genotype; Gene","score_opus":0.023140841154953316,"score_gpt":0.27317210530374103,"score_spread":0.25003126414878774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090453855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994653,0.000037005928,0.00020771584,0.0000088036795,0.0000018920517,0.000004499538,0.00022281427,0.0000026317884,0.000049451304],"genre_scores_gemma":[0.99909425,0.000040256404,0.00033014294,0.000022810886,0.000003258787,0.0000062465238,0.0003804451,0.000004651754,0.00011801633],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99979097,0.00004126183,0.00002341304,0.0000705736,0.000043817516,0.00002998054],"domain_scores_gemma":[0.9997228,0.0000647315,0.00012879635,0.000017598792,0.000021448868,0.00004455415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018182263,0.0002724651,0.0002919835,0.00039621713,0.00012098962,0.00022384003,0.00013028838,0.00033082382,0.00095799373],"category_scores_gemma":[0.00036556998,0.00008559428,0.00040544468,0.0004767124,0.00016037583,0.00008947886,0.0001523244,0.00022330626,0.00012974051],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002785819,0.00019966286,0.14539397,0.000047636404,0.00041579318,0.0012157947,0.000089596564,0.0006578804,0.84435433,0.000084936626,0.0000763917,0.004678187],"study_design_scores_gemma":[0.000096307325,0.0010860271,0.9335603,0.000007064076,0.0004159808,0.004042734,0.00014694149,0.0024364593,0.057559833,0.00007450596,0.0005528696,0.000021077372],"about_ca_topic_score_codex":0.0009144063,"about_ca_topic_score_gemma":0.0007970869,"teacher_disagreement_score":0.00095799373,"about_ca_system_score_codex":0.00012507295,"about_ca_system_score_gemma":0.000098595134,"threshold_uncertainty_score":0.0032048225},"labels":[],"label_agreement":null},{"id":"W2091104811","doi":"10.1097/fpc.0000000000000026","title":"Novel CYP2A6 variants identified in African Americans are associated with slow nicotine metabolism in vitro and in vivo","year":2013,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Nicotinic Acetylcholine Receptors Study","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Canada Research Chairs; Centre for Addiction and Mental Health","funders":"National Cancer Institute; National Institute on Drug Abuse; Canadian Institutes of Health Research","keywords":"CYP2A6; Nicotine; Cotinine; Biology; In vivo; Genetics; Metabolism; Pharmacology; Endocrinology; Cytochrome P450; CYP3A4","score_opus":0.01192582660606469,"score_gpt":0.2467807643076428,"score_spread":0.23485493770157811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091104811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992323,0.00012050236,0.00036940136,0.000024455961,0.0000042478396,0.0000045393745,0.00008884143,0.0000060818256,0.00014959065],"genre_scores_gemma":[0.9988398,0.00009931158,0.00057875895,0.000030183937,0.000007796368,0.000006236047,0.00015517764,0.000007148225,0.00027568854],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998646,0.000033078482,0.000010405301,0.00003935719,0.000030794512,0.000021901062],"domain_scores_gemma":[0.999833,0.000038380233,0.00007633003,0.000014398189,0.000016926362,0.000021030331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016939703,0.0003170073,0.00022973967,0.0002586061,0.00025246243,0.00020347256,0.0000972444,0.00025968484,0.0019673468],"category_scores_gemma":[0.00042059307,0.00012470817,0.00020908155,0.00027770246,0.00016940817,0.00007364533,0.00010672848,0.00032664684,0.0002435863],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019458677,0.00031326248,0.3105214,0.000073607705,0.00022806464,0.0033002547,0.00058753835,0.00025081504,0.6676669,0.00022823959,0.00040443605,0.014479591],"study_design_scores_gemma":[0.00006999796,0.00089118036,0.92931265,0.00002035043,0.00022287882,0.014997584,0.00034139113,0.0011135368,0.05048186,0.00017881066,0.0023506382,0.000019155403],"about_ca_topic_score_codex":0.0010470215,"about_ca_topic_score_gemma":0.0006733005,"teacher_disagreement_score":0.0019673468,"about_ca_system_score_codex":0.00007289207,"about_ca_system_score_gemma":0.00005688339,"threshold_uncertainty_score":0.0065814257},"labels":[],"label_agreement":null},{"id":"W2094881146","doi":"10.1097/fpc.0b013e3282fb02ba","title":"Association between cytochrome P450 3A5 polymorphism and the lung function in Saskatchewan grain workers","year":2008,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Medicine; COPD; CYP3A5; Vital capacity; Odds ratio; Lung transplantation; Internal medicine; Genotype; Spirometry; Pulmonary function testing; Lung; Diffusing capacity; Lung function; Asthma; Biology; Genetics","score_opus":0.0492857758618142,"score_gpt":0.3451118820476309,"score_spread":0.2958261061858167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094881146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993476,0.000101725556,0.00004448568,0.0000347585,0.0000033784988,0.000003345529,0.00025299733,0.0000028697677,0.00020880894],"genre_scores_gemma":[0.99913293,0.00008120932,0.000057347796,0.000034430588,0.0000025316092,0.000005058809,0.00031807533,0.0000017646969,0.0003667524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99974424,0.000052503947,0.000021534963,0.00007362207,0.00004887936,0.00005920791],"domain_scores_gemma":[0.9993772,0.00011405921,0.00015996429,0.00006158675,0.00013301379,0.00015427663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000335933,0.00029471537,0.00023147157,0.0004921575,0.000555745,0.0004063495,0.00029657313,0.0003940965,0.0019432007],"category_scores_gemma":[0.0006099644,0.00023709801,0.0003338041,0.00076223357,0.00026485758,0.00013745527,0.00024593322,0.0004829846,0.00029593112],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009702356,0.0000236623,0.99793375,0.000004098533,0.000067308436,0.000091128604,0.000076009186,0.000021967502,0.000842959,0.0000071155873,0.00009861022,0.0007364475],"study_design_scores_gemma":[0.0000036016454,0.000021611459,0.99969006,0.0000024694164,0.000014357192,0.000041834544,0.00007174702,0.000051074356,0.00003492841,0.0000049186237,0.000061744126,0.0000016605429],"about_ca_topic_score_codex":0.32453135,"about_ca_topic_score_gemma":0.43585846,"teacher_disagreement_score":0.6754687,"about_ca_system_score_codex":0.0010571001,"about_ca_system_score_gemma":0.0009299177,"threshold_uncertainty_score":0.6452848},"labels":[],"label_agreement":null},{"id":"W2095282287","doi":"10.1097/fpc.0b013e328338ac8c","title":"Genetic diversity of levamisole receptor subunits in parasitic nematode species and abbreviated transcripts associated with resistance","year":2010,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Helminth infection and control","field":"Veterinary","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Biology; Haemonchus contortus; Complementary DNA; Caenorhabditis elegans; Genetics; Gene; Teladorsagia circumcincta; Nematode; Rapid amplification of cDNA ends; Levamisole; Expressed sequence tag; cDNA library; Molecular biology; Molecular cloning; Zoology","score_opus":0.037943266580948605,"score_gpt":0.2729979432752523,"score_spread":0.2350546766943037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095282287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987098,0.00012070807,0.0004793961,0.000014522832,0.0000023631417,0.000008757908,0.00028037938,0.00001614049,0.0003679026],"genre_scores_gemma":[0.99669445,0.0001257835,0.000971588,0.000023405613,0.000003513396,0.000025717416,0.0011015007,0.000010521392,0.0010434508],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999082,0.0000076473225,0.0000077954755,0.00003339745,0.000021081412,0.000021875174],"domain_scores_gemma":[0.9997774,0.0000446672,0.00009668729,0.00002081096,0.000026203754,0.000034333767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000056051387,0.00016533166,0.00009127571,0.00042154157,0.00011029825,0.00014518015,0.00015570373,0.00017381788,0.0015174074],"category_scores_gemma":[0.00017900579,0.00012046904,0.00017324588,0.00016516304,0.00016129552,0.000079230165,0.00016122096,0.00022770067,0.000278623],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039857405,0.00000499752,0.001988373,0.000011215601,0.000003822312,0.0000450703,0.000026253423,0.000007898268,0.9972953,0.00001390076,0.000005481201,0.00055784],"study_design_scores_gemma":[0.00004004988,0.00065433345,0.59423035,0.000026476053,0.00009591693,0.0035301168,0.0003856365,0.0008692061,0.3968286,0.00014471095,0.003177358,0.000017197957],"about_ca_topic_score_codex":0.0003950438,"about_ca_topic_score_gemma":0.00083827844,"teacher_disagreement_score":0.0015174074,"about_ca_system_score_codex":0.00013192494,"about_ca_system_score_gemma":0.000072327006,"threshold_uncertainty_score":0.0050762296},"labels":[],"label_agreement":null},{"id":"W211447915","doi":"10.1097/fpc.0000000000000143","title":"Variation in genes controlling warfarin disposition and response in American Indian and Alaska Native people","year":2015,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute of Environmental Health Sciences; National Center for Research Resources; National Institute of General Medical Sciences; National Heart, Lung, and Blood Institute; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"VKORC1; Warfarin; CYP2C9; Pharmacogenetics; Vitamin K epoxide reductase; Pharmacogenomics; Vitamin K antagonist; Genotyping; Population; Biology; Therapeutic index; Pharmacology; Medicine; Demography; Internal medicine; Drug; Genetics; Gene; Atrial fibrillation; Environmental health; Genotype","score_opus":0.058967227767481305,"score_gpt":0.38799223859410265,"score_spread":0.32902501082662133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W211447915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99913824,0.00009969365,0.00009324747,0.000020296397,0.0000032045034,0.00000612747,0.00019962389,0.0000034036373,0.00043613324],"genre_scores_gemma":[0.99949455,0.000054224565,0.00014008908,0.000017737439,0.0000032392327,0.000006852232,0.00010307183,0.0000017574357,0.00017843489],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99971,0.00006619037,0.000028482382,0.00010594273,0.000055762393,0.000033565953],"domain_scores_gemma":[0.9997553,0.000064184904,0.00007721951,0.000024025765,0.000036593086,0.000042700456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002866168,0.0002708792,0.00017721833,0.0006785864,0.00058092416,0.00032045282,0.0002509522,0.0003013926,0.001381045],"category_scores_gemma":[0.000831594,0.000116162555,0.00021286523,0.0008696288,0.000287526,0.000118426506,0.0002049078,0.0002188937,0.0001255393],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022937472,0.00004404507,0.99210745,0.00001590628,0.00009838986,0.00048946484,0.00062349235,0.0001433795,0.0025251284,0.00009519571,0.00014728418,0.003480871],"study_design_scores_gemma":[0.0000073484543,0.000038798546,0.9982931,0.0000060976977,0.00003565754,0.00067236583,0.00028329442,0.00016673295,0.00019105784,0.000056654284,0.00024458492,0.0000042231027],"about_ca_topic_score_codex":0.02639486,"about_ca_topic_score_gemma":0.016086707,"teacher_disagreement_score":0.02639486,"about_ca_system_score_codex":0.00023941735,"about_ca_system_score_gemma":0.0001837089,"threshold_uncertainty_score":0.052482486},"labels":[],"label_agreement":null},{"id":"W2122772347","doi":"10.1097/fpc.0b013e3282fad38a","title":"Genetic aspects of epitestosterone formation and androgen disposition: influence of polymorphisms in CYP17 and UGT2B enzymes","year":2008,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"World Anti-Doping Agency","keywords":"Epitestosterone; Androgen; Disposition; Pharmacogenetics; Enzyme; Genetics; Biology; Genotype; Gene; Biochemistry; Psychology; Hormone","score_opus":0.01654618810411221,"score_gpt":0.25049800495268626,"score_spread":0.23395181684857405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122772347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969447,0.0013723228,0.0008062274,0.00007339169,0.000008697591,0.000010879279,0.00029118502,0.000010470806,0.00048219363],"genre_scores_gemma":[0.9989355,0.00024451906,0.00034162233,0.000020108439,0.0000138761125,0.0000069955368,0.00013887411,0.00000793512,0.00029046333],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99949265,0.00022425423,0.000038739916,0.00013747216,0.00007394915,0.000032925454],"domain_scores_gemma":[0.9993013,0.0002853621,0.00024067485,0.00004787649,0.00004381531,0.00008094948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046879213,0.0005175045,0.00036001657,0.000686145,0.00019410004,0.00029563028,0.00017992794,0.0002994627,0.0020060502],"category_scores_gemma":[0.00078069215,0.00016956897,0.000439227,0.00088687195,0.0003123465,0.00013290968,0.00015971992,0.00027029586,0.00023140143],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021342624,0.00008787036,0.966013,0.00006238666,0.0006265745,0.001388086,0.00020167469,0.0001878141,0.023136191,0.00015302519,0.00013581337,0.0058733295],"study_design_scores_gemma":[0.000023753482,0.00021461459,0.9944859,0.000009416396,0.00019465812,0.0021622668,0.000051325336,0.0003295661,0.0020658541,0.00008483328,0.0003729745,0.0000048256006],"about_ca_topic_score_codex":0.0015740936,"about_ca_topic_score_gemma":0.0011868554,"teacher_disagreement_score":0.0020060502,"about_ca_system_score_codex":0.00012688032,"about_ca_system_score_gemma":0.00013349598,"threshold_uncertainty_score":0.0067109466},"labels":[],"label_agreement":null},{"id":"W2151743833","doi":"10.1097/fpc.0b013e32830a48f3","title":"Race as a variable in pharmacogenomics science: from empirical ethics to publication standards","year":2008,"lang":"en","type":"editorial","venue":"Pharmacogenetics and Genomics","topic":"Race, Genetics, and Society","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; Université de Montréal","funders":"National Institutes of Health; Canadian Institutes of Health Research; Dalhousie University; Canada Research Chairs","keywords":"Bioethics; Pharmacogenomics; Nova scotia; Library science; Race (biology); Family medicine; Medicine; Sociology; Political science; Law; Pharmacology; Ethnology; Gender studies","score_opus":0.02056923455798623,"score_gpt":0.37013161211442336,"score_spread":0.34956237755643715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151743833","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005028943,0.0033904342,0.00022472482,0.09399856,0.9015003,0.00001119818,0.000026621214,0.000027284947,0.000770533],"genre_scores_gemma":[0.0010413547,0.0023057824,0.0002423716,0.040666774,0.9522927,0.000026515016,0.000011672333,0.000031232823,0.0033815564],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98739666,0.004441192,0.0018000905,0.001298006,0.0045250193,0.00053902203],"domain_scores_gemma":[0.871371,0.09542391,0.0036137488,0.0020739716,0.02281851,0.004698896],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.023405204,0.0026984082,0.004109428,0.0037452872,0.0043117064,0.009429201,0.0042951913,0.022120988,0.005739072],"category_scores_gemma":[0.08474589,0.0014407844,0.001899118,0.00193608,0.0065410896,0.0050408184,0.0017222622,0.03174979,0.003214728],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001949198,0.000009318061,0.000034512897,0.00012659062,0.000019632495,0.000094861934,0.00003128301,0.000018713888,0.0000149142215,0.00076096994,0.9963676,0.0025020824],"study_design_scores_gemma":[0.00015274038,0.000032332962,0.0006535405,0.0015498089,0.00017714393,0.0004644445,0.00022680683,0.00062199443,0.00020964704,0.007842119,0.9879981,0.000071217],"about_ca_topic_score_codex":0.0018774905,"about_ca_topic_score_gemma":0.005117197,"teacher_disagreement_score":0.9765948,"about_ca_system_score_codex":0.003718651,"about_ca_system_score_gemma":0.004420405,"threshold_uncertainty_score":0.12378007},"labels":[],"label_agreement":null},{"id":"W2317055602","doi":"10.1097/fpc.0b013e32833ffb56","title":"Doxorubicin pathways","year":2010,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":1614,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute of General Medical Sciences","keywords":"Doxorubicin; Marsh; Philosophy; Art; Biology; Medicine; Internal medicine; Ecology; Chemotherapy","score_opus":0.016079271700832013,"score_gpt":0.26709460583535405,"score_spread":0.25101533413452204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317055602","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.118665904,0.13618226,0.04063694,0.045675028,0.009587343,0.001406436,0.057976294,0.003779746,0.58609],"genre_scores_gemma":[0.3426871,0.06531104,0.0089740995,0.0050852066,0.0006552002,0.0005739826,0.03594012,0.0004367631,0.5403365],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.999627,0.000033024007,0.000028719214,0.00011914891,0.00012786129,0.00006417288],"domain_scores_gemma":[0.9995828,0.000038353654,0.00006472689,0.000060270904,0.00014904662,0.000104791325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034673273,0.0007041328,0.0005431015,0.0007920804,0.0010976315,0.0020662742,0.0006102872,0.001041775,0.07065026],"category_scores_gemma":[0.0006723506,0.0003634092,0.0006409559,0.00039601605,0.00029106962,0.0013440159,0.0012519789,0.0014222859,0.034528174],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015897488,0.0002957371,0.005915286,0.0026103982,0.0001477395,0.0012823998,0.0004934852,0.0010300913,0.3609589,0.083710134,0.2581883,0.28377774],"study_design_scores_gemma":[0.00013419427,0.0002378241,0.010313642,0.00037725322,0.0000802793,0.0016131488,0.00020927424,0.00096038275,0.11018653,0.0082901735,0.8675431,0.00005413424],"about_ca_topic_score_codex":0.0017393627,"about_ca_topic_score_gemma":0.0024322325,"teacher_disagreement_score":0.07065026,"about_ca_system_score_codex":0.0018817282,"about_ca_system_score_gemma":0.0011458948,"threshold_uncertainty_score":0.23634863},"labels":[],"label_agreement":null},{"id":"W2326389927","doi":"10.1097/fpc.0b013e32834cebc6","title":"Relationship of human paraoxonase-1 serum activity and genotype with atherosclerosis in individuals from the Deep South","year":2011,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Paraoxonase enzyme and polymorphisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Environmental Health Sciences; National Institutes of Health; Public Health Agency of Canada","keywords":"PON1; Paraoxonase; Aryldialkylphosphatase; Internal medicine; Medicine; Lipoprotein; Odds ratio; Genotype; Population; Endocrinology; Gastroenterology; Cholesterol; Biology; Genetics; Environmental health; Oxidative stress","score_opus":0.04485640813121527,"score_gpt":0.2606133491242365,"score_spread":0.21575694099302123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326389927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9998142,0.00004115695,0.000056917506,0.000013410701,6.975375e-7,0.0000010417907,0.000027019125,9.882506e-7,0.00004459193],"genre_scores_gemma":[0.999801,0.000018953237,0.00006982138,0.000006151859,0.0000013946075,0.0000019155,0.00003894875,6.4868016e-7,0.00006117549],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997962,0.00006800639,0.000015885831,0.00006215214,0.000030318366,0.0000275275],"domain_scores_gemma":[0.9993394,0.00016962734,0.00025977308,0.00006678476,0.00007077002,0.00009362102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046228332,0.00025506673,0.00022644582,0.00022816184,0.00026354217,0.00025083046,0.00017502115,0.000280768,0.00089684577],"category_scores_gemma":[0.0012859495,0.00019510962,0.00020745282,0.0002840293,0.0001514648,0.000116054165,0.00025765784,0.00038165975,0.00011563781],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009822012,0.000012631099,0.99878937,0.0000023277908,0.000041290565,0.000025988415,0.000058314607,0.00002711095,0.0004200949,0.0000059575814,0.000018558563,0.00050008635],"study_design_scores_gemma":[0.000005674661,0.00009293504,0.9989159,0.0000026073424,0.000031498683,0.00014893967,0.000106713254,0.00053836044,0.000069901886,0.000020755524,0.00006558588,0.0000011677181],"about_ca_topic_score_codex":0.007237881,"about_ca_topic_score_gemma":0.00677972,"teacher_disagreement_score":0.007237881,"about_ca_system_score_codex":0.00012886414,"about_ca_system_score_gemma":0.00019371565,"threshold_uncertainty_score":0.014391482},"labels":[],"label_agreement":null},{"id":"W2328257377","doi":"10.1097/fpc.0b013e3283586c04","title":"Analysis of treatment-resistant schizophrenia and 384 markers from candidate genes","year":2012,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"H. Lundbeck A/S; Mylan; Pfizer","keywords":"Candidate gene; Schizophrenia (object-oriented programming); Pharmacogenetics; Single-nucleotide polymorphism; Genetics; Genetic association; Medicine; Multiple comparisons problem; Biology; Gene; Psychiatry; Bioinformatics; Genotype","score_opus":0.013619644622465177,"score_gpt":0.27539005341950284,"score_spread":0.26177040879703767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328257377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989544,0.00019318232,0.00033731895,0.00003688595,0.000003964971,0.000005951456,0.0002641713,0.0000057661705,0.00019837251],"genre_scores_gemma":[0.99829286,0.00013678201,0.0007129066,0.000032482596,0.0000069128314,0.000022864737,0.00041300768,0.000008923662,0.0003733276],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990552,0.00034430422,0.00009027035,0.00023522001,0.00018772986,0.000087320725],"domain_scores_gemma":[0.9987471,0.0004076339,0.00053971977,0.00012523677,0.00007679825,0.00010346582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000633126,0.00059009844,0.00065592607,0.0012028705,0.00038220864,0.0004927623,0.00042020873,0.00054654595,0.002451156],"category_scores_gemma":[0.002311036,0.00027359382,0.0006609266,0.0012537983,0.00027263403,0.00014692234,0.00045066793,0.00037653357,0.00033892225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024489195,0.0001388988,0.9018963,0.00008270079,0.0012455613,0.0013958307,0.00037968747,0.00089040824,0.07401867,0.00024785937,0.0002393321,0.017015813],"study_design_scores_gemma":[0.000079224614,0.00030872523,0.9913085,0.0000142095005,0.0003454192,0.0012450303,0.00010932954,0.0010461275,0.004389929,0.0003150086,0.0008228775,0.000015654827],"about_ca_topic_score_codex":0.0019385298,"about_ca_topic_score_gemma":0.0020425306,"teacher_disagreement_score":0.002451156,"about_ca_system_score_codex":0.00027052686,"about_ca_system_score_gemma":0.00025297253,"threshold_uncertainty_score":0.00819993},"labels":[],"label_agreement":null},{"id":"W2330143447","doi":"10.1097/fpc.0b013e3283485eb2","title":"Association between polymorphisms of CYP2J2 and EPHX2 genes and risk of coronary artery disease","year":2011,"lang":"en","type":"review","venue":"Pharmacogenetics and Genomics","topic":"Eicosanoids and Hypertension Pharmacology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval","funders":"","keywords":"Coronary artery disease; Meta-analysis; Epoxide hydrolase 2; Haplotype; Case-control study; Genetics; Single-nucleotide polymorphism; Biology; Genetic association; Locus (genetics); Internal medicine; Medicine; Bioinformatics; Allele; Gene; Genotype; Biochemistry","score_opus":0.032175928917966494,"score_gpt":0.29379647754136545,"score_spread":0.26162054862339895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330143447","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9538103,0.042972766,0.0012890038,0.0005343496,0.00006201271,0.00002520627,0.00055951206,0.000024030323,0.0007229174],"genre_scores_gemma":[0.9943414,0.0044012424,0.0005685111,0.00008288911,0.000083021776,0.000015865473,0.00028095525,0.0000045485267,0.00022164323],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987684,0.0005088018,0.000118405034,0.00033029096,0.00020045332,0.00007368101],"domain_scores_gemma":[0.9974679,0.0014520976,0.0006574089,0.00015738695,0.00016516946,0.00010002988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017803541,0.00053005235,0.0008847834,0.0007826914,0.00019199688,0.00060976914,0.00036210628,0.0006625155,0.0015727362],"category_scores_gemma":[0.0037894212,0.00029143895,0.0017436701,0.0015352417,0.00025797,0.00026065868,0.0002399052,0.00046337815,0.00010101871],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027072958,0.00008891848,0.94852597,0.000674872,0.0310458,0.0005540683,0.000048570764,0.0015389803,0.0044663744,0.00014043352,0.00034374435,0.009864948],"study_design_scores_gemma":[0.0005448082,0.00042029296,0.9736849,0.00009992324,0.019659437,0.0011660089,0.00003558058,0.0022214209,0.0011171125,0.00029681734,0.00074020535,0.000013542771],"about_ca_topic_score_codex":0.0016060944,"about_ca_topic_score_gemma":0.0016254599,"teacher_disagreement_score":0.0017803541,"about_ca_system_score_codex":0.0002178911,"about_ca_system_score_gemma":0.00024315079,"threshold_uncertainty_score":0.009415567},"labels":[],"label_agreement":null},{"id":"W2334285469","doi":"10.1097/fpc.0000000000000051","title":"Profound reduction in the tamoxifen active metabolite endoxifen in a patient on phenytoin for epilepsy compared with a CYP2D6 genotype matched cohort","year":2014,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Canadian Institutes of Health Research","keywords":"Tamoxifen; CYP2D6; Phenytoin; Pharmacology; Medicine; Metabolite; Pharmacogenetics; Active metabolite; Therapeutic drug monitoring; Drug interaction; CYP2C9; Genotype; Drug; Internal medicine; Cytochrome P450; Epilepsy; Pharmacokinetics; Biology; Metabolism; Genetics; Cancer; Psychiatry; Breast cancer","score_opus":0.05976936688541686,"score_gpt":0.36975667885828867,"score_spread":0.3099873119728718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334285469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998569,0.00014952329,0.000085096406,0.0001224539,0.000010438053,0.000007926923,0.00008618691,0.000007852188,0.0009614519],"genre_scores_gemma":[0.9995425,0.00006419572,0.00004518612,0.000083047395,0.000013686711,0.0000016103826,0.000052154035,0.0000028855377,0.00019480987],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998454,0.000019361101,0.000016076883,0.00004365535,0.000038309838,0.000037275782],"domain_scores_gemma":[0.9997241,0.000077153345,0.000053805605,0.00001949617,0.000024915087,0.000100542624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000104179555,0.00028023127,0.00037055663,0.00062429474,0.00043144825,0.00032571674,0.00015801513,0.0005305796,0.0015063701],"category_scores_gemma":[0.0008360983,0.00014902011,0.0003057859,0.00031208844,0.00024776923,0.00022473156,0.00024210193,0.00059609895,0.00020840524],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017262336,0.00037701655,0.679958,0.000040067465,0.000100658144,0.27666387,0.0010691843,0.00019507417,0.023691684,0.00019082225,0.0006279838,0.0153595535],"study_design_scores_gemma":[0.000043955755,0.001612576,0.750723,0.0000093292965,0.00009000301,0.24254239,0.0005412168,0.00057210354,0.0025433481,0.00013116197,0.001168437,0.000022493201],"about_ca_topic_score_codex":0.0023245488,"about_ca_topic_score_gemma":0.0017332564,"teacher_disagreement_score":0.0023245488,"about_ca_system_score_codex":0.0002692126,"about_ca_system_score_gemma":0.0001558875,"threshold_uncertainty_score":0.0050392747},"labels":[],"label_agreement":null},{"id":"W2336425722","doi":"10.1097/fpc.0000000000000178","title":"Role of rs3846662 and HMGCR alternative splicing in statin efficacy and baseline lipid levels in familial hypercholesterolemia","year":2015,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal Clinical Research Institute; Université du Québec; McGill University; Douglas Mental Health University Institute","funders":"Canadian Institutes of Health Research","keywords":"Familial hypercholesterolemia; Statin; Genotype; Internal medicine; Endocrinology; HMG-CoA reductase; Cholesterol; LDL receptor; Penetrance; Hydroxymethylglutaryl-CoA reductase; Biology; Medicine; Lipoprotein; Reductase; Genetics; Gene; Enzyme; Biochemistry","score_opus":0.036334708162938746,"score_gpt":0.2970567557859043,"score_spread":0.2607220476229655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2336425722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990742,0.00025238935,0.00009161402,0.00006294954,0.00000410989,0.000004409353,0.0001594565,0.000003939317,0.0003467793],"genre_scores_gemma":[0.99956506,0.00004991477,0.00010371096,0.000014720708,0.0000067011647,0.0000027116655,0.00008061996,0.000001876128,0.00017468502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995629,0.00010269601,0.000040550392,0.00012047855,0.00010515685,0.00006820938],"domain_scores_gemma":[0.9994764,0.00013442317,0.00019272517,0.000045643115,0.00006211537,0.00008877934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005205158,0.0005175997,0.0003914088,0.00048230393,0.0005727734,0.00032929864,0.0002763905,0.0005237972,0.0020534913],"category_scores_gemma":[0.0012433034,0.00018533952,0.0004438114,0.0006822047,0.00038270067,0.00013184822,0.00017409057,0.0003281044,0.0001747155],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021006146,0.00004791111,0.98027873,0.000030309428,0.0002932986,0.00081914436,0.00039662037,0.00020657225,0.010311054,0.00012238498,0.00013704585,0.005256256],"study_design_scores_gemma":[0.00003536378,0.0000817786,0.9978635,0.000007661788,0.000096795025,0.0006880143,0.000082854465,0.00040050046,0.00045596258,0.0000623169,0.0002189659,0.000006255349],"about_ca_topic_score_codex":0.07388801,"about_ca_topic_score_gemma":0.06914087,"teacher_disagreement_score":0.07388801,"about_ca_system_score_codex":0.0006160863,"about_ca_system_score_gemma":0.0006740096,"threshold_uncertainty_score":0.14691585},"labels":[],"label_agreement":null},{"id":"W2341648636","doi":"10.1097/fpc.0000000000000222","title":"Disposition kinetics and metabolism of nicotine and cotinine in African American smokers","year":2016,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Nicotinic Acetylcholine Receptors Study","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"National Center for Research Resources; National Institute on Drug Abuse","keywords":"Cotinine; CYP2A6; Nicotine; Metabolite; Pharmacokinetics; Urine; Chemistry; Pharmacology; Metabolism; Genotype; Excretion; Internal medicine; Medicine; Biochemistry; Gene","score_opus":0.006653470320758963,"score_gpt":0.25519540756796694,"score_spread":0.24854193724720797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2341648636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99963474,0.0001327548,0.00008306932,0.0000087988765,7.515689e-7,0.0000028043407,0.000041021747,0.0000014662402,0.00009464629],"genre_scores_gemma":[0.99946684,0.00010694137,0.00016478056,0.000011754507,0.0000019899298,0.0000035060677,0.000056588793,0.0000016577121,0.00018591665],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998921,0.00003381705,0.00000579619,0.000026084188,0.000027329997,0.00001487236],"domain_scores_gemma":[0.99986446,0.000033360306,0.00005077979,0.000013278902,0.000018723862,0.000019452527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028665396,0.00013996373,0.0001595534,0.00019951994,0.0001882501,0.00020735455,0.00008892569,0.00018799197,0.0010368417],"category_scores_gemma":[0.00074831315,0.00011937093,0.00013152664,0.00022596528,0.000091022775,0.0001486144,0.00009136008,0.0001741349,0.00015611807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022901767,0.00033385667,0.9515307,0.000027024795,0.00015366072,0.0002488569,0.00031328583,0.00013991409,0.03238655,0.00006220248,0.000097999175,0.012415749],"study_design_scores_gemma":[0.000021298238,0.00045828513,0.99582726,0.0000034562195,0.00006226706,0.00053584966,0.00008497736,0.00044469023,0.002261581,0.000041074378,0.00025548396,0.000003691343],"about_ca_topic_score_codex":0.0031605947,"about_ca_topic_score_gemma":0.0023184305,"teacher_disagreement_score":0.0031605947,"about_ca_system_score_codex":0.00014208676,"about_ca_system_score_gemma":0.00011647989,"threshold_uncertainty_score":0.0062844157},"labels":[],"label_agreement":null},{"id":"W2343497810","doi":"10.1097/fpc.0000000000000182","title":"Genetic diversity of variants involved in drug response and metabolism in Sri Lankan populations","year":2015,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Child and Family Research Institute","funders":"Biomedical Research Council; National Medical Research Council; Medical Research Council; National University of Singapore; Agency for Science, Technology and Research","keywords":"Pharmacogenomics; Genetic diversity; Population; Biology; Genetics; Evolutionary biology; Medicine; Environmental health","score_opus":0.16080492077681025,"score_gpt":0.3984915745155805,"score_spread":0.23768665373877024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343497810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988632,0.0002253578,0.00019639624,0.000034080866,0.0000022078348,0.0000068121767,0.00016847931,0.000003929999,0.00049955084],"genre_scores_gemma":[0.99918824,0.00017335596,0.00027851103,0.000018897126,0.0000044951435,0.000009347871,0.00025261537,0.0000024688525,0.000072082556],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992261,0.00021122527,0.00009940079,0.0002658972,0.0001109663,0.000086371525],"domain_scores_gemma":[0.99923635,0.0002261196,0.00027772022,0.00008724357,0.000097241886,0.000075483724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086543534,0.0002794285,0.00033335088,0.0011986649,0.0005238633,0.000638904,0.00033190963,0.000316871,0.0018204483],"category_scores_gemma":[0.0013975551,0.00014864729,0.0005435536,0.0015800039,0.000651755,0.00020443849,0.00047723227,0.000325672,0.00014754864],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020216049,0.00002312874,0.9793331,0.00005064801,0.0006624078,0.00044612115,0.0016394736,0.00037912285,0.006415876,0.00030861824,0.00015770453,0.010381605],"study_design_scores_gemma":[0.000010149763,0.00007186783,0.99775475,0.00001697881,0.00010304265,0.00043941496,0.0006830621,0.0002318911,0.00022510234,0.00012229304,0.00032971165,0.000011740819],"about_ca_topic_score_codex":0.009110206,"about_ca_topic_score_gemma":0.009492987,"teacher_disagreement_score":0.009110206,"about_ca_system_score_codex":0.00036288935,"about_ca_system_score_gemma":0.0003089902,"threshold_uncertainty_score":0.018114388},"labels":[],"label_agreement":null},{"id":"W2399747342","doi":"10.1097/fpc.0000000000000230","title":"Autoantibody presentation in drug-induced liver injury and idiopathic autoimmune hepatitis","year":2016,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Alberta Innovates - Health Solutions","keywords":"Autoimmune hepatitis; Autoantibody; Medicine; Immunology; Anti-nuclear antibody; Human leukocyte antigen; Gastroenterology; Internal medicine; Antibody; Autoimmunity; Genotyping; Hepatitis; Antigen; Genotype; Gene; Biology; Genetics","score_opus":0.01742773387672272,"score_gpt":0.2896364484829043,"score_spread":0.2722087146061816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399747342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99872833,0.00084668247,0.00006436465,0.000023704912,0.000003069386,0.0000034838163,0.000027908445,0.0000019125837,0.00030046672],"genre_scores_gemma":[0.9996136,0.00017143,0.00006229916,0.000014750513,0.000009314671,0.0000020976456,0.00005295168,8.9825414e-7,0.00007270934],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999721,0.00011863976,0.00003252156,0.000050028266,0.00003880216,0.00003893977],"domain_scores_gemma":[0.99943787,0.00012361597,0.00027935824,0.000023592793,0.00004510721,0.00009032414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004295253,0.00021675951,0.000236952,0.00089568563,0.00017840495,0.00032774362,0.00017889454,0.00030645804,0.0023650392],"category_scores_gemma":[0.0010353255,0.00011479164,0.00015322803,0.0007066271,0.00027302472,0.00018090334,0.00030572937,0.00017974037,0.0003505534],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005396156,0.0000453608,0.9909895,0.000047614347,0.000047947167,0.00062587304,0.000081651786,0.000029084256,0.0022881515,0.000029611881,0.00006670633,0.0052088117],"study_design_scores_gemma":[0.000021921973,0.00016992955,0.9964079,0.000011049837,0.000021772523,0.0026812684,0.000118029144,0.000095855125,0.00019538376,0.000054431337,0.00022048077,0.00000195129],"about_ca_topic_score_codex":0.0006685392,"about_ca_topic_score_gemma":0.00047114925,"teacher_disagreement_score":0.0023650392,"about_ca_system_score_codex":0.00015583607,"about_ca_system_score_gemma":0.00012485798,"threshold_uncertainty_score":0.007911861},"labels":[],"label_agreement":null},{"id":"W2427023998","doi":"10.1097/fpc.0000000000000180","title":"A genetic variant in NRP1 is associated with worse response to ranibizumab treatment in neovascular age-related macular degeneration","year":2015,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"European Commission","keywords":"Macular degeneration; Ranibizumab; Single-nucleotide polymorphism; Neuropilin 1; Choroidal neovascularization; Medicine; Oncology; Visual acuity; Allele; Pharmacogenetics; Genotype; Internal medicine; Bevacizumab; SNP; Vascular endothelial growth factor; Ophthalmology; Biology; Genetics; VEGF receptors; Gene; Chemotherapy","score_opus":0.01961434657979248,"score_gpt":0.26885542628451065,"score_spread":0.24924107970471818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2427023998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99940705,0.00027511606,0.0000887318,0.000033669192,0.000006922474,0.0000035247458,0.00006476286,0.0000033731299,0.00011688507],"genre_scores_gemma":[0.99966216,0.000043707998,0.000101275255,0.000020676796,0.000011073604,0.0000030361848,0.000054606295,0.0000020067307,0.0001014659],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995726,0.00013344719,0.000050202536,0.00014480679,0.00006789502,0.00003110394],"domain_scores_gemma":[0.99893314,0.00032892858,0.00052189815,0.00006147249,0.000059748076,0.00009476992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005245308,0.000390055,0.00043444886,0.00031221908,0.0002580288,0.000278137,0.00026363038,0.0005192408,0.0019557124],"category_scores_gemma":[0.0015326185,0.00013982634,0.0004760966,0.00045767354,0.0002103856,0.00014601077,0.00013359149,0.00038850176,0.00019499917],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035513567,0.00018665612,0.96820796,0.00006415271,0.0006767097,0.0017898142,0.000165576,0.00029841278,0.017538173,0.000056291163,0.00019611267,0.0072687264],"study_design_scores_gemma":[0.00006824706,0.00034346178,0.99505377,0.000009094758,0.00018343564,0.002660995,0.000045599816,0.0006115212,0.00077952933,0.00004474535,0.00019298872,0.0000066532066],"about_ca_topic_score_codex":0.000999406,"about_ca_topic_score_gemma":0.0008308245,"teacher_disagreement_score":0.0019557124,"about_ca_system_score_codex":0.00014309125,"about_ca_system_score_gemma":0.00012777392,"threshold_uncertainty_score":0.006542504},"labels":[],"label_agreement":null},{"id":"W2466633910","doi":"10.1097/fpc.0000000000000209","title":"HLA-DRB1*16","year":2016,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Daiichi Sankyo Europe; Menzies Centre for Australian Studies, King's College London, University of London; Medical Research Council; Shanghai Jiao Tong University; University of Nottingham; Universität Zürich; Newcastle University; King's College London; Daiichi-Sankyo; National Institute for Health and Care Research; Bundesinstitut für Arzneimittel und Medizinprodukte; McGill University; McGill University Health Centre; Nottingham University Hospitals NHS Trust; Wellcome Trust; Uppsala Universitet; Universidad de Málaga; Pfizer; Universidad Nacional de Rosario; GlaxoSmithKline; Helsingin ja Uudenmaan Sairaanhoitopiiri; Universiteit Utrecht; Sanofi; Amgen","keywords":"Odds ratio; Minor allele frequency; Genome-wide association study; Haplotype; Medicine; Population; Single-nucleotide polymorphism; Internal medicine; Allele; Genotype; Genetics; Biology","score_opus":0.13275525925313852,"score_gpt":0.4145607073128559,"score_spread":0.28180544805971736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2466633910","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884183,0.0031987645,0.0018755618,0.00044619528,0.000045317167,0.0000351631,0.0015047707,0.0000367906,0.0044390503],"genre_scores_gemma":[0.9967918,0.00037203025,0.0008291583,0.00015348516,0.000037310092,0.00001425024,0.00067645183,0.000006761847,0.0011187799],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99955314,0.00015028208,0.000046800098,0.00012494008,0.000058745274,0.000065998145],"domain_scores_gemma":[0.999178,0.00020189644,0.0004190515,0.000059558857,0.000064635424,0.00007682926],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00064266403,0.00031615948,0.00025782984,0.00034452457,0.0002174988,0.0003368362,0.00027900576,0.0002980323,0.014791431],"category_scores_gemma":[0.0018016205,0.00010570168,0.00020375542,0.00082326686,0.00017769414,0.0002069303,0.00020098386,0.00038465182,0.001518331],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009368292,0.000105109226,0.95633715,0.00017216758,0.00030821923,0.000865042,0.00012281403,0.00024405368,0.010081377,0.00045667967,0.0014384036,0.028932123],"study_design_scores_gemma":[0.00018675088,0.0007378544,0.96700114,0.00017699607,0.00036115735,0.012215356,0.00017444039,0.00080170674,0.0027970162,0.0007272371,0.014807105,0.000013203634],"about_ca_topic_score_codex":0.0006576405,"about_ca_topic_score_gemma":0.00030092863,"teacher_disagreement_score":0.9852086,"about_ca_system_score_codex":0.00013798186,"about_ca_system_score_gemma":0.00012140149,"threshold_uncertainty_score":0.049482286},"labels":[],"label_agreement":null},{"id":"W2538078583","doi":"10.1097/fpc.0000000000000253","title":"Concordance between actual and pharmacogenetic predicted desvenlafaxine dose needed to achieve remission in major depressive disorder","year":2016,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Treatment of Major Depression","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"National Health and Medical Research Council; Pfizer Australia; Pfizer","keywords":"Concordance; Dosing; Pharmacogenetics; Major depressive disorder; Medicine; Internal medicine; Clinical trial; Psychiatry; Biology; Genotype","score_opus":0.019022699031739147,"score_gpt":0.3023839319443738,"score_spread":0.28336123291263465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2538078583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99777395,0.00019456925,0.0010127642,0.00002881695,0.00000920793,0.000021424008,0.00025723636,0.0000108645545,0.0006911361],"genre_scores_gemma":[0.99922764,0.000026696262,0.00046852973,0.00000857088,0.0000028699733,0.000008967875,0.00019958103,0.0000019700863,0.000055173634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99316686,0.0041273874,0.0008344031,0.0008302417,0.0009268227,0.00011431922],"domain_scores_gemma":[0.9605325,0.025716102,0.0091444,0.0027849257,0.0014795751,0.00034245258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010380121,0.00020648881,0.00040054313,0.0006274816,0.00022048566,0.0006611197,0.00052787276,0.00047423094,0.0008780688],"category_scores_gemma":[0.03852099,0.00023960049,0.00041208413,0.00052107323,0.00032624815,0.00032048125,0.00047763638,0.00050616625,0.00024315774],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013301988,0.00009464321,0.9873236,0.00004027257,0.00031939222,0.000031603402,0.0001938829,0.0009192695,0.00030638414,0.00009106359,0.00012225861,0.009227478],"study_design_scores_gemma":[0.000066675166,0.0004865404,0.9941975,0.000017658249,0.0000943984,0.00021851357,0.000047163987,0.0040236088,0.0005296818,0.00011908531,0.00018997538,0.000009190512],"about_ca_topic_score_codex":0.0013634384,"about_ca_topic_score_gemma":0.0014595435,"teacher_disagreement_score":0.010380121,"about_ca_system_score_codex":0.00029655985,"about_ca_system_score_gemma":0.00025645422,"threshold_uncertainty_score":0.054895997},"labels":[],"label_agreement":null},{"id":"W254883539","doi":"10.1097/fpc.0000000000000145","title":"PharmGKB summary","year":2015,"lang":"en","type":"review","venue":"Pharmacogenetics and Genomics","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of General Medical Sciences","keywords":"Biology; Computational biology","score_opus":0.09559619220075762,"score_gpt":0.3947711068157638,"score_spread":0.29917491461500617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W254883539","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007888236,0.59297514,0.002799567,0.015213947,0.017508859,0.0007685099,0.016340232,0.0015154058,0.35208952],"genre_scores_gemma":[0.0042935964,0.70808756,0.0017284349,0.008099923,0.005087328,0.0003607578,0.013534283,0.00030628857,0.2585018],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99945706,0.00006445303,0.000049029444,0.00009235164,0.0002585355,0.00007850185],"domain_scores_gemma":[0.99940145,0.00009724979,0.000075867036,0.000030181593,0.0002555146,0.0001397294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007156262,0.0010091984,0.0015213144,0.0021794452,0.00049953384,0.0027597856,0.0015556159,0.0013945458,0.27711067],"category_scores_gemma":[0.0020958479,0.0003043004,0.00088592514,0.0020628467,0.00026617342,0.001813823,0.001288275,0.0024054,0.24137056],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010640334,0.00003320988,0.000051884057,0.00360861,0.000025553589,0.000104617735,0.000016912181,0.00011148848,0.00050917105,0.0019947481,0.59454525,0.39889202],"study_design_scores_gemma":[0.000033588574,0.00002216735,0.00009373228,0.00090132427,0.000015902431,0.00015924854,0.0000056856675,0.000019383317,0.000097253054,0.0004146908,0.99823195,0.0000050248723],"about_ca_topic_score_codex":0.001480439,"about_ca_topic_score_gemma":0.002316403,"teacher_disagreement_score":0.27711067,"about_ca_system_score_codex":0.0007716023,"about_ca_system_score_gemma":0.0021243354,"threshold_uncertainty_score":0.9270275},"labels":[],"label_agreement":null},{"id":"W2570376902","doi":"10.1097/fpc.0000000000000263","title":"Multiphenotype association study of patients randomized to initiate antiretroviral regimens in AIDS Clinical Trials Group protocol A5202","year":2017,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Research Resources; National Institute of Allergy and Infectious Diseases; National Center for Advancing Translational Sciences; National Human Genome Research Institute; Public Health Agency of Canada","keywords":"Efavirenz; Internal medicine; Genome-wide association study; Clinical trial; Medicine; Pharmacogenetics; Oncology; Biology; Single-nucleotide polymorphism; Viral load; Human immunodeficiency virus (HIV); Immunology; Genetics; Antiretroviral therapy; Genotype; Gene","score_opus":0.10536133911839711,"score_gpt":0.4594565667727651,"score_spread":0.35409522765436796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570376902","genre_codex":"protocol","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13861062,0.0021435404,0.02014251,0.0058579403,0.0022365088,0.4784264,0.31181473,0.0009322755,0.03983552],"genre_scores_gemma":[0.2495966,0.0010496356,0.030318962,0.0058714566,0.0009905177,0.5824276,0.10731642,0.00028180057,0.022147058],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.98438686,0.0117753325,0.0012384765,0.0014152185,0.00068185205,0.0005021571],"domain_scores_gemma":[0.9829573,0.0052699177,0.0029140573,0.0046367845,0.0026123435,0.0016094758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014580159,0.0015912107,0.0016024321,0.0007818144,0.0015606098,0.0010851729,0.00236999,0.0024964334,0.03705348],"category_scores_gemma":[0.023209024,0.00075155334,0.0008821557,0.002752852,0.00059422303,0.0013014433,0.0009897283,0.0021321084,0.012093086],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.38079318,0.0036979895,0.13965672,0.007830343,0.004439784,0.0023315863,0.00090180413,0.0029125686,0.011465446,0.009609089,0.37839314,0.057968367],"study_design_scores_gemma":[0.2782842,0.025513703,0.3941479,0.0030715591,0.0033318684,0.0015054833,0.0005318175,0.00955742,0.0033453715,0.011886062,0.2685206,0.00030401014],"about_ca_topic_score_codex":0.0012701566,"about_ca_topic_score_gemma":0.0027817066,"teacher_disagreement_score":0.03705348,"about_ca_system_score_codex":0.00083441334,"about_ca_system_score_gemma":0.003694613,"threshold_uncertainty_score":0.12395626},"labels":[],"label_agreement":null},{"id":"W2586508238","doi":"10.1097/fpc.0000000000000271","title":"Variation in CYP2A6 and nicotine metabolism among two American Indian tribal groups differing in smoking patterns and risk for tobacco-related cancer","year":2017,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; Centre for Addiction and Mental Health","funders":"National Cancer Institute; National Institute on Drug Abuse; National Center for Advancing Translational Sciences; National Institute of Mental Health","keywords":"CYP2A6; Cotinine; Nicotine; Genotype; Lung cancer; Biology; Medicine; Genetics; Demography; Internal medicine; Oncology; Metabolism; Gene","score_opus":0.04418432566383716,"score_gpt":0.39351837328252376,"score_spread":0.3493340476186866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586508238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996629,0.00002074426,0.00007299878,0.0000101182795,0.0000012021823,0.000005310275,0.000034849436,0.0000013211879,0.00019052596],"genre_scores_gemma":[0.9996345,0.000015580985,0.00012570478,0.000012448856,0.000002540561,0.000006609684,0.000060434028,0.0000016272356,0.00014067261],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996556,0.00013314084,0.00002418239,0.000079846526,0.00006667948,0.00004043849],"domain_scores_gemma":[0.9996338,0.00007106821,0.00008414773,0.000054563097,0.000066816225,0.0000895888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035761527,0.00022631587,0.0001699667,0.00049889716,0.00054050365,0.000376982,0.00026445233,0.00019434004,0.0011183247],"category_scores_gemma":[0.00094457006,0.00010567677,0.00022125663,0.000555427,0.00031828467,0.00014826721,0.00025276013,0.00023148196,0.00016999798],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035058678,0.00017947952,0.98454976,0.000010955779,0.00012567974,0.00031887938,0.001353244,0.00006079028,0.008089745,0.00008089143,0.000099796365,0.004780152],"study_design_scores_gemma":[0.000010014798,0.00009740741,0.99829847,0.0000026288387,0.000027189053,0.00042448964,0.0005891637,0.00016780151,0.00021639238,0.000024735975,0.00013845836,0.0000032989067],"about_ca_topic_score_codex":0.012274738,"about_ca_topic_score_gemma":0.011522902,"teacher_disagreement_score":0.012274738,"about_ca_system_score_codex":0.0001776345,"about_ca_system_score_gemma":0.00016439757,"threshold_uncertainty_score":0.024406612},"labels":[],"label_agreement":null},{"id":"W2587600525","doi":"10.1097/fpc.0000000000000269","title":"Effect of UGT2B10, UGT2B17, FMO3, and OCT2 genetic variation on nicotine and cotinine pharmacokinetics and smoking in African Americans","year":2017,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Nicotinic Acetylcholine Receptors Study","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto; Centre for Addiction and Mental Health","funders":"NIH Clinical Center; National Center for Research Resources; National Institute on Drug Abuse; Canadian Institutes of Health Research; Center for Clinical and Translational Sciences, University of Texas Health Science Center at Houston; Center for Clinical and Translational Research; University of Toronto","keywords":"CYP2A6; Cotinine; Nicotine; Pharmacokinetics; Pharmacology; Cmax; Chemistry; Medicine; Internal medicine; Metabolism; CYP3A4","score_opus":0.010660894542394139,"score_gpt":0.3039189033026535,"score_spread":0.2932580087602593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587600525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995876,0.000119503355,0.00008306493,0.00002038562,0.0000022984598,0.0000020048117,0.000069145564,0.0000016316143,0.00011457178],"genre_scores_gemma":[0.99963355,0.00004622895,0.00013224338,0.000013639133,0.0000033578992,0.0000029128507,0.00005948869,0.0000036329784,0.00010500133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99956053,0.00019325216,0.000026138005,0.00012530373,0.00004915916,0.000045628243],"domain_scores_gemma":[0.9995297,0.00015764582,0.00016571589,0.000053310472,0.000024737328,0.00006880668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005139962,0.00040516822,0.00029012104,0.00029225924,0.00028445205,0.00032119115,0.0001618284,0.0003548972,0.0017012844],"category_scores_gemma":[0.0010477813,0.00017137354,0.000491507,0.00040543173,0.00029263005,0.00013385608,0.00019271621,0.00025937826,0.00010784461],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023374583,0.000080592145,0.98139083,0.000014562577,0.00046656214,0.00033711392,0.00020929684,0.00015087643,0.010973689,0.00010159123,0.00008792784,0.0038494829],"study_design_scores_gemma":[0.000024769271,0.00023856465,0.9978763,0.0000057975103,0.00017760722,0.00033394122,0.000077716446,0.00044230744,0.00056929403,0.0000531815,0.00019672191,0.000003848107],"about_ca_topic_score_codex":0.00535453,"about_ca_topic_score_gemma":0.0034979694,"teacher_disagreement_score":0.00535453,"about_ca_system_score_codex":0.00016526357,"about_ca_system_score_gemma":0.00015758254,"threshold_uncertainty_score":0.010646701},"labels":[],"label_agreement":null},{"id":"W2610038554","doi":"10.1097/fpc.0000000000000281","title":"TPMT, COMT and ACYP2 genetic variants in paediatric cancer patients with cisplatin-induced ototoxicity","year":2017,"lang":"en","type":"review","venue":"Pharmacogenetics and Genomics","topic":"Hearing, Cochlea, Tinnitus, Genetics","field":"Neuroscience","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Family Medicine","funders":"Medical Research Council; Great Ormond Street Hospital for Children; National Institute for Health and Care Research","keywords":"Thiopurine methyltransferase; Ototoxicity; Medicine; Single-nucleotide polymorphism; Confidence interval; Odds ratio; Genotyping; SNP; Oncology; Cohort; Hearing loss; Internal medicine; Genotype; Audiology; Genetics; Cisplatin; Biology; Chemotherapy","score_opus":0.1191138615065322,"score_gpt":0.37287234428017435,"score_spread":0.25375848277364216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610038554","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.37755892,0.61621374,0.0012397276,0.0008800842,0.00018071358,0.00008026761,0.002369512,0.00003258323,0.0014444505],"genre_scores_gemma":[0.9517347,0.046146307,0.00059471023,0.00030606825,0.00010885705,0.000039502193,0.0008990974,0.000012238689,0.00015855927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978569,0.00083769084,0.00040433437,0.0004645898,0.00035469283,0.00008179046],"domain_scores_gemma":[0.9948925,0.0033543867,0.0011120943,0.00025349704,0.00029949742,0.00008803924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023629272,0.00052204565,0.0016144741,0.00091595796,0.0002241215,0.0008658268,0.00054844207,0.00067618914,0.0017456681],"category_scores_gemma":[0.0077706254,0.00029323972,0.0044525987,0.0027533183,0.00034831723,0.00038753892,0.0005037659,0.0006203472,0.0001123955],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009887933,0.00006402723,0.68295556,0.03428094,0.18493186,0.0021645976,0.00029534963,0.0028364358,0.0038061347,0.00037297365,0.0029607401,0.075443454],"study_design_scores_gemma":[0.0015858224,0.0010752061,0.7238609,0.0059733703,0.24711062,0.005208228,0.00023406748,0.0016937553,0.0017246114,0.0008502661,0.0106218355,0.000061230545],"about_ca_topic_score_codex":0.00378945,"about_ca_topic_score_gemma":0.0051543266,"teacher_disagreement_score":0.00378945,"about_ca_system_score_codex":0.0005271369,"about_ca_system_score_gemma":0.0006623151,"threshold_uncertainty_score":0.012496471},"labels":[],"label_agreement":null},{"id":"W2727734214","doi":"10.1097/fpc.0000000000000295","title":"Genetic determinants of impaired awareness of hypoglycemia in type 1 diabetes","year":2017,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Diabetes Management and Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Hypoglycemia; Diabetes mellitus; Pharmacogenetics; Type 2 diabetes; Medicine; Type 1 diabetes; Bioinformatics; Biology; Genetics; Endocrinology; Gene; Genotype","score_opus":0.045756781568769736,"score_gpt":0.3550642547782498,"score_spread":0.3093074732094801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2727734214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991731,0.00037451411,0.00010634213,0.000038452763,0.000006597844,0.0000026750652,0.00008137835,0.0000035509056,0.00021345814],"genre_scores_gemma":[0.99957806,0.00012974204,0.00010170478,0.000015111588,0.0000165748,0.0000020931989,0.00008513789,0.0000012453561,0.00007029241],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997377,0.000084229534,0.000027896609,0.0000630737,0.00005438631,0.00003280563],"domain_scores_gemma":[0.99867463,0.00035957372,0.00068320986,0.00006227353,0.000055736204,0.00016455844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045667685,0.0003592318,0.00033980678,0.00036979263,0.00018774605,0.00043577031,0.00023303117,0.00040149022,0.001489662],"category_scores_gemma":[0.002093661,0.00016007715,0.0002843959,0.00054036663,0.00022860168,0.0001983411,0.0002373735,0.00054623146,0.00012460773],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025362315,0.000037027457,0.99732673,0.000011806324,0.00007521534,0.00021357779,0.000028040353,0.00006587689,0.00051305373,0.000011403319,0.000034438457,0.0014291848],"study_design_scores_gemma":[0.000010650922,0.00011296474,0.9983986,0.0000076271454,0.00004056698,0.0009457146,0.000039004066,0.0002598247,0.000084470106,0.00004218745,0.00005494835,0.0000033821732],"about_ca_topic_score_codex":0.0009128255,"about_ca_topic_score_gemma":0.00057443674,"teacher_disagreement_score":0.001489662,"about_ca_system_score_codex":0.00009355577,"about_ca_system_score_gemma":0.00010544828,"threshold_uncertainty_score":0.004983425},"labels":[],"label_agreement":null},{"id":"W2775001793","doi":"10.1097/fpc.0000000000000317","title":"Novel CYP2A6 diplotypes identified through next-generation sequencing are associated with in-vitro and in-vivo nicotine metabolism","year":2017,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Nicotinic Acetylcholine Receptors Study","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute of Environmental Health Sciences; U.S. National Library of Medicine; National Institute of General Medical Sciences; National Institute on Drug Abuse","keywords":"CYP2A6; Single-nucleotide polymorphism; Nicotine; Biology; Genetics; Linkage disequilibrium; Minor allele frequency; SNP; Genome-wide association study; Genetic association; Genotype; Gene; CYP1A2; In vitro; Microsome","score_opus":0.058005208201422506,"score_gpt":0.2952555316003891,"score_spread":0.23725032339896657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2775001793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977437,0.00019877955,0.0010597472,0.000038224644,0.0000075083385,0.000013416475,0.0006264837,0.000011852131,0.0003002965],"genre_scores_gemma":[0.99803764,0.00006971811,0.00093109463,0.000043314645,0.000011069176,0.0000148380395,0.0005513821,0.000009355797,0.00033166702],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99948126,0.00011800138,0.00008555017,0.00017949751,0.000090356574,0.000045400313],"domain_scores_gemma":[0.9992311,0.00021102176,0.0003443773,0.00007352775,0.000057323352,0.00008265457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047526526,0.0004067212,0.00035627215,0.00070866913,0.00028483578,0.00036808854,0.00017456064,0.0004946848,0.0028864092],"category_scores_gemma":[0.001145802,0.00014577151,0.00045027674,0.0006648923,0.00022057879,0.00009887391,0.00023919762,0.00037884116,0.0005168979],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023354816,0.00016770359,0.72134215,0.0001225346,0.00060171576,0.0025997725,0.00041764957,0.0005898015,0.25585645,0.00031653835,0.00046528372,0.01518489],"study_design_scores_gemma":[0.00006375584,0.00024382235,0.9781739,0.000012465376,0.00020918813,0.0037478267,0.00007402764,0.0009664311,0.01526612,0.00018752075,0.0010419206,0.000013014918],"about_ca_topic_score_codex":0.0009541629,"about_ca_topic_score_gemma":0.001534308,"teacher_disagreement_score":0.0028864092,"about_ca_system_score_codex":0.00012258209,"about_ca_system_score_gemma":0.00011323578,"threshold_uncertainty_score":0.009656012},"labels":[],"label_agreement":null},{"id":"W2779612734","doi":"10.1097/fpc.0000000000000318","title":"Genome-wide meta-analyses identifies novel taxane-induced peripheral neuropathy-associated loci","year":2017,"lang":"en","type":"review","venue":"Pharmacogenetics and Genomics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"Taxane; Medicine; Chemotherapy-induced peripheral neuropathy; Peripheral neuropathy; Internal medicine; Oncology; Odds ratio; Common Terminology Criteria for Adverse Events; Breast cancer; Genome-wide association study; Confidence interval; Cancer; Pharmacogenetics; Diabetes mellitus; Genetics; Single-nucleotide polymorphism; Genotype; Biology; Gene; Endocrinology","score_opus":0.44997370352963967,"score_gpt":0.48725786600588017,"score_spread":0.0372841624762405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2779612734","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6217152,0.35454655,0.010374134,0.0026579686,0.0005706555,0.00011919473,0.007219701,0.00047705293,0.002319498],"genre_scores_gemma":[0.9756085,0.019863747,0.0017730942,0.00044691126,0.00013881167,0.00007336924,0.0016570876,0.00005689414,0.00038151938],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99652666,0.0017178241,0.00027953554,0.0009549326,0.00030879915,0.00021228132],"domain_scores_gemma":[0.9948872,0.0033118369,0.00076937693,0.0005891276,0.000255328,0.000187175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048216404,0.0014869693,0.0027783767,0.0020063787,0.00052157737,0.0020230715,0.0011302641,0.0012107557,0.0025409686],"category_scores_gemma":[0.008584033,0.00062080234,0.014882645,0.0034106227,0.00036393895,0.00046056573,0.0009930743,0.001302594,0.00018040554],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006070947,0.000053448584,0.3756467,0.004798888,0.5854459,0.0005742693,0.000087571236,0.00434717,0.0029396627,0.00037669792,0.0021574523,0.017501319],"study_design_scores_gemma":[0.0009961512,0.0005925332,0.40049368,0.0010657683,0.58521783,0.00061402656,0.00012807918,0.004794318,0.00091746356,0.0012746261,0.0038585898,0.000046897225],"about_ca_topic_score_codex":0.007363877,"about_ca_topic_score_gemma":0.010635333,"teacher_disagreement_score":0.007363877,"about_ca_system_score_codex":0.0005399732,"about_ca_system_score_gemma":0.0007477286,"threshold_uncertainty_score":0.025499582},"labels":[],"label_agreement":null},{"id":"W2792868582","doi":"10.1097/fpc.0000000000000331","title":"PharmGKB summary","year":2018,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pneumocystis jirovecii pneumonia detection and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Institute of General Medical Sciences","keywords":"Pharmacogenetics; Computational biology; Medicine; Biology; Genetics; Gene; Genotype","score_opus":0.018381764398705962,"score_gpt":0.3003895246509963,"score_spread":0.2820077602522903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792868582","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001565106,0.039540615,0.0035374456,0.06960389,0.016598143,0.0010761117,0.13501886,0.0059680333,0.7270918],"genre_scores_gemma":[0.022110822,0.07797164,0.0042787245,0.03826821,0.018460449,0.0014674177,0.15085794,0.0030871006,0.6834978],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985708,0.0003068188,0.00013173567,0.00024897014,0.00048569287,0.00025593923],"domain_scores_gemma":[0.9978617,0.000308052,0.00020718291,0.000155952,0.0005989025,0.0008681911],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016678141,0.0012245971,0.0020038243,0.0015892317,0.0005826509,0.004716907,0.001829939,0.0028013266,0.62054545],"category_scores_gemma":[0.006021469,0.0005064698,0.0010493211,0.0019512363,0.00035672996,0.0017165468,0.0013383669,0.0029896975,0.52822864],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040613115,0.000039321778,0.00014573646,0.00044805417,0.000030928637,0.00008474523,0.0000057948105,0.00009143635,0.00014913973,0.0010782052,0.93226093,0.06525961],"study_design_scores_gemma":[0.00050734734,0.00008129335,0.00039220764,0.0003274929,0.000027774762,0.00017309269,0.000007922036,0.000104115396,0.00014498424,0.0010711527,0.99715155,0.000011201981],"about_ca_topic_score_codex":0.0015451508,"about_ca_topic_score_gemma":0.0018629681,"teacher_disagreement_score":0.62054545,"about_ca_system_score_codex":0.0012638314,"about_ca_system_score_gemma":0.0027282708,"threshold_uncertainty_score":0.5412458},"labels":[],"label_agreement":null},{"id":"W2792897879","doi":"10.1097/fpc.0000000000000329","title":"Reply to Searcy and colleagues","year":2018,"lang":"en","type":"letter","venue":"Pharmacogenetics and Genomics","topic":"Health, Environment, Cognitive Aging","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"National Health and Medical Research Council; Cumming School of Medicine, University of Calgary","keywords":"Mental health; Neuropsychiatry; Library science; Medicine; Psychiatry","score_opus":0.024266382602370046,"score_gpt":0.28104935854533203,"score_spread":0.25678297594296196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792897879","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023754608,0.0010247986,0.000044197135,0.97799015,0.019660955,0.0000064163014,0.000026724012,0.000023552884,0.0009856671],"genre_scores_gemma":[0.002341114,0.0007794751,0.00009144096,0.968255,0.025441451,0.000024227918,0.000016562675,0.000016157537,0.0030345293],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998021,0.00047135324,0.0002730008,0.00037450454,0.0005795084,0.00028061442],"domain_scores_gemma":[0.99183536,0.003642022,0.0005702421,0.0003088622,0.002232167,0.001411356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003135122,0.0008002933,0.0012479413,0.0008001403,0.0037220994,0.0029450548,0.0022908954,0.035717476,0.0065306467],"category_scores_gemma":[0.026275473,0.000666973,0.0007016543,0.0007480362,0.003504183,0.005487008,0.0019018766,0.037035007,0.0076652616],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016798887,0.000012021571,0.00033338764,0.000029684914,0.000005418009,0.0009974216,0.00019781782,0.000015758895,0.00004413521,0.00091171014,0.9938392,0.0035966516],"study_design_scores_gemma":[0.00006067556,0.000043451953,0.0011196781,0.00028178236,0.00002040987,0.0054580905,0.0014942993,0.00017288172,0.00019503142,0.007052824,0.9840215,0.000079305464],"about_ca_topic_score_codex":0.0035470678,"about_ca_topic_score_gemma":0.0049427906,"teacher_disagreement_score":0.035717476,"about_ca_system_score_codex":0.002512031,"about_ca_system_score_gemma":0.0034145373,"threshold_uncertainty_score":0.021847188},"labels":[],"label_agreement":null},{"id":"W2793051516","doi":"10.1097/fpc.0000000000000347","title":"PharmGKB summary","year":2018,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute of General Medical Sciences; National Institutes of Health","keywords":"Biology; Computational biology","score_opus":0.02080660253857839,"score_gpt":0.3026491516667105,"score_spread":0.2818425491281321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793051516","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018182022,0.06712276,0.0032987313,0.109263584,0.028809085,0.0013191723,0.08161665,0.004275635,0.7024762],"genre_scores_gemma":[0.021933328,0.12674135,0.0034450006,0.048225634,0.026983751,0.0012401872,0.08889859,0.0020083429,0.6805239],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987226,0.00024690886,0.0001148361,0.00019700898,0.00047433612,0.00024421993],"domain_scores_gemma":[0.9977943,0.00025510055,0.00022526932,0.0001286562,0.0006580958,0.00093853805],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017705864,0.0011564465,0.0017856302,0.0015027577,0.0006433658,0.004552253,0.0018986976,0.002843079,0.52366525],"category_scores_gemma":[0.0059124194,0.00045658415,0.0009916754,0.0015989754,0.00038628947,0.0017860306,0.001428952,0.0033870554,0.44163474],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032787505,0.000032419335,0.00009639411,0.00044795827,0.000021917638,0.00007705508,0.0000058561886,0.00007767884,0.00016677377,0.0009370723,0.92425036,0.07355867],"study_design_scores_gemma":[0.00042147088,0.00009046438,0.00027333538,0.0003774234,0.000024277137,0.00018823906,0.00000788855,0.00007130882,0.00015278324,0.00088882615,0.9974942,0.000009873495],"about_ca_topic_score_codex":0.0014493723,"about_ca_topic_score_gemma":0.0020877884,"teacher_disagreement_score":0.52366525,"about_ca_system_score_codex":0.0013962775,"about_ca_system_score_gemma":0.002872091,"threshold_uncertainty_score":0.6794337},"labels":[],"label_agreement":null},{"id":"W2913270590","doi":"10.1097/fpc.0000000000000368","title":"International survey of patients undergoing percutaneous coronary intervention and their attitudes toward pharmacogenetic testing","year":2019,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; University of Toronto; Sunnybrook Health Science Centre; Health Sciences Centre; University of Ottawa","funders":"National Heart, Lung, and Blood Institute","keywords":"Pharmacogenetics; Medicine; Percutaneous coronary intervention; Conventional PCI; Confidence interval; Odds ratio; Genotyping; Population; Clopidogrel; Internal medicine; Genotype; Myocardial infarction; Environmental health; Genetics","score_opus":0.03036995556552156,"score_gpt":0.28224366050951033,"score_spread":0.25187370494398875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913270590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967901,0.00014588577,0.000097864446,0.000403237,0.000009515696,0.000026218711,0.0006052554,0.0000046428763,0.0019173159],"genre_scores_gemma":[0.9989473,0.00017937834,0.00010127196,0.00023754005,0.000008643563,0.00002071301,0.00031770644,0.0000013796478,0.00018605709],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898654,0.00040627838,0.00015241194,0.00009383641,0.00021064725,0.00015023873],"domain_scores_gemma":[0.9936445,0.0010075007,0.003613529,0.00021502606,0.00061058905,0.00090887485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001475638,0.00020804173,0.00023896806,0.00071503245,0.0003409739,0.0005827503,0.00024288753,0.0004997065,0.0026135212],"category_scores_gemma":[0.006469442,0.00018000208,0.0003806115,0.0009116577,0.0003332302,0.0006199982,0.0005206803,0.00083196093,0.0004449437],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060332375,0.00007374235,0.99703884,0.000015250181,0.000035351575,0.000022844359,0.00048147357,0.000026509348,0.000066231194,0.00001654861,0.0003206067,0.0018423242],"study_design_scores_gemma":[0.0000125401075,0.0001672177,0.99716574,0.000022328015,0.000018010254,0.00011180501,0.0017976724,0.00012779863,0.000029255725,0.0000143577245,0.00052546884,0.0000078422445],"about_ca_topic_score_codex":0.008360221,"about_ca_topic_score_gemma":0.006467545,"teacher_disagreement_score":0.008360221,"about_ca_system_score_codex":0.00036478025,"about_ca_system_score_gemma":0.0004186512,"threshold_uncertainty_score":0.01662308},"labels":[],"label_agreement":null},{"id":"W3026116380","doi":"10.1097/fpc.0000000000000406","title":"Use of antidepressants with pharmacogenetic prescribing guidelines in a 10-year depression cohort of adult primary care patients","year":2020,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Treatment of Major Depression","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; Hotchkiss Brain Institute; University of Calgary","funders":"","keywords":"Medicine; Venlafaxine; Pharmacogenetics; CYP2C19; Escitalopram; CYP2D6; Sertraline; Citalopram; Internal medicine; Mirtazapine; Pharmacology; Doxepin; Desipramine; Antidepressant; Psychiatry; Genotype; Anxiety","score_opus":0.04284948635188178,"score_gpt":0.29120268439261876,"score_spread":0.24835319804073697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026116380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991253,0.0000949809,0.000032599935,0.00003658667,0.0000034439959,0.000009698857,0.0005312787,0.0000021087087,0.00016406564],"genre_scores_gemma":[0.99903536,0.00007056857,0.00006792262,0.000045317694,0.000008909212,0.000012777312,0.00066359236,0.0000011134514,0.00009444334],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99915934,0.00015661967,0.00010716223,0.00024199273,0.00021082557,0.00012401765],"domain_scores_gemma":[0.9974081,0.00033693094,0.0014763686,0.00016784879,0.00029132928,0.0003194839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006991992,0.0002487193,0.0004121287,0.0008131008,0.0005956628,0.000822605,0.00038434207,0.0006319203,0.0012597555],"category_scores_gemma":[0.0030022713,0.00045012071,0.0005485051,0.001060355,0.00022272831,0.0006200475,0.0004662279,0.0006200549,0.00025843602],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002531021,0.000018310184,0.9995894,0.0000017887521,0.00002394246,0.000032246877,0.000031550833,0.000010408223,0.000050336086,0.000002133614,0.000036313995,0.0001781787],"study_design_scores_gemma":[0.000003987305,0.000045759272,0.9995881,0.0000021386818,0.00000991992,0.00015507778,0.000068438574,0.000072605355,0.000011788704,0.0000022301576,0.000038334878,0.0000015652945],"about_ca_topic_score_codex":0.018215697,"about_ca_topic_score_gemma":0.01814049,"teacher_disagreement_score":0.018215697,"about_ca_system_score_codex":0.0004673871,"about_ca_system_score_gemma":0.00040254722,"threshold_uncertainty_score":0.0362193},"labels":[],"label_agreement":null},{"id":"W3080763434","doi":"10.1097/fpc.0000000000000418","title":"Identification of high-impact gene–drug pairs for pharmacogenetic testing in Alberta, Canada","year":2020,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Children's Hospital; Alberta Health Services; Women and Children’s Health Research Institute; University of Alberta; University of Calgary","funders":"","keywords":"Pharmacogenetics; Identification (biology); Drug; Genetics; Biology; Computational biology; Gene; Pharmacology; Genotype; Ecology","score_opus":0.08342893702688821,"score_gpt":0.3768694939897619,"score_spread":0.2934405569628737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3080763434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95765775,0.0061489283,0.0034338222,0.0047515486,0.00012645204,0.00042210295,0.009428078,0.00014076346,0.01789056],"genre_scores_gemma":[0.9888165,0.0016502008,0.003906435,0.00136069,0.000024244606,0.00004559106,0.0020681184,0.000020505959,0.0021076198],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99781126,0.00026051071,0.00009185746,0.00027395552,0.00092252076,0.0006399498],"domain_scores_gemma":[0.9974577,0.00034546477,0.00043335225,0.00007364743,0.0010802159,0.000609606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016354807,0.0004214234,0.00039717145,0.0019839203,0.0021041008,0.0015691223,0.0013529608,0.00043416215,0.0023820365],"category_scores_gemma":[0.0031202768,0.00028381599,0.0005365282,0.004678817,0.0009884617,0.00025279025,0.0011119589,0.0006595854,0.00018795936],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020788275,0.0000660903,0.95472956,0.0001459454,0.00012384985,0.00089050113,0.00071236934,0.00082377496,0.0011426097,0.0011749483,0.008050503,0.031932004],"study_design_scores_gemma":[0.000044489894,0.000046158868,0.98788226,0.00013834481,0.00013014201,0.00051604037,0.0015998349,0.0017887107,0.0004136822,0.00030961315,0.0071068048,0.000023911944],"about_ca_topic_score_codex":0.99106276,"about_ca_topic_score_gemma":0.99568045,"teacher_disagreement_score":0.029426077,"about_ca_system_score_codex":0.029426077,"about_ca_system_score_gemma":0.06462652,"threshold_uncertainty_score":0.21350211},"labels":[],"label_agreement":null},{"id":"W3133653696","doi":"10.1097/fpc.0000000000000427","title":"Effect of race and glucuronidation rates on the relationship between nicotine metabolite ratio and nicotine clearance","year":2021,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Forensic Toxicology and Drug Analysis","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute on Drug Abuse; Canadian Institutes of Health Research","keywords":"Cotinine; Nicotine; Glucuronidation; Metabolite; Chemistry; Pharmacology; Internal medicine; Medicine; Biochemistry","score_opus":0.06614024801999263,"score_gpt":0.40231527241392684,"score_spread":0.3361750243939342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133653696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99676454,0.0006774042,0.00097286684,0.000081996994,0.000021335736,0.000018632836,0.00024278786,0.000025342275,0.0011950261],"genre_scores_gemma":[0.99834716,0.0001287718,0.00066373916,0.000032696924,0.000015148585,0.000016322732,0.0001440808,0.000023145072,0.0006289782],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825233,0.00096518913,0.00008244999,0.0003708778,0.00020803118,0.00012109115],"domain_scores_gemma":[0.99176085,0.004701588,0.0016797589,0.0008968963,0.00051888375,0.00044201862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026964918,0.00034765588,0.0004099311,0.00029994815,0.00016740386,0.00056821,0.00029216617,0.0004214807,0.0026559264],"category_scores_gemma":[0.008469291,0.00026579227,0.00057300547,0.0002895893,0.00032439906,0.00036457097,0.0002542713,0.00041639307,0.0005879948],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005217234,0.00013989511,0.97523403,0.000030269302,0.00052014674,0.00010760505,0.00016157066,0.00018996507,0.0089551145,0.000093749855,0.00012752325,0.0092229],"study_design_scores_gemma":[0.000016623571,0.0006585707,0.9960913,0.000008409374,0.0001971619,0.00021196995,0.000039993236,0.0007582532,0.0016420222,0.000058430207,0.0003112721,0.0000059680374],"about_ca_topic_score_codex":0.0018361815,"about_ca_topic_score_gemma":0.0012671823,"teacher_disagreement_score":0.0026964918,"about_ca_system_score_codex":0.00013934639,"about_ca_system_score_gemma":0.0002687669,"threshold_uncertainty_score":0.01426065},"labels":[],"label_agreement":null},{"id":"W3165358665","doi":"10.1097/fpc.0000000000000437","title":"Anxiety symptom remission is associated with genetic variation of PTPRZ1 among patients with major depressive disorder treated with escitalopram","year":2021,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Escitalopram; Major depressive disorder; Citalopram; Internal medicine; Sertraline; Psychiatry; Psychology; Antidepressant; Anxiety; Generalized anxiety disorder; Hamilton Anxiety Rating Scale; Anxiety disorder; Hamilton Rating Scale for Depression; Cohort; Paroxetine; Medicine; Cognition","score_opus":0.003625396111086832,"score_gpt":0.2060832140743183,"score_spread":0.20245781796323145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165358665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99972194,0.00010654707,0.000027511862,0.00002026349,0.0000027738445,0.000002159234,0.000050411894,0.0000015573901,0.00006682403],"genre_scores_gemma":[0.99981934,0.00003279486,0.000020905089,0.000008684927,0.000003976431,0.0000015789915,0.00006626311,6.822655e-7,0.000045920653],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997863,0.00004554472,0.00002939259,0.00007772928,0.000033112945,0.000027831135],"domain_scores_gemma":[0.9994905,0.00009129636,0.00027798803,0.00003080751,0.00003735841,0.00007197041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022661492,0.00021464712,0.0003037711,0.00037546223,0.00026471214,0.00029289746,0.00022732692,0.00033219645,0.0015101022],"category_scores_gemma":[0.0010908601,0.00017637206,0.0003782872,0.00046007673,0.00019700744,0.00013854125,0.00020434786,0.00033431363,0.00011664439],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075781444,0.0000434172,0.99272525,0.000012660721,0.00024979273,0.00022948452,0.00010522128,0.000051543266,0.0033206649,0.00001717212,0.00007284568,0.0024141022],"study_design_scores_gemma":[0.00001777914,0.000047708803,0.99949384,0.000001507513,0.00004672468,0.00019360211,0.000026553567,0.00008659998,0.000051540228,0.000008249849,0.000024413841,0.0000014234445],"about_ca_topic_score_codex":0.004032926,"about_ca_topic_score_gemma":0.004131258,"teacher_disagreement_score":0.004032926,"about_ca_system_score_codex":0.00018020198,"about_ca_system_score_gemma":0.000121861485,"threshold_uncertainty_score":0.008018911},"labels":[],"label_agreement":null},{"id":"W3176929014","doi":"10.1097/fpc.0000000000000442","title":"Pharmacogenetic study in gastric cancer patients treated with adjuvant fluorouracil/leucovorin or epirubicin/cisplatin/fluorouracil before and after chemoradiation on CALGB 80101 (Alliance)","year":2021,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"National Institute of General Medical Sciences; National Cancer Institute","keywords":"Pharmacogenetics; Cancer; Epirubicin; Neutropenia; Single-nucleotide polymorphism; Leukopenia; GSTP1; Prospective cohort study","score_opus":0.019932739131002398,"score_gpt":0.2988803284072707,"score_spread":0.2789475892762683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176929014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99953496,0.00008800118,0.0000433716,0.000018214445,0.000002646159,0.000015264948,0.0001720198,0.000001316151,0.00012411918],"genre_scores_gemma":[0.9991823,0.00004480682,0.000079120015,0.00004461848,0.000004688083,0.000018510775,0.00044170904,0.0000017932098,0.00018244564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99971503,0.0001001656,0.000019445562,0.0000827548,0.000039632414,0.000042921365],"domain_scores_gemma":[0.9997496,0.00004908909,0.000081786326,0.00004090898,0.00002068819,0.000057957815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041635634,0.00023047398,0.00042324903,0.00025656648,0.00029704513,0.00034418234,0.00021536401,0.00034612505,0.0010239127],"category_scores_gemma":[0.00072159275,0.00017962728,0.0004679209,0.00046893692,0.00016247609,0.00013418618,0.00021695945,0.00036806276,0.00016082253],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007912833,0.0003179011,0.9813364,0.000029384435,0.00053291855,0.00019024804,0.000102878665,0.00022273835,0.003998092,0.000057293048,0.00034118755,0.004958017],"study_design_scores_gemma":[0.00049623114,0.0012418948,0.99646276,0.000004232464,0.00023104638,0.00020386718,0.000054441287,0.00046625314,0.00023836238,0.000046651887,0.00054912013,0.0000051193288],"about_ca_topic_score_codex":0.0048199864,"about_ca_topic_score_gemma":0.006259281,"teacher_disagreement_score":0.0048199864,"about_ca_system_score_codex":0.0004613384,"about_ca_system_score_gemma":0.00032952853,"threshold_uncertainty_score":0.00958389},"labels":[],"label_agreement":null},{"id":"W3199202727","doi":"10.1097/fpc.0000000000000457","title":"Psychotropic prescribing rates and pharmacogenomic testing implications for autism in the Canadian primary care sentinel surveillance network","year":2021,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Autism Spectrum Disorder Research","field":"Neuroscience","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Children's Hospital","funders":"","keywords":"Primary care; Pharmacogenomics; Autism; Pharmacogenetics; Medical prescription; MEDLINE","score_opus":0.07508248256303808,"score_gpt":0.3359839427223329,"score_spread":0.26090146015929483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199202727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9789818,0.0014084354,0.0003126029,0.0010579497,0.000020940553,0.000095823336,0.01448234,0.000033647328,0.0036065038],"genre_scores_gemma":[0.99480164,0.0006459769,0.00058032287,0.00025638472,0.000011324626,0.000028635584,0.0034783762,0.0000039188362,0.00019341514],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99710363,0.00032317892,0.00023041664,0.00048504214,0.0013802203,0.00047747535],"domain_scores_gemma":[0.99344325,0.00065544614,0.002042705,0.00018656516,0.002931567,0.0007404193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019330852,0.00038136332,0.00028824373,0.0028041652,0.0013367357,0.00081119896,0.0013122676,0.00051427697,0.0013157348],"category_scores_gemma":[0.009417366,0.00029651207,0.000522184,0.003570823,0.00048260542,0.00033270955,0.0009023233,0.0004396505,0.00012688177],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020067204,0.000006914937,0.9961761,0.00003925402,0.00003399859,0.00004335264,0.0001609387,0.00009626719,0.00009765803,0.000035382043,0.0010662246,0.002223825],"study_design_scores_gemma":[0.000003753783,0.000013184491,0.9982925,0.00004812721,0.000025013875,0.000105752966,0.0002777176,0.0006541353,0.00006392545,0.0000140030525,0.00049654767,0.000005297834],"about_ca_topic_score_codex":0.9697323,"about_ca_topic_score_gemma":0.97660977,"teacher_disagreement_score":0.030267715,"about_ca_system_score_codex":0.013000022,"about_ca_system_score_gemma":0.015662523,"threshold_uncertainty_score":0.094322205},"labels":[],"label_agreement":null},{"id":"W3208307657","doi":"10.1097/fpc.0000000000000459","title":"In-vitro characterization of coding variants with predicted functional implications in the efflux transporter multidrug resistance protein 4 (MRP4, ABCC4)","year":2021,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Efflux; Transporter; Wild type; HEK 293 cells; Biology; Intracellular; Gene; Molecular biology; Biochemistry; Mutant","score_opus":0.014368261648528538,"score_gpt":0.23663310260196227,"score_spread":0.22226484095343374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208307657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98670524,0.0010634663,0.0072796196,0.00014903874,0.000063265696,0.000073219475,0.0038160232,0.00007209737,0.00077794655],"genre_scores_gemma":[0.96775514,0.0009659215,0.011509424,0.00013804573,0.000035574732,0.00008608869,0.016398113,0.00019620721,0.0029154746],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995894,0.00009397976,0.00007085188,0.00007701189,0.00011501931,0.00005369717],"domain_scores_gemma":[0.9995127,0.00016146696,0.00012559924,0.00006330281,0.00008985885,0.000047122223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003965427,0.0004314476,0.0004585585,0.000250736,0.000167492,0.00059298653,0.00031486785,0.00040403832,0.001189225],"category_scores_gemma":[0.0007155079,0.0002321968,0.0006405837,0.0004994879,0.00021191748,0.0001343708,0.0002493706,0.0005864347,0.001178767],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006189775,0.000025351697,0.0005976195,0.000044438995,0.000017436381,0.00014914136,0.000030408084,0.00018594072,0.99815124,0.00005667855,0.00006316404,0.00061664253],"study_design_scores_gemma":[0.000025275982,0.00033328822,0.007888563,0.0000103235025,0.0001243577,0.0012706443,0.00008881716,0.0026572903,0.97960883,0.000058348847,0.007916157,0.000018121438],"about_ca_topic_score_codex":0.0015799685,"about_ca_topic_score_gemma":0.0023859185,"teacher_disagreement_score":0.0015799685,"about_ca_system_score_codex":0.00033573818,"about_ca_system_score_gemma":0.00019760265,"threshold_uncertainty_score":0.0039783716},"labels":[],"label_agreement":null},{"id":"W4211027373","doi":"10.1097/fpc.0b013e3283540217","title":"PharmGKB summary","year":2012,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute of General Medical Sciences; National Institute on Drug Abuse; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Philosophy; Humanities","score_opus":0.040592869485244085,"score_gpt":0.34951098396053903,"score_spread":0.30891811447529494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211027373","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014436912,0.034385454,0.0024997839,0.047681235,0.013845961,0.0010455492,0.09634839,0.0040462087,0.79870373],"genre_scores_gemma":[0.012763416,0.05881699,0.0027451338,0.019394586,0.0113876425,0.0008692516,0.08150774,0.001711392,0.8108038],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99896014,0.00020355648,0.00009897993,0.00017842113,0.00038380516,0.0001751336],"domain_scores_gemma":[0.9983236,0.0001921,0.00015881332,0.00011097461,0.00052850606,0.0006859626],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014286995,0.0011891049,0.0016190461,0.0016379646,0.00056034536,0.0039560236,0.0017268035,0.002433105,0.6576544],"category_scores_gemma":[0.004663956,0.00043289407,0.00079646887,0.0020923594,0.00026968375,0.0013975857,0.0012287345,0.0021996305,0.5799508],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029443798,0.000031913198,0.00011693328,0.00037303104,0.000016862135,0.00007170041,0.0000055209434,0.000059696744,0.00015214615,0.0006774131,0.91745955,0.080740854],"study_design_scores_gemma":[0.00021906436,0.000052508152,0.00029100274,0.00020497633,0.00001425935,0.00011846082,0.0000060812627,0.00005118166,0.000113619506,0.00050265057,0.99841976,0.000006446167],"about_ca_topic_score_codex":0.0016781274,"about_ca_topic_score_gemma":0.0021746028,"teacher_disagreement_score":0.6576544,"about_ca_system_score_codex":0.0011968019,"about_ca_system_score_gemma":0.0025140105,"threshold_uncertainty_score":0.48831445},"labels":[],"label_agreement":null},{"id":"W4212906205","doi":"10.1097/fpc.0000000000000466","title":"Accuracy and applications of sequencing and genotyping approaches for CYP2A6 and homologous genes","year":2022,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Cancer Institute; National Institute on Drug Abuse; Canadian Institutes of Health Research","keywords":"Genotyping; Gene; SNP genotyping; DNA sequencing; Chromosome; Homologous chromosome; SNP; Single-nucleotide polymorphism","score_opus":0.15998655469186432,"score_gpt":0.3937307608366337,"score_spread":0.2337442061447694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212906205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77149236,0.017376417,0.20089625,0.0013891138,0.00029747817,0.00021878413,0.0014712971,0.00044822032,0.006410092],"genre_scores_gemma":[0.9424163,0.0010772275,0.053753156,0.00042172728,0.00010817164,0.00011349142,0.0007956533,0.00011986306,0.0011943852],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9123187,0.057822034,0.0033418008,0.012487113,0.012951041,0.0010792878],"domain_scores_gemma":[0.88721913,0.07774791,0.010643222,0.014732229,0.009070984,0.0005864794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.057329424,0.0010804804,0.0009370003,0.0017964602,0.00055280654,0.002110695,0.0016935284,0.0018249829,0.00095405465],"category_scores_gemma":[0.08662928,0.00065555674,0.0011962085,0.0013851639,0.0014171832,0.0010410254,0.0016449067,0.0013244982,0.0006389222],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001337202,0.00010095275,0.7798593,0.00054635416,0.0028990346,0.00017223813,0.0012917848,0.0142987985,0.033346307,0.0020111038,0.0008097015,0.1633272],"study_design_scores_gemma":[0.00012898142,0.0012811379,0.8459053,0.0003449422,0.002129618,0.0023145177,0.00044415222,0.07706937,0.054724023,0.005500621,0.010004348,0.0001528736],"about_ca_topic_score_codex":0.0033924489,"about_ca_topic_score_gemma":0.004621549,"teacher_disagreement_score":0.057329424,"about_ca_system_score_codex":0.0009024935,"about_ca_system_score_gemma":0.0007113144,"threshold_uncertainty_score":0.30319065},"labels":[],"label_agreement":null},{"id":"W4249137086","doi":"10.1097/fpc.0b013e3283335277","title":"Taxane pathway","year":2009,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"National Institute of General Medical Sciences","keywords":"Taxane; Biology; Genetics; Cancer; Breast cancer","score_opus":0.01899387428273902,"score_gpt":0.3110434663305991,"score_spread":0.2920495920478601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249137086","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2207577,0.1374215,0.026361959,0.022661628,0.0049718814,0.0011498694,0.04431212,0.0026857355,0.5396775],"genre_scores_gemma":[0.43109375,0.09357767,0.008468475,0.0024146722,0.00045797264,0.00026851537,0.020396542,0.00019381287,0.44312862],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998834,0.000008533516,0.0000062675213,0.00002945817,0.000050245457,0.000021980528],"domain_scores_gemma":[0.99993134,0.0000042593047,0.0000129441,0.000007717983,0.000022806147,0.000020895312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009715968,0.000479215,0.00027823594,0.0004787023,0.00051229744,0.0010640165,0.00039006822,0.00038240783,0.039214883],"category_scores_gemma":[0.00018618883,0.00013738424,0.00040717467,0.00027537125,0.00013050508,0.0005150889,0.0005424951,0.0008816285,0.009635149],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012549537,0.00029920044,0.0040372615,0.0014348266,0.00012579882,0.0016165163,0.00022334042,0.00080091076,0.39763957,0.04916431,0.11972996,0.42367336],"study_design_scores_gemma":[0.00017841879,0.0003366042,0.009688041,0.00025206068,0.00010965709,0.0033011339,0.00013950067,0.0008114115,0.15317605,0.00805861,0.82392114,0.000027392347],"about_ca_topic_score_codex":0.001986007,"about_ca_topic_score_gemma":0.0029120771,"teacher_disagreement_score":0.039214883,"about_ca_system_score_codex":0.00085757824,"about_ca_system_score_gemma":0.0009928874,"threshold_uncertainty_score":0.13118684},"labels":[],"label_agreement":null},{"id":"W4308956492","doi":"10.1097/fpc.0000000000000486","title":"Impact of organic anion transporting polypeptide, P-glycoprotein, and breast cancer resistance protein transporters on observed tamoxifen and endoxifen concentration and adverse effects","year":2022,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"Canadian Institutes of Health Research","keywords":"Tamoxifen; Abcg2; SLCO1B1; Pharmacology; CYP2D6; Breast cancer; Organic anion-transporting polypeptide; Transporter; Efflux; Antiestrogen; Medicine; Chemistry; Internal medicine; Pharmacogenetics; Cancer; ATP-binding cassette transporter; Genotype; Gene; Metabolism; Biochemistry; Cytochrome P450","score_opus":0.01140252406636221,"score_gpt":0.2528596884057164,"score_spread":0.24145716433935416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308956492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99907804,0.0004026345,0.000075402124,0.000031788906,0.0000026965042,0.0000030135545,0.00015061258,0.000002327518,0.00025346273],"genre_scores_gemma":[0.9997011,0.000050179126,0.000052614814,0.000014096153,0.000002390041,0.0000018810058,0.00007945236,0.0000012885116,0.00009699603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993679,0.00019596398,0.00006266134,0.00015851586,0.00015411049,0.000060771687],"domain_scores_gemma":[0.9985827,0.00043574173,0.00067355135,0.00006570797,0.0001269821,0.00011526303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042380436,0.00015993281,0.00028089198,0.00023852008,0.00017260037,0.00036021846,0.00011160774,0.00022492275,0.0014446093],"category_scores_gemma":[0.0015060087,0.000084160085,0.00027602998,0.00040869205,0.00019551431,0.0001746737,0.00014157825,0.00027788387,0.00016150206],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012562324,0.00005249907,0.98133963,0.00002832847,0.00015898465,0.00027600097,0.00006192849,0.00008260554,0.01241867,0.000020904467,0.000049827522,0.004254364],"study_design_scores_gemma":[0.000010374585,0.00039097178,0.9965718,0.0000042722945,0.00009175552,0.0006469002,0.00005366767,0.0002069599,0.0017769444,0.000018314544,0.00022508045,0.0000029625428],"about_ca_topic_score_codex":0.0011519009,"about_ca_topic_score_gemma":0.0018572138,"teacher_disagreement_score":0.0014446093,"about_ca_system_score_codex":0.00021404872,"about_ca_system_score_gemma":0.0001577777,"threshold_uncertainty_score":0.004832685},"labels":[],"label_agreement":null},{"id":"W4386592972","doi":"10.1097/fpc.0000000000000507","title":"Annual Scientific Meeting of the Pharmacogenomics Global Research Network (PGRN) June 12-13, 2023 Memphis, TN, USA","year":2023,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Memphis; Pharmacogenomics; Pharmacogenetics; Biology; Genetics; Genotype","score_opus":0.17590150158555848,"score_gpt":0.4591286800394171,"score_spread":0.2832271784538586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386592972","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0055848854,0.020610135,0.004945641,0.20142606,0.17947204,0.0015980513,0.01765059,0.0010389668,0.5676737],"genre_scores_gemma":[0.007082114,0.0060687293,0.0027371547,0.01598905,0.012615731,0.0005398358,0.006733496,0.0003558897,0.94787794],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99846727,0.00033110238,0.000048439982,0.0003062579,0.0005548174,0.00029211157],"domain_scores_gemma":[0.9979735,0.00013380403,0.000091593676,0.00004983415,0.0007607361,0.0009906316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038452516,0.0015039329,0.00050996593,0.0006232953,0.0017271454,0.0032847326,0.0011669947,0.0029993327,0.28448784],"category_scores_gemma":[0.0028095385,0.00035464676,0.0005385864,0.00042307153,0.00060738524,0.0014291833,0.0022724452,0.003908362,0.09735235],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011591101,0.000032852415,0.0002216165,0.00007262351,0.000005930686,0.00006981664,0.000025518935,0.000051489184,0.00046372454,0.0007093432,0.97958815,0.018643033],"study_design_scores_gemma":[0.000023879871,0.00004157513,0.0012959931,0.00010605976,0.0000032809296,0.00004025083,0.000078689314,0.00008928657,0.00013856382,0.00040101557,0.99777526,0.0000061161304],"about_ca_topic_score_codex":0.0063339523,"about_ca_topic_score_gemma":0.020497529,"teacher_disagreement_score":0.28448784,"about_ca_system_score_codex":0.0027664234,"about_ca_system_score_gemma":0.006626504,"threshold_uncertainty_score":0.95170665},"labels":[],"label_agreement":null},{"id":"W4388125640","doi":"10.1097/fpc.0000000000000515","title":"Pharmacogenetics of weight gain following switch from efavirenz- to integrase inhibitor-containing regimens","year":2023,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"HIV-related health complications and treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases; National Institute on Aging; Center for AIDS Research, University of Washington; Public Health Agency of Canada; National Institutes of Health; National Center for Research Resources; Public Health Agency; ACT Government; U.S. Department of Veterans Affairs","keywords":"Elvitegravir; Efavirenz; CYP2B6; Weight gain; Dolutegravir; Integrase inhibitor; Pharmacogenetics; Raltegravir; Medicine; Integrase; Internal medicine; Pharmacology; Genotype; Oncology; Virology; Viral load; Human immunodeficiency virus (HIV); Biology; Genetics; Antiretroviral therapy; Body weight; CYP1A2; Cytochrome P450","score_opus":0.029463846367961195,"score_gpt":0.34143788343903064,"score_spread":0.31197403707106947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388125640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999186,0.00016799103,0.00014371489,0.000028557482,0.0000031536074,0.0000059179956,0.00013989097,0.000003988983,0.0003208687],"genre_scores_gemma":[0.9996301,0.000041313935,0.0000893407,0.000019172148,0.0000032859475,0.0000030194326,0.00011071312,0.0000020476925,0.00010093203],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999747,0.000084901316,0.000023454873,0.00006225212,0.000050788833,0.00003160005],"domain_scores_gemma":[0.99910104,0.00021512932,0.00049193326,0.00005794176,0.000057002995,0.00007698763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005348736,0.00014537782,0.00017701616,0.00043083567,0.00015144922,0.00040064717,0.000159758,0.00027440756,0.0010413919],"category_scores_gemma":[0.00161387,0.000098694094,0.00027600417,0.00051600096,0.0001610088,0.00016900143,0.00017347878,0.00034835958,0.00013544147],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047458056,0.000031672345,0.9947865,0.00000587044,0.00007732847,0.000050267277,0.000035035933,0.000108685985,0.0011089048,0.000022211632,0.00006829227,0.003230612],"study_design_scores_gemma":[0.0000075071803,0.0000862685,0.99904066,0.000002971259,0.00002546959,0.00018505637,0.000023421788,0.00033518457,0.00017416598,0.000030121708,0.000087238135,0.0000018492052],"about_ca_topic_score_codex":0.0018643333,"about_ca_topic_score_gemma":0.002376589,"teacher_disagreement_score":0.0018643333,"about_ca_system_score_codex":0.00021119959,"about_ca_system_score_gemma":0.000089375244,"threshold_uncertainty_score":0.003706932},"labels":[],"label_agreement":null},{"id":"W4389346225","doi":"10.1097/fpc.0000000000000517","title":"Development of an ARMS multiplex real-time PCR assay for the detection of HLA-B*13:01 genotype by detecting highly specific SNPs","year":2023,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Science North","funders":"","keywords":"Genotyping; TaqMan; Multiplex; Genotype; Multiplex polymerase chain reaction; HLA-B; Biology; Molecular biology; Typing; Polymerase chain reaction; Single-nucleotide polymorphism; Human leukocyte antigen; Genetics; Gene; Antigen","score_opus":0.04258653698996955,"score_gpt":0.3017678834979318,"score_spread":0.25918134650796226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389346225","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2372267,0.0031624332,0.74746615,0.00061440247,0.0006986648,0.0018483022,0.0014888588,0.002122823,0.005371654],"genre_scores_gemma":[0.29439119,0.0011176048,0.6922387,0.0006873702,0.00013918064,0.002798423,0.0015233736,0.000093924464,0.0070102294],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958407,0.0013223019,0.0002680505,0.0011974911,0.0011799465,0.00019150239],"domain_scores_gemma":[0.99851674,0.00065837894,0.00026475787,0.00013728491,0.0003210605,0.00010182551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032428086,0.0011645516,0.0007720039,0.001213885,0.00023273275,0.00073849893,0.0008829281,0.0011947693,0.002046797],"category_scores_gemma":[0.0030144835,0.0008471064,0.00054319773,0.0004305852,0.0006695712,0.0005504112,0.00054445816,0.0014480271,0.0011980787],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00097287574,0.00040573615,0.009009388,0.00033526332,0.00010401823,0.0002720143,0.00022301085,0.0012436187,0.9089382,0.0009217069,0.0009999219,0.07657425],"study_design_scores_gemma":[0.00037372968,0.0038088318,0.024872556,0.00017482313,0.00032970586,0.0028906127,0.00011360865,0.054827757,0.8898932,0.0012070471,0.02132867,0.00017954623],"about_ca_topic_score_codex":0.00020987148,"about_ca_topic_score_gemma":0.0004240422,"teacher_disagreement_score":0.0032428086,"about_ca_system_score_codex":0.00035796335,"about_ca_system_score_gemma":0.000637539,"threshold_uncertainty_score":0.017149806},"labels":[],"label_agreement":null},{"id":"W4390820681","doi":"10.1097/fpc.0000000000000521","title":"Common dihydropyrimidinase (DPYS) genetic variations do not predict fluoropyrimidine-related chemotherapy toxicity in a Canadian cohort","year":2024,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lawson Health Research Institute; London Health Sciences Centre; Western University","funders":"","keywords":"Pharmacogenetics; Toxicity; Cohort; Oncology; Chemotherapy; Medicine; Internal medicine; Pharmacology; Biology; Genetics; Genotype; Gene","score_opus":0.013323246044716353,"score_gpt":0.2882865617744478,"score_spread":0.27496331572973143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390820681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964713,0.00024534576,0.00018513894,0.00017969302,0.000011565943,0.000029845933,0.0015668462,0.000009047271,0.001301183],"genre_scores_gemma":[0.99754626,0.00024251711,0.00021811214,0.00012392351,0.000009498741,0.000013738271,0.00112303,0.00000996568,0.00071285357],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993931,0.0000334352,0.000027947672,0.00018472467,0.00020901689,0.00015178845],"domain_scores_gemma":[0.9989937,0.00007792496,0.00020237328,0.00011042801,0.00039024767,0.0002253767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004610267,0.0006200215,0.0005699568,0.00070871273,0.0030340625,0.0009104637,0.0009995536,0.00054430147,0.003276838],"category_scores_gemma":[0.001853009,0.0004879792,0.0007636073,0.0014232756,0.00068192685,0.00025760772,0.000493205,0.0008309175,0.00032371382],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003670858,0.00003274753,0.9913536,0.000027728189,0.00014042686,0.0003972895,0.00058873196,0.00012521917,0.0015957415,0.00013074439,0.0017021234,0.003538513],"study_design_scores_gemma":[0.000065609085,0.000091425914,0.9952578,0.000024793302,0.00015001265,0.00087576447,0.000552559,0.00051460194,0.0001759592,0.0000731983,0.0021929701,0.000025305366],"about_ca_topic_score_codex":0.94039726,"about_ca_topic_score_gemma":0.9528804,"teacher_disagreement_score":0.059602737,"about_ca_system_score_codex":0.0057454645,"about_ca_system_score_gemma":0.007875727,"threshold_uncertainty_score":0.11990744},"labels":[],"label_agreement":null},{"id":"W4391838815","doi":"10.1097/fpc.0000000000000523","title":"Pharmacogenomic allele coverage of genome-wide genotyping arrays: a comparative analysis","year":2024,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Children's Hospital","funders":"","keywords":"Genotyping; Pharmacogenomics; Genetics; Allele; Biology; Computational biology; Genome; Pharmacogenetics; Genome-wide association study; Genotype; Single-nucleotide polymorphism; Gene","score_opus":0.09909228692229773,"score_gpt":0.41518326556243795,"score_spread":0.31609097864014024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391838815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9732587,0.0017954502,0.012288817,0.00022934581,0.000014360259,0.00003794695,0.0073393355,0.00023626183,0.004799809],"genre_scores_gemma":[0.98489755,0.00036866983,0.0076825414,0.00011781991,0.000017434893,0.0000669788,0.006137373,0.0000810748,0.0006305174],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99270093,0.0031448866,0.000497188,0.0016355041,0.0016582087,0.00036328993],"domain_scores_gemma":[0.9822863,0.012239551,0.00195395,0.001687917,0.0016457305,0.0001866403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005202799,0.0002655686,0.00051642535,0.0027081063,0.00025925983,0.0010834958,0.00037217457,0.00048365217,0.0023778637],"category_scores_gemma":[0.018136974,0.00025386747,0.0010209841,0.0030800223,0.000357796,0.00057131896,0.00087295705,0.00034348498,0.00047831162],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001990816,0.000044081942,0.84053564,0.00041704814,0.0023301307,0.00031287275,0.0013876689,0.0033008952,0.05331534,0.0013316032,0.0018111944,0.093222715],"study_design_scores_gemma":[0.000018718247,0.0001888042,0.97965014,0.00003446407,0.0005691224,0.0007259061,0.00030712888,0.0037406324,0.009659195,0.00045509383,0.00462601,0.000024806968],"about_ca_topic_score_codex":0.0020127248,"about_ca_topic_score_gemma":0.0023943502,"teacher_disagreement_score":0.005202799,"about_ca_system_score_codex":0.00032561398,"about_ca_system_score_gemma":0.00027387048,"threshold_uncertainty_score":0.027515352},"labels":[],"label_agreement":null},{"id":"W4392700120","doi":"10.1097/fpc.0000000000000526","title":"Association between CYP2C9 and VKORC1 genetic polymorphisms and efficacy and safety of warfarin in Chinese patients","year":2024,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CAE (Canada)","funders":"","keywords":"VKORC1; Warfarin; CYP2C9; Odds ratio; Internal medicine; Pharmacogenetics; Univariate analysis; Medicine; Vitamin K epoxide reductase; Logistic regression; Genotype; Single-nucleotide polymorphism; Biology; Multivariate analysis; Genetics; Gene; Atrial fibrillation","score_opus":0.03598974033285063,"score_gpt":0.3694414487508352,"score_spread":0.33345170841798455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392700120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991171,0.00039108147,0.000055695262,0.000047162273,0.000003969279,0.0000058693586,0.000112429334,0.000001427446,0.00026521075],"genre_scores_gemma":[0.9996414,0.00008962947,0.000050050625,0.000016570793,0.000007275454,0.0000043231657,0.00009497542,6.8313625e-7,0.00009514603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99968886,0.00005957533,0.000042561223,0.00009324239,0.00006788738,0.000047855745],"domain_scores_gemma":[0.9995927,0.00009203199,0.00015096333,0.00004658047,0.000052866566,0.0000647946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005828053,0.00026172952,0.00036101413,0.00045261258,0.00044117536,0.000280153,0.00024410314,0.00028919752,0.0014516106],"category_scores_gemma":[0.0010024738,0.00014921534,0.00065272505,0.00091426563,0.00022259307,0.00013554379,0.00016140738,0.000247569,0.0000869623],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038822353,0.000030686224,0.9956838,0.00003348265,0.00030455046,0.00020257912,0.00008603834,0.00009727531,0.0009136009,0.000052538035,0.00007909898,0.0021280851],"study_design_scores_gemma":[0.000030643914,0.000097818796,0.99854916,0.0000063865546,0.00024978,0.000216696,0.000054364566,0.0003915977,0.00018677548,0.00005085984,0.00016145845,0.0000044180524],"about_ca_topic_score_codex":0.010459408,"about_ca_topic_score_gemma":0.01116679,"teacher_disagreement_score":0.010459408,"about_ca_system_score_codex":0.00033836273,"about_ca_system_score_gemma":0.00057835184,"threshold_uncertainty_score":0.020797074},"labels":[],"label_agreement":null},{"id":"W4393094532","doi":"10.1097/fpc.0000000000000529","title":"Effect of CYP2D6 genetic variation on patient-reported symptom improvement and side effects among children and adolescents treated with amphetamines","year":2024,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Neurotransmitter Receptor Influence on Behavior","field":"Neuroscience","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Children's Hospital; University of Manitoba; University of Calgary","funders":"","keywords":"Pharmacogenetics; CYP2D6; Genetic variation; Medicine; Variation (astronomy); Pharmacology; Genetics; Biology; Genotype; Gene","score_opus":0.0059950686178924855,"score_gpt":0.24249627903422383,"score_spread":0.23650121041633135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393094532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995938,0.00011149135,0.00003128673,0.00002177581,0.0000023425205,0.0000034057412,0.000108764274,0.000001433159,0.00012569618],"genre_scores_gemma":[0.9997739,0.000034617384,0.000045598874,0.000008404206,0.0000018437768,0.0000023948126,0.00008275873,0.0000013520488,0.00004918781],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990345,0.0003914889,0.00007926638,0.00019695965,0.00020306768,0.00009470545],"domain_scores_gemma":[0.9976763,0.0008023555,0.000985888,0.00011687164,0.00017888703,0.00023979932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086864666,0.0002831376,0.00029097643,0.0004281954,0.00029233532,0.00042205985,0.0002745481,0.0004129522,0.0013930777],"category_scores_gemma":[0.0033323998,0.00017554143,0.0005802739,0.00054547185,0.00033739992,0.00016836385,0.00026342386,0.00056103896,0.000104229934],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018258537,0.000022621934,0.9986695,0.0000037550933,0.000071538634,0.00005308447,0.00006404028,0.00002057854,0.0001809445,0.0000067392016,0.000023416862,0.0007011673],"study_design_scores_gemma":[0.000005606283,0.000055619308,0.9996061,0.0000023900418,0.000024683955,0.0001195458,0.000044842243,0.00007717714,0.000031347205,0.000003569468,0.000028065577,0.0000010851414],"about_ca_topic_score_codex":0.015819965,"about_ca_topic_score_gemma":0.01806201,"teacher_disagreement_score":0.015819965,"about_ca_system_score_codex":0.00038550864,"about_ca_system_score_gemma":0.0002735547,"threshold_uncertainty_score":0.031455755},"labels":[],"label_agreement":null},{"id":"W4393164398","doi":"10.1097/fpc.0000000000000531","title":"Unraveling the genetic link: an umbrella review on HLA-B*15:02 and antiepileptic drug-induced Stevens–Johnson syndrome/toxic epidermal necrolysis","year":2024,"lang":"en","type":"review","venue":"Pharmacogenetics and Genomics","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Toxic epidermal necrolysis; Medicine; Antiepileptic drug; Drug; Dermatology; Pharmacology; Epilepsy; Psychiatry","score_opus":0.08609287012759637,"score_gpt":0.3804731871880918,"score_spread":0.29438031706049544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393164398","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003301429,0.99816555,0.00010191074,0.00071687263,0.00031501256,0.000058630445,0.00009587552,0.0000042257784,0.00021180208],"genre_scores_gemma":[0.0042347834,0.9929789,0.00047522227,0.0014655582,0.00039105484,0.00019679175,0.00011897122,0.0000041050607,0.00013469356],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99251926,0.0028752885,0.0025079572,0.00076958264,0.0010595501,0.00026834945],"domain_scores_gemma":[0.96274066,0.027664619,0.006221388,0.0006511299,0.0023869849,0.00033522316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010397229,0.0016578205,0.007597801,0.015840499,0.0006831846,0.0035051203,0.002174097,0.0029943918,0.004371946],"category_scores_gemma":[0.03624853,0.0010401029,0.0060608587,0.013767231,0.0011639228,0.0038365033,0.0022083046,0.0017345564,0.0005896422],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000197529,0.000036611254,0.0010547637,0.8935528,0.008332131,0.00017917374,0.00046475642,0.00015881668,0.0005930345,0.0012212001,0.008075421,0.08613385],"study_design_scores_gemma":[0.000095517724,0.0002384774,0.0031170207,0.8871636,0.036776684,0.00050691556,0.00036541614,0.00011621841,0.00017695571,0.0011827435,0.070220225,0.00004020478],"about_ca_topic_score_codex":0.0047339126,"about_ca_topic_score_gemma":0.009319305,"teacher_disagreement_score":0.015840499,"about_ca_system_score_codex":0.0032593375,"about_ca_system_score_gemma":0.009401992,"threshold_uncertainty_score":0.054986417},"labels":[],"label_agreement":null},{"id":"W4396229659","doi":"10.1097/fpc.0000000000000533","title":"Novel variant in Nudix hydrolase 15 gene influences 6-mercaptopurine toxicity in childhood acute lymphoblastic leukemia patients","year":2024,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Thiopurine methyltransferase; Mercaptopurine; Medicine; Pharmacogenetics; Adverse effect; Allele; Genotype; Pharmacology; Internal medicine; Gene; Oncology; Biology; Genetics; Disease; Azathioprine","score_opus":0.011548026433544507,"score_gpt":0.2776264064011444,"score_spread":0.26607837996759987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396229659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999368,0.00016551898,0.000079991754,0.000030711104,0.0000047261324,0.0000052653463,0.000112684625,0.0000041488383,0.00022893828],"genre_scores_gemma":[0.99959236,0.00005686912,0.00007906776,0.000020433386,0.0000064359565,0.0000036419237,0.00010809766,0.0000034317673,0.00012966325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99971396,0.00006227322,0.000029450759,0.0001092831,0.000041919007,0.00004305608],"domain_scores_gemma":[0.999629,0.000114207796,0.00013601201,0.000024962876,0.0000232994,0.00007241076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016485027,0.0003526813,0.000357116,0.00053145294,0.00042222725,0.00045306262,0.00021646003,0.0003964108,0.0022457084],"category_scores_gemma":[0.0007819094,0.00020370433,0.0004344261,0.00092799705,0.0002418032,0.00013683827,0.00016685567,0.00040410686,0.00019884574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050985056,0.000054724806,0.9896107,0.000018226743,0.00011227399,0.0020185772,0.00022465241,0.00010977194,0.0044393116,0.00008253591,0.00015985454,0.0026596438],"study_design_scores_gemma":[0.000029587152,0.00016454112,0.99346304,0.000009052309,0.0001318329,0.0041005365,0.0001701036,0.00037550848,0.0007710351,0.00008385525,0.0006928841,0.000008065153],"about_ca_topic_score_codex":0.004374145,"about_ca_topic_score_gemma":0.00383802,"teacher_disagreement_score":0.004374145,"about_ca_system_score_codex":0.00032942646,"about_ca_system_score_gemma":0.00026503843,"threshold_uncertainty_score":0.008697391},"labels":[],"label_agreement":null},{"id":"W4399996207","doi":"10.1097/fpc.0000000000000541","title":"Healthcare provider and patient perspectives on the implementation of pharmacogenetic-guided treatment in routine clinical practice","year":2024,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Health care; Pharmacogenetics; Test (biology); Clinical Practice; Family medicine; Clinical decision support system; Medicine","score_opus":0.15340570376545057,"score_gpt":0.5266863950790736,"score_spread":0.37328069131362296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399996207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.971199,0.0014287418,0.0011377704,0.01815981,0.000065064676,0.000048617007,0.000122036545,0.000015997242,0.007823027],"genre_scores_gemma":[0.9968663,0.0006552828,0.0006665063,0.0015419848,0.00004040599,0.000020673804,0.000034818724,0.000003897027,0.00017001177],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.97526634,0.019681202,0.0011261042,0.0005490531,0.0022481747,0.0011291744],"domain_scores_gemma":[0.9584263,0.024833968,0.010144172,0.00050128077,0.0030203983,0.0030738653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010872586,0.00015353048,0.00021863486,0.00046666965,0.001018749,0.0021558735,0.0003365645,0.0010861326,0.003147424],"category_scores_gemma":[0.03861932,0.00025279724,0.00038329654,0.00034501974,0.00093128235,0.0015014324,0.0015197861,0.0010852184,0.00028566006],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006075071,0.00065994984,0.6502338,0.0010752825,0.00023980203,0.0026246586,0.21413706,0.000517765,0.003177023,0.0017230301,0.006589622,0.11841443],"study_design_scores_gemma":[0.00016231791,0.0020102079,0.51283926,0.0017788,0.00019776,0.0051918826,0.43843392,0.0019268232,0.0017820549,0.0014319884,0.034067035,0.00017796815],"about_ca_topic_score_codex":0.0037321155,"about_ca_topic_score_gemma":0.0029610277,"teacher_disagreement_score":0.010872586,"about_ca_system_score_codex":0.0013946015,"about_ca_system_score_gemma":0.0027516165,"threshold_uncertainty_score":0.057500422},"labels":[],"label_agreement":null},{"id":"W4403968392","doi":"10.1097/fpc.0000000000000547","title":"The Pharmacogenomics Global Research Network Implementation Working Group: global collaboration to advance pharmacogenetic implementation","year":2024,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institute of General Medical Sciences; University of North Carolina at Chapel Hill; University of California, Davis; University of Montana; University of Pennsylvania Health System; University of Illinois at Urbana-Champaign; National Institutes of Health; Univerza v Ljubljani; Rijksuniversiteit Groningen; St. Jude Children's Research Hospital; University of Minnesota; University of Pennsylvania; Moffitt Cancer Center; U.S. Department of Veterans Affairs","keywords":"Pharmacogenetics; Pharmacogenomics; Workflow; Dosing; Drug response; Medicine; Drug; Computer science; Pharmacology; Biology; Genotype; Genetics","score_opus":0.12556258059787465,"score_gpt":0.5459056649859957,"score_spread":0.42034308438812107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403968392","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017336562,0.0067099794,0.062812574,0.83253473,0.015802905,0.010103168,0.0022951323,0.0012884629,0.051116508],"genre_scores_gemma":[0.14538437,0.0090412665,0.44411826,0.28949538,0.006401428,0.02222458,0.011893488,0.0018573905,0.06958383],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.889677,0.07540366,0.004384473,0.003938557,0.01308286,0.013513443],"domain_scores_gemma":[0.7443926,0.04605609,0.012849535,0.016434725,0.046244964,0.13402222],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.22735943,0.0023920212,0.0015352827,0.0024922667,0.005173063,0.011674394,0.0071734446,0.012399651,0.020401243],"category_scores_gemma":[0.10670673,0.0012949113,0.0024436645,0.002604601,0.0042799963,0.010155911,0.03898713,0.015772194,0.0066847564],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096881395,0.0026335143,0.027304647,0.0025067248,0.0004168357,0.0008040823,0.0072855856,0.0022304915,0.0030983498,0.03324856,0.49122798,0.42827445],"study_design_scores_gemma":[0.0014462472,0.0019759976,0.020053117,0.0037529154,0.00020059374,0.0004900719,0.008082275,0.0019153471,0.0024809157,0.025380094,0.93405306,0.00016940439],"about_ca_topic_score_codex":0.0075741117,"about_ca_topic_score_gemma":0.0070570353,"teacher_disagreement_score":0.22735943,"about_ca_system_score_codex":0.0070469356,"about_ca_system_score_gemma":0.19241092,"threshold_uncertainty_score":0.9528034},"labels":[],"label_agreement":null},{"id":"W4415782400","doi":"10.1097/fpc.0000000000000579","title":"Pharmacogenetic testing coverage by Canadian insurance providers","year":2025,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Children's Hospital; University of Calgary; Dalhousie University","funders":"","keywords":"Reimbursement; Test (biology); Genetic testing; Quality (philosophy); Pharmacogenetics","score_opus":0.06169952826165205,"score_gpt":0.3837315103934607,"score_spread":0.32203198213180867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415782400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8057958,0.017143281,0.0029442247,0.018026063,0.0001587878,0.00064285647,0.06471527,0.00022854217,0.09034531],"genre_scores_gemma":[0.97786194,0.005209362,0.0027545688,0.0029415935,0.0000401213,0.00012098195,0.008143546,0.000031863845,0.0028960947],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.990507,0.00095400255,0.0006782607,0.00082445744,0.0056338757,0.0014024172],"domain_scores_gemma":[0.98118687,0.0045042676,0.004436931,0.0007628027,0.0069065336,0.0022026838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051481905,0.00029613718,0.00029243538,0.0039292215,0.0026653593,0.0015314587,0.0013038452,0.00046160366,0.0044583604],"category_scores_gemma":[0.024639321,0.00029644,0.0007109494,0.0066922833,0.0008106163,0.0005601881,0.0013001845,0.0006302732,0.00020188346],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019666669,0.000042357206,0.8471399,0.00062339817,0.00019554456,0.00046051925,0.003066778,0.0006360107,0.0005649325,0.00448026,0.041834664,0.100759],"study_design_scores_gemma":[0.000038637772,0.000038386257,0.9343279,0.00092545827,0.00018120796,0.00063407107,0.0024619463,0.0015149987,0.00047919885,0.00051058334,0.05882522,0.00006243577],"about_ca_topic_score_codex":0.98506224,"about_ca_topic_score_gemma":0.9871062,"teacher_disagreement_score":0.038673338,"about_ca_system_score_codex":0.038673338,"about_ca_system_score_gemma":0.07593715,"threshold_uncertainty_score":0.28059602},"labels":[],"label_agreement":null},{"id":"W4417342758","doi":"10.1097/fpc.0000000000000590","title":"NFIB rs28379954 does not affect CYP2D6-mediated metabolism of prototypical substrates, tamoxifen or solanidine","year":2025,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Lawson Health Research Institute; Western University","funders":"Canadian Institutes of Health Research","keywords":"CYP2D6; Tamoxifen; Metabolism; Affect (linguistics); Pharmacogenetics; Metabolite; Genetic variation","score_opus":0.07339022960160214,"score_gpt":0.4154692999812545,"score_spread":0.34207907037965235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417342758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978155,0.00051066023,0.0002497703,0.000053941974,0.00001759298,0.000011065382,0.0005384858,0.0000114056875,0.00079152937],"genre_scores_gemma":[0.99920624,0.000049615373,0.00011448243,0.000032020074,0.0000067426563,0.00000954972,0.0003133863,0.0000076093297,0.00026040018],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99966466,0.00006370029,0.000047826754,0.00012526923,0.00005664978,0.00004201035],"domain_scores_gemma":[0.99961996,0.000102890495,0.00014386262,0.00005757812,0.000028143344,0.000047622812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020006592,0.0003201923,0.00041488168,0.00024276275,0.00027992445,0.00026263014,0.00021497914,0.0004964411,0.006141409],"category_scores_gemma":[0.00102013,0.000104137034,0.0006195153,0.0003020845,0.00023732372,0.00011573004,0.00011893771,0.00024484788,0.00054753723],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025311595,0.0005077483,0.5316029,0.0003039597,0.002958979,0.004701366,0.00039361708,0.00082667376,0.3977007,0.0004772461,0.0018523335,0.03336282],"study_design_scores_gemma":[0.00075954216,0.002053065,0.95864856,0.000046023302,0.0015110463,0.009643648,0.00012358763,0.0014516639,0.019218259,0.00042957085,0.0060872585,0.000027936436],"about_ca_topic_score_codex":0.0024856725,"about_ca_topic_score_gemma":0.002749252,"teacher_disagreement_score":0.006141409,"about_ca_system_score_codex":0.0002714896,"about_ca_system_score_gemma":0.00014812758,"threshold_uncertainty_score":0.020545006},"labels":[],"label_agreement":null},{"id":"W4417342762","doi":"10.1097/fpc.0000000000000585","title":"Pharmacogenetic testing versus standard prescribing of psychotropics for the treatment of severe mood disorders: A randomized controlled trial protocol","year":2025,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Randomized controlled trial; Pharmacogenetics; Protocol (science); Randomization; Mood; Mood stabilizer","score_opus":0.051505005309462754,"score_gpt":0.35439083754332573,"score_spread":0.302885832233863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417342762","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008044649,0.000609777,0.0027324038,0.00036559574,0.0006463462,0.98474914,0.0012496633,0.0002156616,0.0013868532],"genre_scores_gemma":[0.008720732,0.000230657,0.003755954,0.0002671066,0.00011588996,0.98597604,0.00018907271,0.000013859402,0.00073078787],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.97632277,0.015700122,0.0021099765,0.0023199571,0.0017056304,0.0018415645],"domain_scores_gemma":[0.98586303,0.0051157475,0.0032319757,0.0016648117,0.0022887844,0.0018356206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03048481,0.007167025,0.0114522455,0.0024648882,0.002268264,0.0034303863,0.0037623777,0.00786737,0.047530178],"category_scores_gemma":[0.029849883,0.0021701541,0.006392399,0.002936402,0.0036438464,0.0033356322,0.001933948,0.0068371594,0.008061202],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9660271,0.007192375,0.0003768625,0.006370165,0.0021801642,0.000077899196,0.00014625698,0.00087696005,0.00077532296,0.0015245845,0.004193993,0.010258208],"study_design_scores_gemma":[0.9697992,0.019021694,0.0006520038,0.0008291397,0.0010085334,0.000026078149,0.000039281036,0.0017628145,0.0003046056,0.0013298695,0.005179236,0.000047533],"about_ca_topic_score_codex":0.0016515771,"about_ca_topic_score_gemma":0.002999026,"teacher_disagreement_score":0.047530178,"about_ca_system_score_codex":0.0035787686,"about_ca_system_score_gemma":0.009829945,"threshold_uncertainty_score":0.16122103},"labels":[],"label_agreement":null},{"id":"W4417342776","doi":"10.1097/fpc.0000000000000589","title":"Effects of glutathione-S-transferase polymorphisms on intravenous busulfan in hematopoietic stem cell transplant patients: a meta-analysis","year":2025,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Glutathione Transferases and Polymorphisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Busulfan; Dosing; Pharmacogenetics; Genotype; Hematopoietic stem cell transplantation; Stem cell; Pharmacokinetics","score_opus":0.00930921782057272,"score_gpt":0.23512502857015988,"score_spread":0.22581581074958715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417342776","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022110283,0.9750312,0.0011377909,0.0003326903,0.00024228779,0.00013954651,0.0006398686,0.000042726464,0.00032352007],"genre_scores_gemma":[0.5888336,0.40481555,0.0027156665,0.000981006,0.00042334214,0.0005058445,0.0011195007,0.00006671612,0.00053873216],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9917892,0.0043162284,0.0017050651,0.0011502546,0.00074663205,0.000292527],"domain_scores_gemma":[0.98874414,0.008197992,0.001624216,0.00049352384,0.0007375364,0.0002025917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010579354,0.0033833652,0.016704727,0.004866313,0.00057780114,0.0031220615,0.0018603075,0.002499835,0.0028295373],"category_scores_gemma":[0.018660795,0.0015158433,0.062233116,0.0059169307,0.00052918255,0.001361612,0.0011905369,0.0021409062,0.00027448163],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025625797,0.000021912476,0.006622229,0.038152177,0.9471714,0.00009849088,0.00002707399,0.0009896221,0.00021679394,0.000061009272,0.0001867879,0.003890046],"study_design_scores_gemma":[0.00035785342,0.00016341948,0.0038735878,0.0023080264,0.9923084,0.000052247844,0.00001577821,0.000287931,0.000075738964,0.00009725456,0.00044864992,0.000011125598],"about_ca_topic_score_codex":0.006005924,"about_ca_topic_score_gemma":0.0076606674,"teacher_disagreement_score":0.016704727,"about_ca_system_score_codex":0.0017164013,"about_ca_system_score_gemma":0.0018158297,"threshold_uncertainty_score":0.05594963},"labels":[],"label_agreement":null},{"id":"W7118919211","doi":"10.1097/fpc.0000000000000588","title":"The role of pharmacogenomics and opioid prescribing for infants with surgical congenital heart disease","year":2025,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pediatric Pain Management Techniques","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","keywords":"Pharmacogenomics; Pharmacogenetics; Stewardship (theology); Heart disease; Precision medicine; Opioid; Exome","score_opus":0.009961526798017465,"score_gpt":0.2849085221694319,"score_spread":0.2749469953714144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7118919211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976641,0.0012936965,0.00010564014,0.00018382425,0.0000064854717,0.000002702598,0.0003342041,0.0000027522067,0.00040656945],"genre_scores_gemma":[0.9992112,0.0003680608,0.00012223725,0.000027592401,0.000009567633,0.000002251763,0.00017817908,0.0000021552225,0.00007870125],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992411,0.00023655946,0.00009605492,0.00017569566,0.0001507165,0.000099950965],"domain_scores_gemma":[0.99735415,0.00076621765,0.0014183433,0.000117069794,0.00016330191,0.00018098575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009468645,0.0002195268,0.0002377071,0.00044601446,0.00022094273,0.0005611607,0.0003151375,0.00034755483,0.0014029237],"category_scores_gemma":[0.0041531543,0.00013467879,0.0004247125,0.0007653984,0.00020638292,0.0003004055,0.0003868507,0.0004582509,0.00015024672],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002902666,0.0000053028557,0.99827766,0.0000061555866,0.000032161744,0.00008406563,0.000017430277,0.000028580514,0.00009798993,0.000013483572,0.0000329777,0.0013752023],"study_design_scores_gemma":[0.0000012461253,0.00003343956,0.9989334,0.000012601515,0.000022075108,0.0005059044,0.000054399075,0.00022448748,0.00007918446,0.000015903199,0.00011568681,0.0000016446722],"about_ca_topic_score_codex":0.0038451876,"about_ca_topic_score_gemma":0.004987234,"teacher_disagreement_score":0.0038451876,"about_ca_system_score_codex":0.00027566677,"about_ca_system_score_gemma":0.0003615261,"threshold_uncertainty_score":0.007645607},"labels":[],"label_agreement":null}]}